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Comprehensive understanding of functional elements in the human genome will require 
thorough interrogation and comparison of individual human genomes and genomic 
structures. In particular, one of the most important questions in gene expression 
regulation is how remote control of transcription regulation in a complex genome is 
organized. The Paired-End Tag (PET) strategy involves extraction of paired short tags 
from the ends of linear DNA fragments for ultra-high-throughput sequencing. In addition 
to new methods of constructing PETs, here I show a novel application of PET in 
understanding molecular interactions between distant genomic elements. Using this 
Chromatin Interaction Analysis with Paired-End Tag (ChIA-PET) sequencing method, I 
present the first-ever global estrogen receptor α-mediated human interactome chromatin 
map. I show that chromatin interactions are important in gene regulation. With its 
versatile and powerful nature, the PET sequencing strategies and the new application, 
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Chapter One: Paired-End Tag Technologies 
 
Introduction 
Genomics holds much promise for huge improvements in human healthcare. However, 
genomics faces several practical challenges. Human genomes are read out as linear 
sequences, but in the cell, there are many complex interactions and mechanisms that operate 
around human DNA to transduce DNA information into biological function (Birney et al. 
2007). Conventional DNA sequencing has been used to extensively explore genetic elements 
and structures (Birney et al. 2007); however, high sequencing costs and low throughputs have 
historically limited in-depth analysis of a broad range of genomic elements, making the 
development of new sequencing strategies necessary.  
The Paired-End Tag (PET) sequencing strategy consists of extracting paired tags 
from the two ends of DNA fragments. The target DNA fragments may come from a variety of 
sources: cDNA reverse transcribed from mRNA, ChIP enriched DNA, and randomly sheared 
genomic DNA fragments. The end signatures, or “tags”, consist of short DNA fragments 
(approximately 20-50bp) that are sequenced and mapped to the genome for accurate 
demarcations of the locations of the targeted DNA fragments in the genomic landscape.  
The PET strategy has many benefits (Table 1).  First, PET constructs can be easily 
sequenced by cheaper, massively parallel next-generation sequencing technologies. While 
these new technologies have much promise to transform biological exploration (Schuster 
2008), they have shorter read lengths than Sanger capillary sequencing instruments and hence 
cannot sequence long templates (Wold et al. 2008). PETs are short enough to fit within this 
read length and yet contain sufficient information to identify the fragment through genome 
mapping. Another benefit is the higher mapping specificity of PETs over single tags. This is 
because PETs from long source fragments can span repeat regions which would otherwise 
lead to multiple, ambiguous mappings, as well as bridge unknown DNA sequences such as 
gaps in the genome assembly. Also, sequencing quality might drop as longer stretches are 
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sequenced, such that two sequenced tags each might have higher sequencing quality than a 
single sequenced tag that is twice as long. Hence, the PET sequencing strategy can double the 
amount of high quality sequencing data that can be obtained from a single template than 
might be otherwise possible using single tags. A further benefit is the decreased costs of 
sequencing a PET as opposed to sequencing one long single tag that spans the same genomic 
distance as the two ends of a PET, while retaining information regarding the defined distance 
and relationship between the two different ends. While just one end is insufficient to 
characterize a linear structure, a linear structure can be accurately and definitively defined 
using two points on either end. A caveat is that what is inside the linear structure, such as 




 Table 1: PET technology applications for the study of genomes and 
transcriptomes. 
Application Benefits of PET Techniques and References 
General sequencing PET template is compatible with 
next-generation machines 
Higher mapping specificity of 
PETs over single tags 
Decreased sequencing costs 
Retains information regarding the 
distance and relationship between 
the ends 
Paired-End Tag (PET) (Ng et 
al. 2005; Wei et al. 2006) 
Paired End Sequencing 
(PES) (Holt et al. 2008; 
Lander et al. 2001) 
Paired End Mapping (PEM) 
(Korbel et al. 2007) 
Mate-pairs (Shendure et al. 
2005) 
Transcriptome Identify 5’ and 3’ ends of 
transcription units 
Identify alternative TSS and PAS 
Enables ultra-high-throughput 
genome-wide identification of gene 
fusion events, which is not possible 
with other methods 
GIS-PET (Ng et al. 2005) 




Epigenetic Sites  
Improved specificity and 
demarcation of fragments 
containing sites of interest 
ChIP-PET (Wei et al. 2006) 
Paired End Genomic 





genome-wide identification, which 




Paired readout of DNA sequence 
for accurate genome assembly 
Span repeats and gaps 
Enables ultra-high-throughput 
genome-wide identification of even 
small insertions, deletions and 
translocations, which is not 
possible with other methods 
Ditag Genome Scanning 
(Chen et al. 2008a) 
DNA-PET 
Paired End Mapping (PEM) 
(Korbel et al. 2007) 
Paired End Sequencing 
(PES) (Holt et al. 2008; 
Lander et al. 2001) 




PET technology has been applied to the characterization of genetic elements and 
structures (Table 1). The advantages of PETs for transcriptome characterization are the 
abilities to quantitatively detect transcripts, detect transcript start and end points 
simultaneously, and identify fusion transcripts. When applied to the characterization of 
fragmented genomic DNA of a specific size, PETs can help to identify misassemblies and 
structural variants as well as provide valuable genome sequence data. Genomic regions 
containing repeats that cannot be independently mapped can be oriented and positioned by 
their connectivity to sequence-specific regions As applied to the analysis of chromatin, PETs 
can be used to identify transcription factor binding sites and epigenetic marks, as well as 
interactions between genetic elements.  
In the future, PET technologies will continue to improve and expand to cover a 
greater range of applications in medical genomics. Eventually, PET technologies may help to 
overcome the challenges of personal genomics to make personal genomics a reality. Here, I 
provide a retrospective of the development of the PET sequencing strategy and its recent 
applications in transcriptome, epigenome, interactome and genome structure analyses. I also 
discuss the challenges faced by PET technologies. In this thesis, I propose several new 
solutions that may be offered by further developments in PET technologies, for answering 
novel biological questions.   
The development of the Paired-End Tag (PET) strategy 
The intellectual traces of the development of this PET strategy converged from two important 





Figure 1. Sequencing-based methods for understanding genetic elements in 
genomes.  
DNA fragments can be read from one end (single end) and/or both ends (paired 
end). EST was the first tag-based approach, generating one tag per sequencing 
read, used for characterizing expressed genes. The original SAGE tag was 13bp, 
and used for tagging transcripts. SAGE tags are concatenated for sequencing 
analysis with increased efficiency of 20-30 tags per sequencing read. LongSAGE 
and MPSS using MmeI as the tagging enzyme to generate 20bp tags that can be 
specifically aligned to reference genome sequences. The CAGE and 5’ SAGE 
tags are derived from the 5’ end of DNA fragments. 5’ and 3’ Long SAGE tags 
are derived from the two ends of DNA fragments, and can mark the 5’ end or 3’ 
end of the represented DNA fragments. PET combines the 5’ and 3’ signature 
tags of the same DNA fragment covalently into one ditag unit. When mapped to 
a reference genome sequence, a PET sequence can demarcate the boundaries of 
DNA elements in the genome landscape. 
 
The first straightforward description of Paired End sequencing was reported by Hong (Hong 
1981) using DNA inserts cloned into bacteriophage vectors and sequenced from both ends, 
thus reading twice as much sequencing data from long inserts. Then, in 1994, so-called 
“mate-pairs” consisting of sequencing reads from both ends of 2kb and 16 kb DNA inserts 
were used to help assemble the genome of Haemophilus influenzae, which was the first 
genome of a free-living organism to be sequenced (Fleischmann et al. 1995). Turning to 
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larger genomes, paired end sequencing was an important component of early proposals 
(Venter et al. 1996; Weber et al. 1997) and actual sequencing efforts such as the Drosophila 
genome, the public and the Celera human genome sequencing efforts (Adams et al. 2000; 
Lander et al. 2001; Myers et al. 2000; Rubin et al. 2000; Venter et al. 1998) . Later efforts to 
close up gaps in assemblies also employed paired end sequencing (Bovee et al. 2008). The 
benefits of paired end sequencing were similar to PETs, and in addition, cost savings from 
sequencing both ends of a plasmid prep rather than sequencing two single ends from two 
different plasmid preps could be substantial. Recently, many studies have employed paired 
fosmid (Kidd et al. 2008; Tuzun et al. 2005) or Bacterial Artificial Chromosome (BAC) end 
sequencing (Volik et al. 2006; Volik et al. 2003) to uncover structural variations in individual 
human genomes as well as chromosomal aberrations in cancer genomes.  However, 
conventional Paired End Sequencing requires laborious cloning and expensive sequencing as 
it typically involves two full Sanger sequencing reads per Paired End Sequence.   
 The “chromosome jumping” method introduced by Collins and Weissman in 1984 
was a novel approach that did not simply perform paired end sequencing from both ends of 
an insert, but instead first cloned the junctions formed by circularized ligation of the two 
DNA ends of large fragments, and then sequenced the junctions to reveal the two paired end 
sequences of large DNA segments (Collins et al. 1984). As this “chromosome jumping” 
method creates physical junctions between the two paired ends, it can be thought of as a 
direct precursor to later PET techniques which rely on the creation of physical junctions 
between two paired ends. The “chromosome jumping” method was designed to enable big 
“jumps” of hundreds of kilobases of DNA, as opposed to little “steps” across the genome, to 
aid positional cloning of disease genes. High molecular weight DNA was circularized under 
dilute ligation conditions to include a marker gene, such that the two ends of the DNA 
fragment were connected to the two sides of the marker gene. Digestion with another 
restriction enzyme would generate shorter DNA fragments, some of which consist of the 
junctions between the marker gene and the two DNA ends from the large fragments. These 
7 
 
shorter DNA fragments including the junction constructs were cloned into vectors for 
selection of the marker gene. Junctions containing the DNA of interest as well as DNA from 
a large jump away could be isolated and sequenced. This method was applied to efforts in 
cloning the disease gene for cystic fibrosis (Collins et al. 1987).  
Around the same time, short tag methodologies were developed to overcome the 
prohibitively high costs of sequencing. The idea behind short tags was that not all of a DNA 
fragment had to be sequenced to identify it: a sequenced short tag from a particular fragment 
could be mapped to the reference genome, thus revealing the identity of the fragment. 
Expressed Sequence Tags (EST) were the first example of the tag-based sequencing concept, 
by using single direction Sanger sequencing reads to tag cDNA sequences reverse transcribed 
from mRNA, instead of sequencing full length cDNAs (Adams et al. 1991; Milner et al. 
1983; Putney et al. 1983). Many cDNA libraries were characterized by EST sequencing, 
which led to the discovery of many genes (Adams et al. 1992) and the characterization of 
cancer transcriptomes (Brentani et al. 2003). Despite instant success and recognition, the high 
costs both in time and in resources for DNA sequencing promoted the desire to further 
shorten the sequenced tags, leading to the development of Serial Analysis of Gene Expression 
(SAGE) (Velculescu et al. 1995), and Massively Parallel Signature Sequencing (MPSS) 
(Brenner et al. 2000). In SAGE and MPSS, a special type of restriction enzyme, called a 
“tagging” enzyme, is employed. The tagging enzyme cuts DNA at a certain distance away 
from the restriction enzyme site. Examples include type IIS restriction enzymes (Velculescu 
et al. 1995). Adaptors with flanking tagging restriction enzyme sites are attached to the target 
DNA, and then libraries of short SAGE or MPSS tags are created by cutting these constructs 
with the type IIS restriction enzyme, thus resulting in a population of tags from different 
fragments (Velculescu et al. 1995). Because only short tags which represent a complete RNA 
fragment need to be sequenced as opposed Expressed Sequence Tags (ESTs) (Adams et al. 
1991), the costs of sequencing SAGE tags to a depth necessary to adequately characterize 
transcriptomes are much lower than EST, and in turn flcDNA experiments. LongSAGE 
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featured the type IIS restriction enzyme, MmeI, that can cut DNA 18/20bp downstream of its 
recognition site, to produce 20bp SAGE tags, and was used for de novo identification of 
expressed genes (Saha et al. 2002). By contrast, the original SAGE method used enzymes that 
cut shorter tags, which often could not be mapped uniquely to the genome. The SuperSAGE 
method, introduced later, used the type III restriction enzyme, EcoP15I, which cuts 25/27bp 
downstream of its recognition site, allowing for the extraction of even longer SAGE tags 
(Matsumura et al. 2003). However, EcoP15I only cleaves head-to-head orientated recognition 
sites in supercoiled DNA, and does not turnover (Raghavendra et al. 2005). However, 
recently, it has been shown that the incorporation of sinefungin into EcoP15I allows cleavage 
at all recognition sites regardless of DNA topology (Raghavendra et al. 2005). In addition, 
prior methylation of EcoP15I sites within the target sequences prevents these internal 
EcoP15I sites from being cut and thus reducing the effective concentration of EcoP15I in the 
reaction. Taken together, these new results show promise in making EcoP15I a useful 
laboratory tool. The 27bp tags generated by this enzyme will be very useful for improving 
short tag mapping rates and mapping accuracies.  
Besides extracting tags near the 3’ side of cDNA fragments, SAGE and MPSS 
methods have been used in many other applications, including digital karyotyping (Dunn et 
al. 2002; Wang et al. 2002), mapping ChIP-enriched DNA fragments to identify transcription 
factor binding sites (Bhinge et al. 2007; Kim et al. 2005), and DNAseI-digested DNA to 
identify DNAseI-hypersensitive sites (DACS) (Sabo et al. 2004a; Sabo et al. 2004b). In order 
to characterize 5’ transcription start sites and hence identify gene promoters, Cap Analysis of 
Gene Expression (CAGE) was introduced based on the Cap-trapper method (Carninci et al. 
1999) to retain 5’ intact transcripts for cDNA synthesis with modified linkers containing the 
type IIS restriction enzyme recognition sequence at the 5’ ends, followed by enzymatic 
digestion and the standard LongSAGE method on these 5’ CAGE tags (Shiraki et al. 2003). 
Two other groups (Hashimoto et al. 2004; Wei et al. 2004) also independently developed 
similar approaches such as 5’LongSAGE to map transcription start sites and infer the 
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locations of gene promoters. In addition, the companion 3’LongSAGE method was 
simultaneously developed, so as to map both 5’ transcription start sites and the exact 3’ 
polyadenylation sites to define the boundaries of expressed genes using two end tags as 
opposed to a single tag (Wei et al. 2004). Expanding from such a capacity, the Paired-End 
Tag (PET) method that covalently links the 5’ tag and 3’ tag of a DNA fragment into a ditag 
structure for cost-efficient sequencing analysis of linked structures was then developed (Ng et 
al. 2005).  
Construction of PET structures 
Construction of a PET structure is necessary because many next generation technologies are 
only compatible with short templates in specific formats. Hence, libraries need to be prepared 
which covalently link the two DNA ends to each other, remove the rest of the DNA, and 
adapters containing priming sites for universal primers need to be incorporated into the PET 




Figure 2. Schematic view of PET methodology.  
The PET concept is the extraction of paired end signatures from the ends of 
target DNA fragments. These end signatures, or “tags” are short DNA fragments 
that are sequenced and mapped to the genome for the accurate demarcations of 
the locations of the targeted DNA fragments in the genomic landscape. The PET 
method may be carried out through cloning-based or cloning-free procedures. 
The PET structures may be analyzed through high-throughput sequencing of 
clones containing concatemers of tags using conventional Sanger capillary 
sequencing instruments or diPET constructs using 454 GS20/GS FLX or single 
PET constructs using Illumina GA/GAII and ABI SOLiD. The sequenced PETs 
























The original PET method was a “cloning-based” approach: it used plasmid vectors to link 5’ 
and 3’ tags. It was implemented as Gene Identification Signature analysis using PETs (GIS-
PET) for studying transcriptomes, in which the starting mRNA was converted into full-length 
cDNA with flanking adaptor sequences containing MmeI restriction sides immediately next 
to both cDNA ends. The full-length cDNA fragments were then ligated to linearized 
plasmids, and transformed into Escherichia coli (E. coli) cells as a full-length cDNA library. 
The purified plasmids of this full-length cDNA library are then digested with MmeI, which 
cuts into the cDNA insert to result in two 18/20bp tags attached to the vector backbone. The 
tag-vector-tag structures are gel-purified and re-circularized under intra-molecular ligation 
conditions, so that the two tags are joined covalently. The resulting single PET library can be 
amplified in bacteria cells and the PET constructs are then excised by a restriction digestion 
from purified PET library plasmids (Ng et al. 2007). A similar strategy was applied to 
characterize ChIP enriched DNA fragments for genome-wide identification of transcription 
factor binding sites in human cancer cell genomes (Wei et al. 2006) and mouse embryonic 
stem cell genomes (Loh et al. 2006).  The strategy has been since extended to epigenetic 
modifications (Dunn et al. 2007; Zhao et al. 2007).   
 We and others (Shendure et al., 2005) developed a linker-based methodology (further 
described in Chapters 3 and 4). This methodology involves direct circularization of the target 
DNA fragments with linker oligonucleotides that covalently join the two ends of a DNA 
fragment. As the linker sequence linker sequence is typically designed to contain two MmeI 
or EcoP15I sites flanking the two ends of the circularized DNA fragment, restriction 
digestion with these enzymes would release the tag–linker–tag structure for sequencing. This 
strategy was first demonstrated in resequencing an E. coli genome using the polony 
sequencing method (Shendure et al., 2005). Besides tagging enzymes such as MmeI and 
EcoP15I that generate uniform sizes (18/20 bp and 25/27 bp) of PET constructs for easy 
manipulation, frequently cutting restriction enzymes and physical shearing by nebulization 
are also choices for generating randomly sized tag–linker–tag constructs. As reported (Korbel 
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et al., 2007), circularized DNA was randomly sheared by nebulization, and the fragments 
with biotinylated linkers were isolated using streptavidin. This method produces tags with a 
median size of 106 bp and is very useful for obtaining long tags because no type IIS or III 
restriction enzyme is currently known to produce tags more than 30 bp; however, many PETs 
prepared this way are unbalanced with tags of lengths under 15 bp, which would mean that 
these sequences would have to be discarded. 
 A benefit of the cloning-based method is that it preserves the original full-length 
cDNA or ChIP DNA fragments in a sustainable format of library clones. However, the 
construction process is long (2-4 weeks) and can be technically challenging. By contrast, the 
cloning-free method is rather straightforward and can avoid many biases related to cloning. In 
both cases, care needs to be taken to ensure that every step is done efficiently and accurately, 
such that the resulting libraries are accurate and of high complexity. If the library has low 
complexity, which might happen if too many PCR cycles are used to amplify the DNA, many 
redundant sequencing reads will be obtained.   
   
Sequencing analysis of PET constructs 
Here I review the multiple sequencing options for PET constructs (Figure 2), focusing on the 
specific method and benefits of each sequencing technology (Holt et al. 2008) with respect to 
PET sequencing. 
PETs can be sequenced by Sanger sequencing. PETs can be concatenated into long 
stretches of DNA followed by cloning into a sequencing vector. An average Sanger 
sequencing read of several hundred base pairs would read out 20-30 PETs. This 
concatenation sequencing strategy was applied to PET sequencing with great success, 
demonstrating the value of PETs for transcriptome analysis (Ng et al. 2005) and genome 
functional analysis (Loh et al. 2006; Wei et al. 2006). However, the costs of conducting PET 
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experiments were still relatively high due to the high costs involved in DNA sequencing 
using conventional sequencing platforms.  
 One of the first successful next-generation sequencing methods was published in 
2005 (Margulies et al. 2005) by 454 Corporation. In 2006, when it was first introduced to the 
research community, the GS20 instrument could generate about 200,000 sequence reads with 
average read lengths of approximately 100bp. It was straightforward to sequence single PET 
templates of about 40 bp with 454/Roche pyrosequencing. However, such an approach cannot 
fully utilize the sequencing capacity of each GS20 read; hence, we conceived a one-step 
ligation method to allow two units of PET constructs ligate to one another and to form a 
diPET template that is approximately 80 bp, perfectly fitting within the read length of the 
GS20 pyrosequencer. Using this approach we instantly doubled the output of GS20 for PET 
sequencing (Ng et al. 2006a). A single run of diPET templates in 4-hour of GS20 machine 
time can generate half a million PET sequences. This advance represented an immediate 100-
fold increase in efficiency for PET sequencing when compared to the use of Sanger 
sequencing method to read PET concatemer clones which requires more than a month (Ng et 
al. 2006a).  
 Towards the end of 2006, the Illumina Genome Analyzer (GA) sequencing machine 
was introduced to the market. The most impressive feature of this method is its massively 
parallel capacity for reading up to 80 million DNA template clusters simultaneously, even 
though it reads only approximately 36-50bp from each template (Barski et al. 2007; Johnson 
et al. 2007). There are three ways to use the Illumina platform to obtain PET information. 
First, a PET construct can be read from both directions, one at a time, to cover the two tags in 
a PET construct, respectively. One strand of the PET template is read from one direction, the 
second strand is synthesized in situ to replace the first strand, and then read from another 
direction. The second way is simply to sequence the entire length of the PET construct using 
the improved GAII’s maximum read length of 50 bp. A third way is to bypass the 
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construction of the PET, and simply sequence paired ends from the DNA of interest using the 
two directional sequencing method wherein one strand of a template of less than 1 kb is read 
from one end to give one tag, and then the second strand is synthesized in situ to replace the 
first strand, and then read from another direction to give the second paired tag (Campbell et 
al. 2008). This last method requires the least effort in constructing the library, but is limited to 
the analysis of short DNA fragments. Bridging repeats and gaps is difficult using short DNA 
fragments. 
 SOLiD is another massively parallel short tag sequencing platform introduced in late 
2007 by Applied Biosystems. This sequencing platform was adapted from the polony 
ligation-based sequencing method (Shendure et al. 2005). The current version of SOLiD is 
designed for paired end sequencing, and can read about 200 million tags for 25bp from each 
end per machine run in two weeks of time.   
After sequencing, the PETs have to be mapped to a suitable reference genome 
(Figure 2). The millions of PET sequences generated from each machine run have imposed 
immense challenges on how to efficiently process the data and accurately map the PET 
sequences to reference genomes. The companies that are developing the new sequencing 
technologies have been also developing software for base calling and tag mapping. More 
efforts in this area would be expected from end users as well as bioinformatics-based 
companies. To process PET sequences specifically, we developed PET-Tool, a user-friendly 
software package that does all steps, from PET extraction from raw sequence reads, to 
mapping the PET sequences to reference genomes, as well as provide a management system 
for hosting different PET experimental datasets (Chiu et al. 2006). PET-Tool maps efficiently 
using compressed suffix arrays , such that searching the human genome is within the 
capabilities of personal computers (Hon et al. 2007). A different method was described by 
Korbel et al., which uses a fleet of over 400 multiple processors employing Megablast in the 
first pass analysis and then the Smith-Waterman sequence alignment methods for further 
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refinement (Korbel et al. 2007). Roche/454 GSFLX has developed its own de novo genome 
assembler (GS de novo assembler) and mapping algorithm (GS reference mapper) which are 
capable of taking a combination of Sanger long reads, 454 shotgun and paired end reads to 
generate contigs and scaffolds or map to a reference genome. ELAND (Efficient Large-Scale 
Alignment of Nucleotide Databases) and SXOligoSearch (http://www.synamatix.com) were 
developed by Illumina and Synamatix for aligning Illumina short tag reads to mammalian 
genomes quickly and accurately. These different methods use the same stringency (up to 2 
mismatches), and closely agree in terms of performance and time. Furthermore, Illumina and 
SOLiD have now independently developed pair end analysis pipelines for analyzing PETs 
based on their mapping coordinates and orientations. 
In summary, the steps of the PET technique have been well developed, from PET 
construction to sequencing and data analysis. In the following sections, we review the 
applications of the PET technology in genome analysis and future perspectives (Figure 3).  
 
Figure 3. PET applications to address genome biology questions.  
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The cell has many different mechanisms for modifying, controlling, and 
transducing information encoded in the genome. The PET technology can be 
applied to investigate many questions regarding nuclear processes, such as 
transcriptomes, transcription factor binding sites, epigenetic modification sites, 
long range chromatin interactions, regulation mechanisms in 3-dimensional 
spaces, and genome structural variants (SVs). Examples of PET data from GIS-
PET, ChIP-PET and ChIA-PET experiments of human breast cancer MCF-7 
cells with estrogen induction treatment at the TFF1 locus (chr21:42,653,000-
42,673,000) are shown: the high level of expression of the TFF1 gene and the 
low level of expression of the TMPRSS3 gene, the ERα binding at the TFF1 
promoter sites and enhancer site, and the interaction of these two ERα binding 
sites. An example of DNA-PET data at the TNFRSF14 locus in the genome of 
MCF-7 cells shows an inversion event detected by two clusters of discordant 
DNA-PET mapping. 
 
Insights from PET applications to transcriptome studies 
Transcriptome studies include understanding gene structures encoded in the genome and gene 
transcription dynamics (Figure 3). The structural elements of genes include exons, introns, 
transcription start sites (TSS), polyadenylation sites (PAS) and transcription end sites. The 
gold standard for uncovering gene structure is the use of flcDNA sequencing to obtain 
complete gene structure information (Carninci et al. 1999). However, this is a very expensive 
and laborious approach. Whole genome tiling arrays have proved effective for identifying 
exons and measuring transcription dynamics (Birney et al. 2007; Kapranov et al. 2002); 
however arrays can be ambiguous in defining the exact boundaries of transcription units 
particularly in gene dense regions, because arrays lack connectivity information between 
exons identified by array hybridization. Mono-tag based approaches such as CAGE or 
5’SAGE are effective in defining and quantifying alternative usage of transcription start sites, 
but only transcription start sites and no other aspects of gene structure (Hashimoto et al. 
2004; Shiraki et al. 2003). Recently, shotgun sequencing of transcripts (RNA-Seq) has been 
used to profile genes, and has generated an unprecedented wealth of information about gene 
structures, particularly alternative splicing (Marioni et al. 2008; Morin et al. 2008; Mortazavi 
et al. 2008; Nagalakshmi et al. 2008; Sultan et al. 2008; Wilhelm et al. 2008). However, as 
RNA-Seq requires many reads to characterize a transcript, it is rather expensive, even with 
the use of next-generation sequencing methods.  
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By contrast, the GIS-PET approach is a high-throughput method most suited for 
efficiently demarcating the boundaries of transcription units and defining transcription start 
sites and polyadenylation sites (Figure 3). The GIS-PET method is uniquely able to detect 
unconventional fusion genes because GIS-PET reads out the sequences of paired 5’ and 3’ 
ends from the same transcript, thereby delineating the relationship between two ends of the 
mRNA transcript. Human cancer cell lines are known to contain extensive chromosomal 
aberrations. Fusion genes created through chromosomal rearrangements could play roles in 
oncogenesis. Several successful diagnostic methods and therapies target fusion gene products 
(Mitelman et al. 2007); for example, Gleevec targets the BCR/ABL fusion in chronic 
myelogenous leukemia (Mauro et al. 2002). Although GIS-PET is very efficient and accurate 
in identifying the first and last exons of transcription units, an obvious limitation is that it 
does not generate information regarding internal exons. GIS-PET is therefore a 
complementary tool to tiling array RNA data and RNA-Seq.        
In GIS-PET, flcDNA is prepared using the PET method: the capped 5’ ends and the 
polyA-tailed 3’ ends are captured in a pairwise manner by 20bp signature tags, and these 
paired end sequences may then be mapped to the genome, allowing the complete 
transcriptional unit to be inferred from the genome sequence in between the paired 5’ and 3’ 
tags. GIS-PET is designed to contain a residual AA dinucleotide from the mRNA polyA tail 
that indicates the orientation of the PET. In the Gene Scanning CAGE variant (GSC-PET), 
the PET sequences are generated from normalized flcDNA libraries in which highly abundant 
cDNA clones are removed, thus enriching for rarer clones, and hence allowing for more 
efficient discovery of rare genes (Carninci et al. 2005).  
              GIS-PET has been applied to the studies of transcriptomes in E14 mouse embryonic 
stem cells (Ng et al. 2005), various mouse tissues as part of the FANTOM3 project (Carninci 
et al. 2005), and a number of human cells as part of the ENCODE project (Consortium 2004). 
Many isoforms of transcripts with alternative transcription start sites and polyadenylation 
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sites were characterized, and large numbers of novel transcription units were identified. From 
E14 mouse embryonic stem cells, a trans-splicing fusion mRNA between Ppp2r4 and Set was 
found, in which the first exon of Ppp2r4 was joined to the second exon of Set. This fusion 
gene is preferentially expressed in embryonic as opposed to adult tissues, and the fusion gene 
might encode a new functional protein, suggesting that the fusion might play a role in early 
development in mice (Ng et al. 2005). Additionally, two human cancer cell lines, MCF-7 
(breast cancer) and HCT116 (colon cancer), were characterized with GIS-PET to understand 
unconventional fusion transcripts in cancer cells (Ruan et al. 2007). From an analysis of 
865,000 GIS-PETs from MCF-7 and HCT-116, 70 fusion genes were found including a 
fusion between BCAS3/BCAS4 that had been previously identified in MCF-7 cells. Other 
fusion genes identified and validated by RT-PCR included CXorf15/SYAP1 and 
RPS6KB1/TMEM49 (Ruan et al. 2007). Interestingly, SYAP1 has been implicated in 
chemotherapy response (Al-Dhaheri et al. 2006), and RPS6KB1 is an oncogenic marker (van 
der Hage et al. 2004), suggesting a possible role for these fusion genes in cancer progression.  
In conclusion, GIS-PET is the most efficient and accurate approach to demarcate the 
boundaries of transcription units of genes and complements other methods for transcriptome 
studies. The most unique benefit of GIS-PET is that it is the only efficient system for large 
scale investigations of unconventional fusion gene transcripts. A large scale GIS-PET 
program to investigate unconventional fusion gene transcripts could lead discovery of new 
candidates as biomarkers for diagnostic and therapeutic options. 
Insights from PET applications to genome structure analysis 
Genomes are variable at both nucleotide level and large structural levels (Figure 3). Genome 
variations at nucleotide level such as SNPs and mutations are well understood to have 
functional roles in normal traits and diseases (Shastry 2007). However, our understanding of 
large structural variations in the human genomes is very limited. SAGE-based digital 
karyotyping (Dunn et al. 2002; Wang et al. 2002) and array comparative genomic 
hybridization (a-CGH) (Pinkel et al. 1998) have contributed to this field by identifying large 
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chunks of deletions and assessing copy numbers of amplified regions in disease genome 
compared to normal or reference genome. However, both the mono-tag based sequencing 
approach and a-CGH cannot identify balanced structural variations such as insertions, 
inversions, and translocations in genome rearrangement. Although paired end sequencing of 
large genomic DNA inserts in fosmid and BAC clones using conventional sequencing 
technique have been used to generate highly valuable information regarding human genome 
structural variations (Kidd et al. 2008; Tuzun et al. 2005), the costs of such efforts is 
prohibitive.  
DNA-PET is an ideal method for sequencing and assembling genomes as well as 
studying genome structural variations (Korbel et al. 2007). DNA-PET provides linked 5’ and 
3’ tag sequences from genomic DNA fragments of specific sizes, for example, 400bp 
(Campbell et al. 2008) or 3 kb (Korbel et al. 2007) (Figure 3). To accomplish this, genomic 
DNA is sheared by nebulization and purified to a specific size range. Paired end 5’ and 3’ 
tags are then obtained from the genomic DNA fragments, which are then sequenced and 
mapped to the reference genome sequence to infer the size of DNA fragments. Most PET 
sequences would match well to the reference genome with correct orientation and specific 
size range. PETs with discordant mapping orientation and distance between the two tags 
would be located at the breakpoints of structural variations between the reference genome and 
the genome under study.  
The DNA-PET method was first demonstrated in resequencing an evolved E. coli 
genome using the polony sequencing-by-ligation method (Shendure et al. 2005). The early 
polony sequencing method was very limited in terms of tag lengths (6-7 bp), but because a 
PET structure contains 4 different places for sequencing to begin (1 end from the left, 2 ends 
from the center linker region, and 1 end from the right), the PET structure allowed for the 
acquisition of approximately 26 bp per amplicon. In addition to high PET mapping accuracy, 
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Shendure et al. found nucleotide changes and genomic rearrangements that had been 
engineered into the sequenced genome (Shendure et al. 2005).  
 In an effort to study human genomic structural variation  (Korbel et al. 2007), 
genomic DNA from an African and a European individual were sheared into 3 kb fragments, 
PETs of the DNA fragments were sequenced by 454/Roche, and the PET sequences were 
mapped to the reference human genome. Simple deletions were predicted from PET mapped 
spans that were much larger than 3 kb, and simple insertions were predicted from PET 
mapped spans that were much shorter than 3 kb, while inversions were predicted from altered 
end orientations. More complex structural variations were also found from PET mapping 
patterns that did not match expected mapping patterns. Through this analysis, 1,297 structural 
variations were found. 45% of structural variations were shared between the two individuals, 
suggesting that some structural variations might be common. Hotspots of structural variations 
were found, which turned out to be regions that have been found to be involved in genomic 
disorders. Additionally, many structural variations could affect gene functioning by either 
removing exons, creating gene fusions, being present in introns, altering gene orientation, or 
by amplifying the genes. Interestingly, genes with protein products that were associated with 
interactions with the environment contained more structural variants than expected by chance 
(Korbel et al. 2007). This observation suggests a possible role for differences in these genes 
in order to cope with differences in environments. 
 The DNA-PET approach has also been applied to map cancer genome variations 
(Campbell et al. 2008). The authors took an even simpler approach to generate PET 
sequences from two cancer cell line genomes, in genomic DNA was sheared to an average 
size of 200 bp, isolated, and 29-36bp at either end were sequenced by Illumina paired end 
sequencing methods. About 7 million PET sequences from each of the two cell lines were 
uniquely mapped to reference genome and more than 400 rearrangements were identified to 
base pair resolution. Because of the high density of the tag sequence data, accurate copy 
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numbers of amplified regions in the human cancer genome were also obtained. Further 
analysis of the data allowed the authors to identify 103 somatic rearrangements and 306 
germline structural variations. It has suggested that many somatic variations are associated 
with amplicon regions of the genome, while most germline rearrangements are mediated by 
retrotransposition elements such as AluY and Line. This work demonstrates the feasibility of 
systematic genome-wide efforts to characterize the architecture of complex human cancer 
genomes. It should be noted that the authors had to discard 48% of the sequenced reads as 
they did not map to the reference genome. These results suggest that inefficiencies in the 
library construction steps, or the new Illumina Paired End sequencing method, reduced the 
amount of data that might otherwise have been obtained from the sequencing run. Moreover, 
of the reads that did map well, the authors excluded 38% because they precisely duplicated 
other sequences from the same library. The authors suggest that these sequences might have 
been preferentially amplified during the PCR step. Increased amounts of starting genomic 
DNA, reduction in the number of PCR cycles used, and PCR amplification of the entire 
ligation mix as opposed to a small aliquot, are measures that could increase the complexity of 
the resulting library. In addition, care should be taken during library preparation such that all 
steps go to completion, to ensure that the resulting library is of high quality.   
 Recently, a variation of DNA-PET called Ditag Genome Scanning (DGS) used 
restriction enzymes to digest the genomic DNA instead of shearing. As a proof of principle, 
Chen et al. applied this method to the study of normal human GM15510 and human leukemia 
Kasumi-1 DNA, and demonstrated that DGS could uncover DNA fragments that vary from 
the reference human genome sequences (Chen et al. 2008a). The use of restriction enzymes 
has the advantage of higher mapping rates as well as faster mapping times (minutes on a 
regular desktop computer) because a smaller database consisting of sequences near the 
particular restriction enzyme site can be used as a reference (Chen et al. 2008a). However, a 
limitation is that structural variants or regions of the genome that are not near any restriction 
enzyme sites cannot be analyzed. Multiple libraries may be constructed using different 
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restriction enzymes to circumvent this problem, but this approach also increases the 
laboriousness of the procedure.  
The power of connectivity provided by DNA-PET may be used to facilitate the 
assembly of whole genome shotgun sequence reads for de novo genome sequencing and 
resequencing. With the current dramatic increase of DNA sequencing capacity, getting 
enough coverage of shotgun reads is no longer a serious issue. Using the massively parallel 
short tag sequencing platforms, 10-20X fold base-pair coverage of a human genome can be 
generated with a fairly small budget and within weeks. However, assembling such short tag 
sequences alone would result in large numbers of contigs that cannot be joined up with each 
other. The real challenge is how to connect and orientate these contigs into the complete 
assembly of a complex genome such as the human genome. DNA-PET experiments 
(Campbell et al. 2008; Korbel et al. 2007) and computer simulations (Shendure et al. 2005) 
suggest that short tag (20-30bp) PET sequences could be used for de novo complex genome 
sequencing.  
A critical aspect in developing such a DNA-PET based strategy is the construction of 
PETs for large DNA insert fragments, such as 10 kb or even 100 kb fragments. One reason 
for this is that mammalian genomes have many repeat elements that are greater than 3 kb 
long. PETs that are longer than the repeat element length are needed to assemble fragments, 
by crossing over the repeated elements. Another reason is that longer DNA fragments will 
enable the discovery of insertions and translocation events greater than 3 kb, which is the 
upper limit of the current DNA-PET approaches. In our lab, we are able to generate PET 
sequences from up to 15Kb genomic DNA inserts. Our preliminary data shows that large 
insert DNA-PET is clearly better than short insert DNA-PET, because large insert DNA-PET 
gives higher physical coverage.  In silico analyses support this finding: as the length of the 
insert DNA increases, the physical coverage increases, and hence the probability of detecting 
a fusion point increases (Bashir et al. 2008). With these improvements, the DNA-PET 
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method combined with ultra-high-throughput sequencing platforms will become a very 
powerful strategy for de novo genome sequencing and individual genome resequencing. Just 
as the human genome sequencing experiments were performed with paired end sequences 
from inserts of multiple sizes, a combination of multiple DNA-PET sizes could be useful in 
resequencing the human genome as well as in de novo sequencing. Small structural variants 
might be detected and small repeats might be crossed using 10 kb DNA-PET approaches, and 
large structural variants might be detected and large repeats might be crossed using 100 kb 
DNA-PET approaches. If this strategy proves successful, this development in DNA-PET will 
pave the way for personal genomic approaches to resequence many individual human 
genomes. 
In conclusion, the DNA-PET strategy for genome structure analysis has immediate 
value and long term promise. Already, DNA-PET with the current sequencing capacity can 
provide comprehensive characterizations of human structural variations associated with 
genetic diseases. Further development of DNA-PET with improved speeds, reduced costs, 
and the ability to use clinical samples would create a new digital cytogenetics platform for 
clinical implementation. In the long term, DNA-PET can become a vital part in the concept of 
personal genomics for personal medicine. 
Insights from PET applications to identify regulatory and epigenetic elements 
Besides gene coding sequences, genomes contain many non-coding elements that have 
important regulatory functions through interaction with protein factors (Figure 3). Thus, 
mapping protein factor binding sites in the genome is an important starting point for 
understanding regulatory circuits. The traditional mainstream approach for mapping such 
protein/DNA interactions is ChIP-chip, a method in which chromatin is formaldehyde-fixed, 
sonicated to randomly fragment the DNA, and enriched for desired protein target regions by 
Chromatin ImmunoPrecipitation (ChIP). The enriched DNA fragments are then detected by 
whole genome microarray (chip) hybridization (Ren et al. 2000). Although ChIP-chip has had 
phenomenal success, array-based detection methods are limited to partial genome coverage 
24 
 
using tiled probes with gaps in between probes, and repeats and unhybridizable regions left 
out.  
 ChIP-PET represents the first serious sequencing-based alternative approach to 
characterize ChIP enriched DNA fragments (Wei et al. 2006) (Figure 3). The ChIP-PET 
method provides linked 5’ and 3’ sequences for ChIP-enriched DNA molecules, which are 
mapped to the genome such that the complete ChIP DNA fragment can be inferred from the 
genome sequence in between the 5’ and 3’ tags, and transcription factor binding sites can be 
determined. ChIP-PET analysis depends on several principles. First, as the chromatin is 
sonicated, the probability of generating exactly identical DNA fragments is low; hence any 
redundant PETs are considered to be copies amplified during the cloning and/or PCR 
amplification processes. Therefore, only nonredundant distinct PETs are used for further 
analysis. Next, while ChIP enriches for transcription factor binding sites, there is still a lot of 
non-specific noise in the ChIP DNA, as a result of nonspecific antibody binding. Hence, the 
“multiple overlaps” concept is used to distinguish true signals from noise. The principle of 
this concept is that we expect PETs derived from nonspecific fragments to be randomly 
distributed in the genome as background PETs, whereas PETs derived from the same ChIP-
enriched transcription factor binding site will overlap with each other to form a cluster of 
PETs. The region of maximum PET overlap in this PET cluster is taken to define the 
transcription factor binding site at base pair level resolution (Wei et al. 2006). Further, some 
cell lines have amplified regions in their genomes as compared with the reference human 
genome. Amplified regions would be sequenced more and hence some amplified regions 
might be mistaken for binding sites when the sequenced enrichment is due to genome 
amplification rather than ChIP enrichment. Thus, a method was developed for making 
corrections on the basis of the numbers of non-specific fragment noise PETs (Lin et al. 2007). 
The ChIP-PET method was used to examine p53 transcription factor binding sites in 
HCT116 colon cancer cells, and found 542 high confidence binding sites (Wei et al. 2006). 
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Over 99% of these high confidence binding sites could be verified by ChIP-qPCR validation 
experiments, and PET-defined binding regions could be narrowed down to as little as 10 bp. 
These binding sites are clinically relevant to p53-dependent pathways in primary cancer 
samples. Interestingly, in addition to 5’ promoter proximal regions of genes, many 
transcription factor binding sites can be found in gene introns, 3’ ends of genes, and also far 
away from any genes. However, no transcription factor binding sites were found in exons. 
This observation is statistically significant, and not due to random chance (Wei et al. 2006). 
ChIP-PET was then used to map whole genome binding profiles for a number of important 
transcription factors, including Oct4 and Nanog (Loh et al. 2006), cMyc (Zeller et al. 2006); 
ERα (Lin et al. 2007); and NF-KB (Lim et al. 2007). We also applied ChIP-PET to map 
epigenetic marks for epigenomic profiles of histone modifications in human embryonic stem 
cells (Zhao et al. 2007).  
Recently, a similar method called Paired End Genomic Signature Tags (PE-GST) has 
been independently developed. It has been used to identify transcription factor binding sites 
in a similar manner as ChIP-PET, as well as DNA methylation patterns (Dunn et al. 2007). 
Cancer cells exhibit aberrant methylation, and further understanding of cellular methylomes 
could help in the development of new diagnostic and treatment modalities (Feinberg et al. 
2006). To investigate 5’ methylation of cytosine in CpG dinucleotides, Dunn et al. describe a 
method involving the digestion of genomic DNA using MseI, which cuts rarely in CpG 
islands. Following this, DNA containing methylated cytosines is enriched by affinity 
purification, and these fragments are then subjected to the PE-GST procedure (Dunn et al. 
2007). Alternatively, the genomic DNA may be digested with SmaI, a methylation-sensitive 
restriction enzyme which only cleaves unmethylated CpG islands present in its recognition 
sequence (Toyota et al. 2002). These fragments are then subjected to the PE-GST procedure 
(Dunn et al. 2007).  
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Comparisons of binding sites found by ChIP-chip and ChIP-PET technologies have 
concluded that both methods agree well on strong binding sites. However, there is less 
overlap with respect to weak binding sites, and ChIP-chip and ChIP-PET are frequently 
complementary in being able to detect true binding sites that the other method misses 
(Euskirchen et al. 2007). Microarrays do not typically include sequences with repeats; 
however, many true binding sites contain repeats, which will be missed by ChIP-chip 
methods (Euskirchen et al. 2007). There is a conceptual disadvantage of ChIP-PET that it has 
to read out all the non-specific sequence noise to identify true binding signals. Even in the 
best ChIP experiments, the majority of sequences in a library are non-specific. However, the 
ChIP sequence noise can also be useful. As ChIP fragments are randomly sampled from the 
genomes of the cells under investigation, a ChIP-PET experiment does not only generate a 
global map of transcription factor binding sites, but can also provide enough tag sequences 
for digital karyotyping of the genome (Dunn et al. 2002; Wang et al. 2002). Such an approach 
can be used to understand copy number variations in the cell genomes (Lin et al. 2007).  
The arrival of next-generation sequencing is critical to further advance the 
sequencing-based measurement of ChIP DNA. The 454 sequencing platform has been used 
for ChIP-PET sequencing (Ng et al. 2006a), particularly with regards to the characterization 
of epigenomic profiles of histone modifications in mouse embryonic stem cells (Zhao et al. 
2007). Recently, the ChIP sequencing strategy has been further extended by taking the 
advantage of the Illumina sequencing platform.  In this new ChIP-Seq method, randomly 
sheared ChIP DNA is ligated to adaptors, and optionally amplified by PCR. A narrow size 
range, for example 200-300 bp, is gel-excised and sent for single direction Illumina 
sequencing. Many ChIP experiments yield very little DNA, therefore the low sample amount 
requirements of Illumina (10 ng), combined with high-throughput and low cost, make this 
option very attractive. ChIP-Seq has been used to generate exciting results in mapping 
histone modifications, transcription factor binding sites, and other DNA binding proteins 
(Barski et al. 2007; Chen et al. 2008b; Johnson et al. 2007). Even more recently, Illumina has 
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developed a Paired End sequencing method, which can be used to sequence PETs from the 5’ 
and 3’ ends of adaptor-ligated and gel-excised ChIP DNA, instead of only single tags. The 
PETs that define the two ends will then unambiguously infer the genome sequence content of 
ChIP DNA fragments. Collectively, ChIP-PET and ChIP-Seq powered by Illumina and other 
massively parallel short tag sequencing platforms have generated and will continue to 
generate valuable maps of protein factors interacting with genomic DNA in the genomic 
landscape. From these analyses, general pictures of transcription factor binding have started 
to emerge. Many transcription factors show complex binding patterns with relation to target 
genes (including p53 (Wei et al. 2006), Oct4 and Nanog (Loh et al. 2006), cMyc (Zeller et al. 
2006); ERα (Lin et al. 2007); and NF-KB (Lim et al. 2007)). Many transcription factor 
binding sites are far away from transcription start sites and the promoters of target genes. 
How remote transcription factor binding sites function, if at all, is still largely unknown.      
New developments in PET technology 
The unique feature of building connectivity between two points of DNA from linear and non-
linear structures in PET analysis has tremendous value in many aspects of genomic analysis 
that cannot be simply and easily replaced by just improving sequencing capacity in near 
future. The PET concept is versatile allowing for ready adaptation to new sequencing 
technologies. In the future, one way by which PET technology will grow is by finding new 
applications for answering biological questions and overcoming limitations. 
One such limitation lies in the cloning step, which is a tedious affair that involves 
large scale plating, scrapping of bacteria from solid surface agar plates, and plasmid 
maxiprep. In this thesis, I present two proposed methods for overcoming the requirements for 
large scale scrapping. One method, called Selection-MDA, involves the use of a new Phi29 
polymerase to amplify DNA after a short period of selection of circular, non-chimeric DNA 
in bacteria. This method is able to replace tedious solid-phase agar scraping steps used for the 
amplification of complex cloning-based libraries, while still maintaining high accuracy and 
efficiency. These advantages go beyond use in PET library construction methods: all complex 
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libraries, such as full-length cDNA libraries, that typically involve library scrapping may use 
Selection-MDA to replace library scrapping steps yet still maintain low levels of chimerism. 
The development of Selection-MDA is described in Chapter 2.  
Another method is the use of alternative methods for PET library construction 
involving direct circularization of the target DNA fragments with linker oligonucleotides that 
covalently join the two ends of a DNA fragment. As the linker sequence is typically designed 
to contain two MmeI or EcoP15I sites flanking the two ends of the circularized DNA 
fragment, restriction digestion with these enzymes would release the tag-linker-tag structure. 
These PET templates can be further manipulated by adding flanking adaptors and PCR 
amplification before sequencing analysis. This strategy was first demonstrated in 
resequencing an E. coli genome using the polony sequencing method (Shendure et al. 2005). 
Another unique feature in linker design is the inclusion of a biotin group in the 
oligonucleotide, which allows efficient separation of the biotinylated tag-linker-tag structures 
from unwanted DNA debris by streptavidin-biotin based purification before and after 
restriction digestion. Besides tagging enzymes such as MmeI and EcoP15I that generate 
uniform sizes (18/20bp and 25/27bp) of PET constructs for easy purification, frequently 
cutting restriction enzymes and physical shearing by nebulization are also choices for 
generating randomly sized tag-linker-tag constructs. As reported (Korbel et al. 2007), 
circularized DNA was randomly sheared by nebulization and the fragments with biotinylated 
linkers are isolated using streptavidin. This method produced tags with a median size of 106 
bp, and is very useful for obtaining long tags because no type IIS or III restriction enzyme is 
currently known to produce tags more than 30bp; however, many PETs prepared this way are 
unbalanced with tags of lengths under 15 bp, which would mean that these sequences would 
have to be discarded. In this thesis, I demonstrate the use of linker sequences to ligate DNA 
fragments followed by MmeI digestion in a new procedure to analyze chromatin DNA, which 
is a new application of the “cloning-free” approach. This new application is described in the 
proposal below, and in Chapter 3.  
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Proposal: Finding chromatin interactions with PETs 
The applications described above have concentrated on finding genetic elements in linear 
DNA. However, thinking of genomic information in a one-dimensional form is far less than 
sufficient to elucidate the complexity of genome functions implemented through 3-
dimensional organization structures in the limited nuclear space. Evidence suggests that DNA 
molecules are packaged with protein factors to form chromatin fibers and are folded into 
higher-order structures and eventually chromosomes as organizational units (Woodcock 
2006) (Figure 3).  Genetic elements may interact by coming into close proximity as a result of 
chromosome conformation to produce spatial-based functions (Figure 3). Genome functions 
such as transcription and replication could be closely associated with this higher-order 
genome organization (Fraser et al. 2007); however, we are still in early stages of 
understanding the complex structure-function interplay of the human genome.  
Much of our current understanding of genome organization and function has come 
from two categories of technologies: molecular probing and molecular interaction mapping. 
The molecular probing technology enables us to visualize the 3-dimensional structure of 
genome organization at the nuclear compartment level and monitor the dynamics and 
functions of genomic structures in living cell nuclei. Electron Microscopy has been used to 
directly visualize DNA loops (Mastrangelo et al. 1991; Su et al. 1990), but Electron 
Microscopy requires harsh fixation and staining conditions, which could disrupt looping 
structures to be visualized. Atomic Force Microscopy does not have these limitations, and 
works by measuring forces between the scanning probe and the sample under study. It has 
been applied to studies of DNA looping (Yoshimura et al. 2004). Fluorescence in situ 
hybridization (FISH) and variants such as Cryo-FISH use fluorescently labeled DNA or RNA 
probes to visualize specific regions of chromatin, and has been used to generate much 
valuable data regarding very long interactions and chromatin conformation in the entire 
nucleus (Branco et al. 2006; Cremer et al. 2001; Osborne et al. 2004). However, FISH is 
limited by low resolution. RNA-TRAP, an extension of FISH methods capable of studying 
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local chromatin loops near genes in high resolution (Carter et al. 2002); however, it is limited 
by its inability to study multiple loci at the same time.     
Molecular interaction mapping approaches identify functional DNA elements that are 
in close spatial proximity and hence are likely to be potential interaction points in spatial 
genomic organization. One of the first experiments in this area was the Nuclear Ligation 
Assay (Cullen et al. 1993), which sought to understand the potential of enhancer sites to form 
looping interactions. The enhancer sites were cloned into minichromosomes that were stably 
transfected into a rat cell line. The chromatin was then digested with restriction enzymes, and 
ligated under dilute conditions to join the sticky ends. This ligation product was then 
inspected using PCR with specific primers for the presence of particular known interactions 
that bring together target genomic regions and the transfected minichromosomal regions. If 
the interaction was not present, then the sequences would not be brought into close proximity, 
and PCR with specific primers would show no products as the primers were not on the same 
template. If the interaction is present, then the sequences would have been in close proximity, 
and the PCR would yield specific products. This Nuclear Ligation approach was further 
optimized in the Chromosome Conformation Capture (3C) protocol (Dekker et al. 2002). 3C 
was the first application to investigate in vivo chromatin interactions in yeast cells without the 
need to insert DNA sequences into minichromosomes. In 3C, chromatin is formaldehyde 
cross-linked, digested with restriction enzymes, diluted, ligated in a dilute manner, reverse 
cross-linked, and interactions are detected by PCR similar to the Nuclear Ligation Assay 
(Dekker et al. 2002). 3C was subsequently applied to the study of long range chromatin 
interactions between the ß-globin locus and locus control regions (LCR) in mammalian cells 
(Tolhuis et al. 2002). Further, the 3C method had been combined with ChIP in the ChIP-loop 
assay to identify long range interactions mediated by MECP2 at the Dlx5-Dlx6 locus (Horike 
et al. 2005). However, 3C or ChIP-3C methods are limited to the detection of specific 
interactions using prior knowledge or perception of the existence of such interactions. To 
overcome this limitation, a number of groups have developed Associated Chromatin Trap 
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(ACT) (Ling et al. 2006), Chromosome Conformation Capture using Chip (4C) (Simonis et 
al. 2006), Circular Chromosome Conformation Capture (also called 4C) (Zhao et al. 2006), 
Open-ended Chromosome Conformation Capture (Wurtele et al. 2006) and Chromosome 
Conformation Capture Carbon Copy (5C) (Dostie et al. 2006) methods to expand the scope of 
detection for chromatin interactions. Starting from 3C or ChIP-3C ligation products, 4C, 
Open-ended Chromosome Conformation Capture and ACT methods all essentially use PCR 
to prime on known target sites and extend into unknown DNA fragments. The amplified 
products can then be characterized by either microarrays or cloning and sequencing analysis. 
Hence, these methods have the potential to detect many chromatin interactions between a 
known site in one location and all known and unknown counterparts in other locations; 
however, they are still constrained to at least one known location. The 5C method starts with 
a 3C template, and uses multiplex primers based on all possible combination of the restriction 
sites used for chromatin digestion to interrogate many interactions at the same time. 
However, the multiplexing is currently limited; hence 5C studies have focused on specific 
genomic regions (Dostie et al. 2006). In conclusion, although the currently available 
technologies are valuable for providing insights of chromatin interactions at limited loci or 
limited resolutions, they are constrained by their inability to provide a whole genome view of 
chromatin interactions (Simonis et al. 2007). Therefore new genome-wide technologies are 
needed to advance the field to provide comprehensive views and datasets of whole genome 
interactions and the 3-dimensional structure of chromosomes. 
We have previously applied the PET approach to identify unconventional fusion 
genes originating from chromosomal re-arrangement events such as deletions, insertions, 
inversions and translocations, through mapping of 5’ tags to the first exon of one gene in a 
genomic locus and the 3’ tags to the last exon of another gene in a different genomic locus. 
The same concept can also be extended to characterize artificially fused DNA fragments, 
such as nuclear proximity ligation products. With this in mind, we propose a new strategy for 
whole genome Chromatin Interaction Analysis using Paired-End Tag sequencing (ChIA-
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PET) (Figure 3). The basic concept of ChIA-PET is to introduce a linker sequence in the 
junction of two DNA fragments during nuclear proximity ligation to build connectivity of 
DNA fragments that are tethered together in same chromatin complex. Therefore, all linker 
connected ligation products can be extracted for the tag-linker-tag constructs that can be 
analyzed by ultra-high-throughput PET sequencing. When mapped to the reference genome, 
the ChIA-PET sequences are read out to detect the relationship of two DNA fragments in 
chromatin interactions captured by chromatin proximity ligation. As this strategy is not 
dependent on any specific sites for detection like 3C or 4C, ChIA-PET has the potential to be 
an unbiased genome-wide approach for de novo detection of chromatin interactions.  
We anticipate that the complexity of potential substance for proximity ligation is 
high, the non-specific noise can be excessive; hence the cost of sequencing such material to 
the required depth to find true proximity ligation products can be prohibitive even for the 
most advanced sequencing technology currently available. To reduce the complexity and 
background level, we propose to use ChIP against specific protein factors to enrich specific 
chromatin fragments of interest before proximity ligation (Fullwood et al. 2009a). This 
enrichment approach would not only make the ChIA-PET sequencing approach practical by 
reducing the complexity of the system to be examined, but also add specificity to the 
identified interaction points. Depending on the protein factors used for ChIP enrichment, 
ChIA-PET analysis can be applied to the detection of all chromatin interactions involved in a 
particular nuclear process. For instance, the use of general transcription factors or RNA 
Polymerase II components for ChIP enrichment and ChIA-PET analysis would identify all 
chromatin interactions involved in transcription regulation, and the use of protein factors 
involved in DNA replication or chromatin structure would allow identification of all 
chromatin interactions due to DNA replication and chromatin structural modification. More 
specifically, the use of specific transcription factors for ChIA-PET analysis would further 
reduce ChIA-PET library complexity and add specificity to chromatin interactions, and 
enable examination of specific chromatin interactions mediated by particular transcription 
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factors. Our preliminary experimental data (Chapter 3) has demonstrated that ChIA-PET can 
generate PET sequences that identify transcription factor binding sites and interactions 
between remote binding sites.   
Through large-scale application of ChIA-PET to the system of estrogen receptor α-
mediated chromatin interactions in human MCF-7 breast cancer cells, we have generated the 
first global chromatin interactome map (Chapter 4). We found that the great majority of ERα 
binding sites are anchored at promoter regions of target genes through long-range chromatin 
interactions. Our data suggests that ERα functions in transcription regulation by bringing 
genes together through intensive looping of chromatin interactions into transcription foci. 
These findings suggest that chromatin interaction is a primary mechanism for regulating 
transcription in mammalian genomes particularly in transcriptional induction. 
 With further development and optimization of the ChIA-PET prototype protocol, 
and with our new findings from this first application of ChIA-PET, we expect that this whole 
genome approach for unbiased and de novo discovery of long range chromatin interactions 
and these chromatin interaction maps will help to establish an emerging field for studying 
genome interaction and regulation networks in 3 dimensions. 
In conclusion, the PET technology is a versatile method which can couple methods 
for asking biological questions with next-generation sequencing (Fullwood et al. 2009b). In 
this thesis, I present new methods which can improve current library construction methods as 
well as ask new biological questions, thus furthering both PET technology and our 




Chapter Two: Selection-MDA for amplifying complex DNA libraries 
 
Introduction 
A mainstay of genomic technologies to interrogate genomes and functional genomic elements 
is the generation of complex cloning-based DNA libraries. Examples of such libraries include 
genomic DNA libraries used in the sequencing of the human genome (Lander et al. 2001) as 
well as other genomes (Waterston et al. 2002); full-length cDNA (flcDNA) libraries 
(Strausberg et al. 1999) and Gene Identification Signatures with Paired-End Tags (GIS-PET) 
libraries used for elucidating the transcriptome (Ng et al. 2005); as well as Chromatin 
Immunoprecipitation with Paired-End Tags (ChIP-PET) libraries used for elucidating 
transcription factor binding sites (Wei et al. 2006).  
In constructing such libraries, the starting DNA samples are often limited, and 
therefore DNA amplification is often necessary. The method of choice has been bacterial 
propagation of DNA fragments in plasmid vectors. To ensure accurate representation, the 
bacteria must not be allowed to compete with each other for nutrients. Therefore, growth and 
scraping from solid-surface agar is commonly used because colonies are spread out on solid-
surface agar such that they will not encounter each other and compete. As the libraries are 
complex and contain many different DNA molecules, a large number of colonies must be 
scraped from the agar to ensure that the resulting library contains sufficient coverage of the 
different DNA molecules present in the original pool. Plating and scraping large numbers of 
solid-surface agar bacteria clones then results in methods that are tedious, time consuming, 
and difficult to scale up. 
Multiple Displacement Amplification (MDA) has been recently developed as a 
method for in vitro amplification of DNA. MDA is a method for amplifying plasmids and 
long strands of DNA in a cell-free system using phi29 polymerase, a newly discovered 
polymerase enzyme that has very high fidelity (Esteban et al. 1993), proof-reading activity 
(Garmendia et al. 1992), and processivity (Blanco et al. 1989). Such a system would be ideal 
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for replacing the tedious solid-phase agar scraping steps used for the amplification of 
complex cloning-based libraries. The use of MDA would remove this bottleneck, as MDA is 
able to amplify complex mixtures with high accuracy and efficiency.  
However, one obstacle to the use of MDA for the amplification of complex cloning-
based libraries is the fact that cloning ligation reactions into vectors typically results in 
multimers of plasmid vectors and DNA fragments. Bacterial propagation can remove 
multimers because replication constructs that contain multiple origins of replication will not 
survive during bacterial replication, while MDA alone is not capable of such selection to 
eliminate multimers during amplification. 
To overcome this problem, we developed a method, called Selection-MDA, which 
combines the selection capability of bacterial replication for single vector/insert constructs 
with the efficiency and convenience of MDA. In this method, we first transfer the 
vector/insert ligation into electrocompetent E. coli for a short period of replication and 
selection in liquid media. Because the bacteria are harvested after a short period of growth in 
liquid media, the bacteria would not have multiplied to such an extent that they begin to 
compete for nutrients, yet plasmids with multiple origins of replication would be selected out. 
The multimer-free pool of plasmids is then purified from liquid media and used for MDA, 
which amplifies large quantities of multimer-free DNA, thus eliminating tedious and time-
consuming plating and scraping of solid-surface agar. As such, the selective advantage of 
bacterial propagation can be combined with the efficiency convenience of the MDA method 
without the disadvantages of sample bias or chimeras. The end result is an MDA-amplified 
library of the same quality as a similar library prepared by bacterial propagation. 
To validate the Selection-MDA method in a complex library, we prepared a GIS-PET 
library (Ng et al. 2005) with the Selection-MDA method, and compared it with the same 
library prepared by conventional bacterial amplification on solid surface agar (Zhao et al. 
2007). Short Paired-End Tag (PET) libraries, including GIS-PET, were conceived of in order 
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to improve sequencing efficiency. In GIS-PET, the 5’ and 3’ signatures of each full-length 
cDNA are covalently linked into structures in which the 5’ and 3’ tags were paired together, 
and then sequenced, allowing a 20-30 fold increase in efficiency compared with bidirectional 
sequencing of DNA (Ng et al. 2006a). The paired end nature of the method also allows the 
use of GIS-PET to study unconventional fusion transcripts (Ruan et al. 2007). The same 
concept has also been applied to ChIP DNA characterization (ChIP-PET) (Wei et al. 2006). 
The PET analysis method involves the construction of two libraries: the original DNA insert 
library (flcDNA library for GIS-PET), and the single PET library, which is derived from the 
original DNA insert library. The amplification of the libraries using bacteria propagation is 
time consuming and labor intensive. To further improve PET analysis, we applied the 
Selection-MDA method to replace the single PET library amplification step (Figure 4) 
(Fullwood et al. 2008).  
 




FlcDNA maxiprep was cut with MmeI, self-ligated, and transformed into 
bacteria, which were recovered for 4 hours. After this, cells were washed with 
media, plasmids were extracted. MDA was then performed, followed by 
enzymatic digestion, concatenation, and then cloning and sequencing. We ran 
quality control aliquots of the reactions on PAGE gels after the plasmid 
purification. Clean plasmids of the correct size, 2,800 bp, were obtained. After 
BamH1 digestion, 50 bp PETs were successfully recovered, as may be seen from 
the PAGE gel which shows a band of 50 bp (marked by a white box) separated 
from a high molecular weight smear from the plasmid backbone. PETs were 
successfully excised and concatenated, as may be seen from the smear from the 
concatemers, which was seen on a third PAGE gel. The concatemers were 
excised from the PAGE gel and prepared for subsequent cloning and sequencing. 
(Note: Selection-MDA GIS-PET library was prepared by Jack Tan). 
 
Results  
The starting point for this analysis was HES3 human embryonic stem cell RNA, from which 
we generated a full-length cDNA (flcDNA) library (Figure 5A, B, and C). We then generated 
two libraries: (1) a GIS-PET library by the standard approach, called SHE001 (Figure 5D), 
which comprised 613,905 unique PETs that were collapsed into 25,845 transcriptional units; 
and (2) a GIS-PET library prepared by the Selection-MDA approach, called SHE002 (Figure 
4), which comprised 12,888 unique PETs which were collapsed into 3,584 transcriptional 
units. 
 
Figure 5. Full-length cDNA and GIS-PET library quality controls. 
A. HES3 Human embryonic stem cells were grown and prepared as described. 
Total RNA was prepared by the Trizol isolation method. A smear of RNA with 
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two bright bands corresponding to the 28S and 18S rRNA was obtained. The 
ladder used in all panels is Generuler 1 Kb (Fermentas) 
(http://www.fermentas.com/catalog/electrophoresis/images/generuler031123.jpg)
. B. The mRNA prepared by the use of the μMACS mRNA isolation kit on total 
RNA showed no bright bands corresponding to the rRNA. C. A full-length 
cDNA library was prepared by the Captrapper method, which had a titer of 4.6 × 
10
6
 cfu. Colony PCR Quality Control of the library was performed. An empty 
vector will produce a PCR product of size 260 bp (corresponds to the first band 
of the ladder); insert sizes were therefore calculated by subtracting off the size of 
the empty vector. Colony PCR therefore showed a range of insert sizes from 
250-2,000 bp (corresponds to the second to seventh bands of the ladder). This is 
expected, as a full-length cDNA library is expected to give a range of different 
sized inserts, with no single dominant size. Given that the library was of good 
quality, as can be seen from the colony PCR, the library was used to prepare two 
libraries: A single-PET library by the classic method, and a single-PET library 
by the Selection-MDA method. D. A single-PET library was prepared from the 
full-length library as per the classic bacterial propagation method. Colony PCR 
Quality Control of this library showed a single predominant fixed size of 300 bp 
in many colonies, which is expected, as single-PET plasmids all have a fixed size 
of 2,800 bp, and hence upon PCR, will give a band of 300 bp. Certain clones do 
not show this fixed size, which could be the result of the incorporation of foreign 
DNA, or other factors. Colony PCR QC showed an insert ratio of 75% based on 
the number of wells that had PCR products of the correct size (300 bp). (Note: 
HES3 cells were prepared by Andrew Choo and Steve Ho, and the flcDNA and 
GIS-PET libraries were constructed by Liu Jun). 
 
To construct the MDA-amplified library (schematic in Figure 4), a single-PET 
ligation mixture was generated from the maxiprep of the flcDNA library, transformed into 
bacteria, and recovered for 4 hours in the “Selection” part of the procedure. The short 4 hour 
growth in liquid media, which allows for the selection of single insert clones because multiple 
insert clones have multiple origins of replication and cannot survive. However, the time is not 
long enough to result in crowding of bacteria in liquid media, such that size bias is 
minimized. To investigate whether the bacteria would have multiplied such that they crowd, 
we analyzed and plotted the optical density of the liquid media at 0 h, 1 h, 2 h and 4 h. The 
optical density absorbance at 600 nm (OD600) of the media increased from 0.728 at 0 h to 
0.897 over 4 h. Using the approximation that 1 OD600 is approximately 1 x 10
9 
cells, our 
bacteria increased from 7.3 x 10
8
 to 9.0 x 10
8
 cells over 4 h. Hence, our bacteria are still in 
log growth, and the increase in cell number should not be sufficient to cause crowding.  At 
the end of 4 h, the bacteria were washed well and harvested. Plasmids were prepared by 
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miniprep and DNAse cleanup. A quality control check showed that clean plasmids (Figure 4) 
were obtained. PETs were then released by BamHI digestion (Figure 4). Released PETs were 
concatenated for Sanger sequencing (Figure 4). These quality controls indicate that the 
Selection- MDA procedures were successful in producing PETs for sequencing. 
We analyzed the library of PET sequences derived from the MDA approach using 
standard GIS-PET quality control measures (Ng et al. 2005), to investigate whether libraries 
prepared by the MDA approach are of good quality. Of a total 12,888 unique PETs 
sequenced, the number of PETs that could not be mapped to the human genome was 22.9%. 
This number is comparable to the percentage of unmappable PETs (26%) shown in a mouse 
embryonic stem cell library (Ng et al. 2005), and indicates that the MDA approach has a low 
percentage of chimeras due to multimers as well as high accuracy amplification, which 
allows the amplified sequences to map well to the genome. In addition, the mapping accuracy 
(percentage within + 100 bp of the transcription start site or polyadenylation site) for all 
known PETs in SHE002 was 92.5% for 5’ tags and 91.9% for 3’ tags, comparable to the 
mouse embryonic stem cell GIS-PET (Ng et al. 2005), which showed results of 90.7% for 5’ 
tags and 86.9% for 3’ tags. Overall, the percentage of PETs with both 5’ and 3’ tags that map 
accurately is 88.4% for the entire library. While high, this measure includes mRNAs that 
have alternative splicing and alternative transcription start sites and hence represents a lower 
bound. The 12,888 unique PETs were collapsed into 3,584 transcriptional units. To more 
accurately measure the mapping accuracy of the library, we examined PET sequences from 
the top 20 most abundant transcriptional units, which are well-annotated. The overall 
mapping accuracy is 98.5% for the top 20 transcriptional units of SHE002. This high level of 
mapping accuracy indicates that Selection-MDA method can accurately capture gene 
identification signatures.   
In order to directly compare the performance of the Selection-MDA protocol with the 
standard protocol, we wanted to compare the quality control measures of the MDA-prepared 
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GIS-PET library with those of a GIS-PET library (SHE001) prepared by conventional 
bacterial amplification. As the size of the data sampled from library SHE001 (the total 
number of PETs is 613,905) is almost 50-fold larger than the size sampled from library 
SHE002 (the total number of PETs is 12,888), a direct comparison of these two library will 
not be meaningful. Therefore, in order to compare the two libraries at the same number of 
PETs, we created 3 smaller virtual libraries, SHE004, SHE005, and SHE006 (Table 1), by 
randomly selection of data from bacterial propagation library SHE001, such that the virtual 
libraries had the same approximate size as that of the MDA-prepared SHE002. Differences 
within the set of these 3 virtual libraries would reflect sampling variation. Hence, if the 
differences between the MDA approach and the conventional approach are significant, then 
the differences between SHE002, and SHE004, SHE005 and SHE006 should be much larger 
than the differences between SHE004, SHE005, and SHE006 (Figure 6).  
 
Figure 6. Data analysis method. 
A Selection-MDA GIS-PET library was created. This library was compared with 
a GIS-PET library created from the same source material, but which was 
prepared with the classic bacterial propagation protocol. We wished to assess 
whether the differences between the new protocol and the classic protocol are the 
41 
 
result of sampling differences between the libraries or actual biases in the 
protocol. Therefore, we randomly chose 3 smaller libraries from the bacterial 
propagation library. Each smaller library is of the same size as the library 
prepared by Selection MDA. If the differences between the new protocol and the 
classic protocol are the result of sampling differences, then the differences 
between the three libraries randomly selected from the same parental library 
should be the same as the libraries between each of the libraries and the library 
prepared by the new method. Otherwise, the differences are the result of actual 
biases, either on the part of the classic bacterial propagation protocol, the new 
Selection-MDA protocol, or both. 
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The percentages of PET matches to the genome, numbers of transcriptional units, as 
well as mapping accuracies of SHE004, SHE005, and SHE006 are comparable to that of 
SHE002, indicating that the MDA-prepared library is of similar quality as that of the 
conventionally-prepared library constructed from the same starting material (Table 2).  
Next, we checked whether the MDA procedure caused any biases in the sample. 
Because MDA is a different amplification method from bacterial amplification, we wished to 
investigate if there was any base bias. Base bias was measured by calculating the GC 
percentage of the library. There is minimal base bias between the MDA method and the 
conventional method (Table 2).  
Again because MDA is a different amplification method, we investigated whether 
there is any bias towards any category of genes, such as novel genes. We grouped the PETs 
into “known genes”, “gene predictions”, “ESTs” and “novel genes”. All libraries showed 
similar distributions, indicating minimal category bias (Table 2).  
The Selection-MDA step could not have introduced a length bias in this particular 
library, because Selection-MDA was performed on single PET clones, which are all of a 
fixed size. Therefore, we could not test whether Selection-MDA would result in length biases 
or not. However, given that MDA was performed on the full-length cDNA library maxiprep 
to obtain more material for the construction of the single-PET library in the MDA procedure, 
we reasoned that this step might have introduced a length bias, and hence investigated 
whether there was a length bias. We tested for the presence of length bias by investigating the 
mRNA lengths of the best-matching Known Genes, ESTs, or Gene Predictions, and found 
there was a length bias towards shorter mRNAs on the part of Selection-MDA, but the bias is 
small (Figure 7). Given that the bias is small, it is possible that the apparent bias could still be 




Figure 7. Analysis of length bias between the MDA approach and the 
bacterial amplification approach. 
We tested for the presence of length bias by classifying the mRNA lengths of the 
best-matching Known Genes, ESTs, or Gene Predictions from each library into 
500-bp bins, which were then plotted on a graph. There is a small length bias.  
Because the length bias is small, it is possible that the apparent bias is due to 
sampling variation.  
 
Next, we reasoned that the contents of the SHE002, SHE004, SHE005, and SHE006 
libraries should be similar, because the same starting full-length cDNA library was used for 
the preparation of the two libraries. Hence, we compared the top 20 most abundant 
transcriptional units of each library with each other (table 3). The average number of 
transcriptional units that are the same between SHE002 (the MDA-prepared library) and any 
randomly selected library from a bacterial propagation library is 13. The average number of 
transcriptional units that are the same between the bacterial propagation libraries is 14, 
suggesting that the agreement between the MDA method and the bacterial amplification 
method is similar to the agreement between randomly selected libraries chosen from the same 
bacterial propagation library. This analysis thus indicates that the contents of the MDA-
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1 FTL FTL FTL FTL 
2 GAPDH MIF ENO1 MIF 
3 MIF ENO1 MIF ENO1 
4 TPI1 PRDX1 RPL13 LOC388817 
5 ENO1 IFITM1 RPS2 RPS2 
6 LOC388817 C14orf172 TPI1 RPL13 
7 RPL13 K-ALPHA-1 LOC388817 H3F3A 
8 OAZ1 PGK1 RPL9 PRDX1 
9 FTH1 RPL13 K-ALPHA-1 TMSL3 
10 TMSL3 PFN1 FTH1 TPI1 
11 H3F3A LOC388817 MDK H2AFZ 
12 IFITM1 RPL18 H2AFZ K-ALPHA-1 
13 H2AFZ IFITM3 H3F3A FTH1 
14 PRDX1 ACTG1 PGK1 PRDX4 
15 C14orf172 PRDX4 RPL18 PFN1 
16 PFN1 MDK TMSL3 C14orf172 
17 RPL15 OAZ1 IFITM1 IFITM1 
18 TPT1 RPL8 PRDX1 RPL9 
19 RPL9 RPLP0 C14orf172 RPL18 




Taken together, we have shown the method of inserting plasmids into bacteria for a short 
selection interval followed by MDA is a feasible method for the construction of a complex 
library. We have successfully applied Selection- MDA to the construction of a complex GIS-
PET library and found that the Selection-MDA method results in a library with similar 
content and quality control statistics as compared with a library constructed from the same 
starting material that was amplified with bacteria and harvested through scraping bacterial 
colonies from solid surface agar. 
Comparing the steps between the MDA version and the bacterial propagation 
method, it is clear that the MDA version requires much less hands-on labor (Figure 8). In 
terof the physical handling, the MDA version uses small scale 1.5 ml tubes of material 
whereas the bacterial propagation method uses 10 large Q-trays and many maxiprep columns. 
The approximate times for each step that differed between the two protocols was estimated 
(Figure 2A). Comparing the absolute times required, the MDA method requires 4 h less time 
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than the bacterial propagation method. Considering the fact that many of the time-consuming 
steps in MDA do not require hands-on activities and hence allows other projects to be carried 
out in parallel, the time requirement of the MDA method is much less than the bacterial 
propagation method. With recent improvements in the MDA method (for example, the 
Illustra Genomiphi V2 DNA Amplification kit from GE Healthcare), further time savings 
could be possible.  
 
Figure 8. Differences between the GIS-PET method with classic approach 
and the GIS-PET method with the new Selection-MDA approach. 
The Selection-MDA version allows for further amplification of the flcDNA 
library maxiprep by MDA, as well as amplification of the single-PET library 
solely by Selection-MDA without the need for tedious plating and scraping of 
large numbers of bacterial colonies from solid surface agar. Approximate times 
required for steps that are different between different protocols are given in 
brackets. Comparing the steps between Selection-MDA and the bacterial 
propagation method, it is clear that Selection-MDA requires much less hands-on 
labor and time, and also, in terof absolute time, is at least 4 hours shorter.  
 
The concept of performing bacterial selection followed by MDA (Selection-MDA) 
may be used to replace amplification steps in complex libraries, and represents a substantial 
improvement to existing cloning-based protocols. The Selection-MDA method is an effective 
and simple method for the unbiased amplification of a pool of complex clones, which allows 
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scale-up and elimination of tedious scraping steps in library preparation protocols. The 
method may be readily integrated and applied to current cloning-based protocols.  
In conclusion, Selection-MDA is a novel method for the amplification of cloned 
libraries consisting of complex DNA. We applied Selection-MDA to a GIS-PET library, an 
example of a cloned, complex DNA library, to illustrate the benefits of Selection-MDA. 
Library preparation was made simpler, and differences between the MDA-prepared library 
and a library prepared by the classic protocol were minimal. Hence, Selection-MDA is an 










While genomic information is usually presented as a linear series of bases, genomes are 
known to be organized into three-dimensional structures in vivo (Woodcock 2006). Genome-
wide studies of transcription factor binding sites (TFBS) using chromatin 
immunoprecipitation (ChIP) followed by microarray detection (ChIP-chip) (Cawley et al. 
2004), paired end sequencing (ChIP-PET) (Lim et al. 2007; Lin et al. 2007; Loh et al. 2006; 
Wei et al. 2006; Zeller et al. 2006; Zhao et al. 2007) or single end sequencing (ChIP-Seq) 
(Johnson et al. 2007), particularly for estrogen receptor α (ERα) (Lin et al. 2007), have shown 
that many TFBS are not located 5’ proximal to genes, suggesting extensive remote regulation 
in many systems. Possible models of remote regulation include looping and sliding (West et 
al. 2005). Various methods can investigate looping interactions, such as Chromosome 
Conformation Capture (3C) and variants including ChIP-3C, 4C and 5C (Cai et al. 2006; 
Carroll et al. 2005; Dekker et al. 2002; Dostie et al. 2006; Simonis et al. 2006; Wurtele et al. 
2006; Zhao et al. 2006), as well as RNA-Trap (Carter et al. 2002) and FISH (Cremer et al. 
2001), which have provided many insights into higher level organization of chromatin 
structures. However, these methods are limited to one-point oriented or partial genome 
detection of interactions, and are incapable of de novo detection of genome-wide interactions. 
A global strategy for investigating higher-order chromatin structures is needed to understand 
mechanisms for the remote control of transcription regulation in 3-dimensional nuclear space. 
We therefore developed a genome-wide, high-throughput, and unbiased approach called 
ChIA-PET with the incorporation of the original concept of “nuclear proximity ligation” 
(Cullen et al. 1993) that has been applied in the 3C approach (Dekker et al. 2002) to capture 
interacting DNA segments bound by protein factors, the exploitation of the Paired-End Tag 
(PET) strategy (Ng et al. 2006a; Ng et al. 2005; Wei et al. 2006), as well as the utilization of 
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next generation sequencing technologies (Margulies et al. 2005) for de novo detection of 
chromatin interactions. Here, we demonstrate this method using the system of ERα-mediated 
transcription regulation.  
 
Results 
Construction and mapping of ChIA-PETs 
The basic principle of detecting chromatin interactions is the use of “proximity ligation” to 
capture DNA elements that are in close spatial distances as a result of juxtaposition by protein 
factors but which are located far away from each other in the linear genome (Cullen et al. 
1993; Dekker et al. 2002). In “proximity ligation”, chromatin is diluted, and spatially 
proximate DNA fragments within the same chromatin complex connect to each other through 
ligation, while chimeric ligations between different chromatin complexes are minimized. One 
of the major challenges of developing an unbiased whole genome approach for de novo 
detection of chromatin interactions is to find a method for manipulation of the connected 
DNA fragments. An even bigger challenge is the expected high level of complexity of 
chromatin interactions in the compacted nuclear space crowded by masses of DNA and 
related proteins. Consequently, any region of the genome could potentially interact with 
multiple segments of the genome, specifically or non-specifically. Moreover, such 
interactions may act transiently and proximately (Misteli 2007). Further challenges arise 
when a population of non-synchronized cells is studied, in which specific interactions may 
occur only in a small portion of the cell population (Misteli 2007; Simonis et al. 2007). 
Hence, analyses of chromatin interactions are expected to be very noisy, and the question of 
how to reduce the complexity for detection of specific interactions is a critical issue. The 3C 
and variant methods use sequence-specific approaches to reduce the complexity by detecting 
interactions that are only related to the targeted genome locations, but exclude interactions in 
all other regions(Simonis et al. 2007).      
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To overcome these issues, we devised a strategy to introduce a specific 
oligonucleotide sequence into the junction of all proximity ligation products. We coupled this 
strategy with Chromatin Immunoprecipitation (ChIP) to enrich specific chromatin 
interactions, as well as ultra-high-throughput sequencing technology for deep coverage, and 
thus formulated the ChIA-PET analysis procedure (Figure 9).  
 
Figure 9. The ChIA-PET method.  
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Two biological replicates were analyzed simultaneously in the same ChIA-PET 
experiment, using barcoded linkers (H and N). ChIP-enriched chromatin was 
labeled with different linkers to represent different replicates, pooled, and ligated 
in a dilute manner. PETs were obtained from these products after MmeI 
digestion. The biotinylated PETs were bound to streptavidin beads, ligated to 
universal adapters, PCR-amplified, gel-purified, sequenced, and mapped to the 
genome. (Note: ChIA-PET was performed together with Liu Jun. All sequencing 
was done by the Genome Technology and Biology Sequencing Team, led by Wei 
Chialin. All names are given in the Materials and Methods, Chapter 6). 
 
Briefly, after ChIP enrichment, tethered DNA fragments in chromatin complexes are 
first ligated to excess half-linker oligonucleotides; the intermediate molecules are then 
circularized under dilute conditions for “proximity ligation”, resulting in two kinds of ligation 
products: the “self-ligation” where a complete linker joins the two ends of one DNA 
fragment, and the “inter-ligation” where a complete linker connects two different DNA 
fragments. The linker sequence is designed to contain a MmeI site flanking each end of the 
ligated DNA fragments, so as to allow type IIS restriction digestion to release a PET structure 
(20bp tag – linker – 20 bp tag) from each of the linker-ligated products. In addition, the 
linkers are biotinylated, allowing for easy manipulation of the PETs using streptavidin 
magnetic beads. The PET structures derived from both self-ligated and inter-ligated DNA 
fragments are then subjected to ultra-high throughput sequencing using a Roche 454 
pyrosequencer (Margulies et al. 2005), and the PET sequences are mapped to the reference 
genome sequences. Therefore, the sequencing of one ChIA-PET library can generate two 
datasets: the self-ligation PETs from individual ChIP DNA fragments, and the inter-ligation 
PETs from interacting DNA fragments (Figure 10A). 
We expect that real and specific chromatin interactions would be enriched, and this 
enrichment would be reflected as increased frequencies of multiple PETs occurring at, or 
between, specific regions in the ChIA-PET library sequence dataset, while non-specific 
sequence data would scatter randomly along the genome. Using this principle of multiple 
PET overlaps as a readout for real binding sites (Wei et al. 2006) and interactions, a ChIA-
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PET experiment can identify precise transcription factor binding sites (TFBS) using the 
overlap density of the PET data as a measure of ChIP enrichment, and reveal true interactions 
between TFBS using overlapping inter-ligation PET data. Thus, we can distinguish true 
binding sites and interactions from random background noise (Figure 10B). 
 
Figure 10. ChIA-PET structures allow inference of self-ligation and inter-
ligation status. 
A. Schematic of PET structure and mapping. PETs with both tags that map to the 
same chromosome with the genomic span in the range of ChIP DNA fragments 
(less than 3 kb), with expected self-ligation orientation and on the same strand, 
are considered to derive from the self-ligation of a single ChIP DNA fragment, 
and are therefore called “self-ligation PETs”. The genomic span in the range of 
the ChIP DNA fragments was determined by examining the sizes of the 
sonicated products on an agarose gel and taking an upper limit. If a PET did not 
fit into these criteria, we considered that the PET most likely resulted from a 
ligation product between two DNA fragments, an “inter-ligation PET”. B. 
Clustering method for determining binding sites and interactions. Self-ligation 
PET clusters involving multiple overlapping unique self-ligation PETs were 
taken to represent binding sites; intrachromosomal inter-ligation PET clusters 
involving multiple overlapping unique inter-ligation PETs were taken to 
represent intrachromosomal interactions; interchromosomal inter-ligation PET 
clusters involving  multiple overlapping unique inter-ligation PETs were taken to 
represent interchromosomal interactions; and singleton PETs were taken to 
represent noise (Note: PET processing was done by Hong-Sain Ooi, Pramila 




 We applied this method to characterize ERα-mediated chromatin interactions in 
human breast adenocarcinoma cells MCF-7. ERα is a ligand-dependent transcription factor 
that plays important roles in breast cancer and normal human physiology (Ali et al. 2000). 
Whole genome maps of ERα binding sites have been generated by ChIP-chip (Carroll et al. 
2005; Lupien et al. 2008) and ChIP-PET (Lin et al. 2007) approaches. In addition, a few 
ERα-mediated long-range chromatin interactions have been characterized between the 
promoters and enhancers of the estrogen-responsive genes TFF1 (also known as pS2) (Carroll 
et al. 2005) and GREB1 (also known as KIAA0575) (Deschenes et al. 2007). Hence, the ERα 
system constitutes an excellent model for testing the ChIA-PET method in complex genomes.  
We first generated two ERα ChIA-PET libraries as two biological replicates of MCF-
7 cell cultures treated with estradiol (E2) using two linker sequences with different nucleotide 
barcodes. As a linker sequence can include a unique nucleotide barcode, multiple linkers with 
distinctive nucleotide barcode sequences can be used to specify different experiments or 
replicates, and monitor the non-specific inter-ligation (chimeric) rate between ChIP 
complexes. Hence, different biological samples or replicates may be analyzed under similar 
experimental conditions in a time and cost-effective manner to reduce technical variations of 
measurement. Using the Roche 454 pyrosequencing platform (Margulies et al. 2005), we 





















































508,211 436248  403,149 
(92%) 
0 0 
Notes: A: “False Discovery Rate” is abbreviated “FDR”. B: The chimeras are 
inter-ligation PETs between the two ChIA-PET library materials with hybrid 
linker H and N. C: Of these 2 interactions, 1 was in an amplicon. The other 
showed no abnormalities upon manual curation, but could be a random noise. D: 
These PET clusters have genomic spans of over 10 Mb and have only 2 
overlapping PETs. They are therefore considered to be non-specific. 
 
We also generated control libraries for comparison with the ChIA-PET libraries to 
validate the ChIA-PET library data. For a genome-wide negative control of proximity 
ligation, we constructed a ChIP-PET library using MCF-7 cells with the same E2 induction 
and ChIP treatment, and generated over 1 million PET sequences (Table 4). The ChIP-PET 
and ChIA-PET library procedures are almost identical. A key difference is that for the ChIP-
PET method, DNA fragments are released from protein-bound chromatin complexes by 
reverse cross-linking before ligation is done under dilute volumes to circularize the linker-
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ligated ChIP DNA (Figure 11), while for the ChIA-PET method, the proximity ligation under 
dilute volumes is done when the linker-ligated ChIP DNA fragments are still tethered 
together in chromatin complexes (Figure 11). As a result of this experimental design, the 
ChIP-PET data would only reveal the enrichment of ChIP DNA fragments, while the ChIA-
PET data would reveal both ChIP enrichment and chromatin interaction events. Any 
“interactions” found in a ChIP-PET library would be the result of random in vitro chimeric 
ligations, mapping errors, and chromosomal aberrations in MCF-7 cells. For an even more 
general control, we used IgG, which binds to chromatin nonspecifically, to perform a mock 




Figure 11. Control libraries.  
A. ChIA-PET construction:  Tethered DNA fragments in ChIP complexes were 
ligated to half-linkers containing flanking MmeI restriction sites (the first 
ligation). The DNA fragments were further ligated (the second ligation) under 
dilute conditions (further described in Materials and Methods) to produce two 
kinds of ligation products: “self-ligation” fragments through circularization of 
DNA fragments, or “inter-ligation” fragments between different DNA fragments 
in close proximity within the same chromatin complex. Paired-End Tags (PETs) 
were extracted from the ligation products by MmeI digestion. The released PETs 
were subjected to Roche 454 pyrosequencing analysis, and the PET sequences 
were mapped to the reference genome. B. ChIP-PET construction:  After adding 
half-linkers, the tethered DNA fragments were released from protein-bound 
chromatin complexes by reverse cross-linking. The purified free DNA fragments 
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were then circularized by self-ligation (the second ligation), followed by PET 
extraction and sequencing similar to ChIA-PET analysis. C. Mapping and 
display of ChIA-PET and ChIP-PET data:  The P2RY2 locus on chromosome 11 
shows the mapping of ChIA-PET and ChIP-PET sequences in the human 
genome ChIA-PET browser. The top box shows the P2RY2 gene model 
including alternative isoforms, the RNAPII ChIP-Seq density track, and the ERα 
ChIP-chip data track. The four boxes below show different PET library data 
mapped in this locus: two ERα ChIA-PET replicates, one ERα ChIP-PET, and 
one IgG ChIA-PET control. Self-ligation PETs (orange) are shown as two 
vertical bars with a horizontal line in between. The inter-ligation PETs are 
presented as vertical bars with extended horizontal lines to represent the average 
length of ChIP DNA fragments. The intrachromosomal inter-ligation PETs are 
shown in purple and the interchromosomal inter-ligation PETs are in light blue. 
The dotted lines (purple) indicate the connection between the two paired 
interacting tags. The sum of PET-defined ChIP DNA fragments was converted 
into a ChIA-PET density peak track. (Note: The ERα control ChIP-PET library 
was prepared by Ruan Xiaoan’s team. The IgG control ChIA-PET library was 
prepared by Andrea Ho and Ruan Xiaoan. Genome Browser visualization was 
performed by Hong Sain Ooi, Pramila Ariyaratne, and Yusoff Bin Mohamed.) 
 
The PET sequences were mapped to the reference human genome sequence assembly 
(hg18). If a pair of tags aligned in same chromosome, in head-to-tail orientation, and within 
the upper size range of the ChIP DNA fragments (Figure 10), then this PET was most 
probably derived from a self-ligation product, and therefore originates from a single DNA 
fragment. Otherwise, if the paired tags of PET sequences mapped with genomic distances 
beyond the upper size range of the ChIP DNA fragments or to different chromosomes, they 
were assumed to be derived from inter-ligated products of two different DNA fragments, with 
each of the tags originating from one of the paired DNA fragments (Figure 10). The sum of 
overlapping ChIP DNA fragments reflects the ChIP enrichment and the most overlapped 
region of a PET mapping cluster indicates the core binding site at the nucleotide level. 
ERα binding sites and interactions determined by ChIA-PETs 
As expected, the PET sequences of ERα ChIA-PET libraries included both self-ligation PETs 
and inter-ligation PETs (intrachromosomal and interchromosomal) that are highly enriched at 
known ERα binding sites. The high numbers of multiple overlapping unique 
intrachromosomal inter-ligation PETs connecting the two ERα binding sites at the P2RY2 
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locus suggests a possible chromatin interaction between the two sites (Figure 11). The similar 
mapping patterns of the two ChIA-PET libraries at specific loci such as P2RY2 (Figure 11), 
TFF1 (Figure 12), and GREB1 (Figure 13), as well as CAP2 (Figure 14), also suggest that the 
interactions found by ChIA-PET are reproducible. By contrast, in control libraries, the ChIP-
PET library data had only abundant self-ligation PETs at these two ERα binding sites, which 
supports the notion that the frequent intrachromosomal inter-ligation PETs observed here are 




Figure 12. The TFF1 positive control chromatin interaction. 
Genome browser views are provided of the TFF1 locus, which is known to have 
a chromatin interaction (Carroll et al. 2005). Views from the ChIA-PET library 





Figure 13. The GREB1 (also known as KIAA0575) positive control 
chromatin interaction. 
Genome browser views are provided of the GREB1 locus, which is known to 
have a chromatin interaction (Deschenes et al. 2007). Views from the ChIA-PET 





Figure 14. A novel chromatin interaction at CAP2. 
Genome browser views are provided of the CAP2 locus, which has a novel 
interaction identified by ChIA-PET. Views from the ChIA-PET library 1, 2, 
ChIP-PET library, and IgG ChIA-PET are provided. 
 
We identified 2,179 and 2,720 putative ERα binding sites (FDR≤ 0.01) from the two 
ERα ChIA-PET libraries. The majority of the binding sites are shared between both libraries 
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(Figure 15A): 1,459 out of 2,179 (67%) and 2720 (54%) binding sites overlapped, and most 
of the binding sites that did not overlap had low ChIP enrichment counts (Appendix). Of the 
shared binding sites, the Pearson correlation between the ChIP enrichment levels of the same 
sites in the two different replicates was 0.90, indicating that the ChIA-PET procedure is 
highly reproducible for quantitative measurement of transcription factor binding sites. We 
then combined the sequences from these two libraries, used the same false discovery rate as a 
cutoff (FDR≤ 0.01), and identified 4,124 putative ERα binding sites. We compared the ERα 
binding sites found in the ChIA-PET libraries with the sites identified by the ChIP-PET 
library data in this study and the ChIP-PET data of our previous study (Lin et al. 2007), as 
well as the ERα ChIP-chip data (Lupien et al. 2008). 48.6% and 71.9% of the ERα binding 
sites identified by ChIP-chip and ChIP-PET experiments overlapped with ChIA-PET data. Of 
the binding sites that were previously identified by ChIP-PET data and that did not overlap 
with ChIA-PET data, the majority had low PET counts, suggesting they were most likely low 
occupancy sites. In many examples (Figures 11-14), the self-ligation PETs overlapped at 
binding sites which correlated precisely with previously reported ChIP-chip (Lupien et al. 





Figure 15. ERα binding sites and interactions determined by ERα ChIA-
PET. 
A. The ERα binding sites identified by ERα ChIA-PET experiments are largely 
reproducible. Most ERα binding sites found in one library can also be found in 
the other library. The enrichment intensities (as measured by overlapping PET 
counts) of the ERα binding sites in both libraries are highly correlated (Pearson 
correlation coefficient = 0.9). B. Venn Diagram of ERα binding sites found by 
different studies. The comparison was performed between the ERα binding sites 
found by ChIA-PET, ChIP-PET (Lin et al. 2007), and ChIP-chip (Lupien et al. 
2008). The combined dataset from the two ChIA-PET libraries identified 4,124 
binding sites. The ChIP-PET library in this study and a previous one found 1,297 
binding sites. The ChIP-chip experiment found 3,260 binding sites (Lupien et al. 
2008). Of the 1,297 ChIP-PET binding sites, 933 (72%) overlapped with the 
ChIA-PET study, whereas only 27 sites (0.65%) overlapped with the ChIP-chip 
data solely. Of the 3,260 sites in the ChIP-chip study, about half were overlapped 
with the ChIA-PET data. C. Distribution of ERE motifs in ERα binding sites 
identified by ChIA-PET, ChIP-PET, and ChIP-chip data. The background level 
is shown as a grey line. D. Reproducibility of ERα-mediated interactions from 
two ChIA-PET libraries. The high confidence interactions (29 and 34) identified 
in the two ChIA-PET libraries largely overlap. H= high confidence interactions, 
M= medium confidence and singleton interactions, NO= no interaction PETs 
found. The overlap percentage by random chance is less than 0.5%. (Note: 




We selected 9 binding sites defined by ChIA-PET not found in ChIP-PET and ChIP-
Chip experiments for validation testing by ChIP-qPCR, and all of them showed ChIP 
enrichment under estrogen induction (Figure 16). We also analyzed the ERα binding sites for 
the presence of the ERE motif, and found that 1,217 (55.9%) out of 2,179 and 1,456 (53.5%) 
out of 2,720 binding sites contain at least one ERE motif within 100 bp, which is significantly 
higher than random background (Fig. 15C). As noted before (Lin et al. 2007), the majority of 
the ERE motifs were located at the center of the ERα binding sites (Fig. 15C). These analyses 
collectively prove that binding sites identified by overlapping PET sequences of ChIA-PET 
data are bona fide. 
 
Figure 16. ChIP-qPCR validation of new ERα binding sites identified by 
ChIA-PET. 
9 sites were selected for ChIP-qPCR validation. All sites show ChIP enrichment, 
indicating the new ERα binding sites identified by ChIA-PET are bona fide. 
(Note: ChIP-qPCR was performed by Shi Chi Leow).  
 
 From the two ChIA-PET libraries, we captured 422,813 inter-ligation PET 
sequences. These PETs could represent proximity ligation products of true chromatin 
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interaction events, but could also be derived from random in vivo interactions, chromosomal 
aberrations, chimeric ligation products between chromatin complexes, or incorrect tag 
sequence mapping. To distinguish the inter-ligation PETs representing real interactions from 
noise, we reasoned that if the proximity ligations of tethered DNA fragments occurred non-
randomly, specific inter-ligation PETs between particular regions would be detected at higher 
frequencies than random background in the dataset. In addition, we rationalized that ERα-
mediated interactions would be associated with ERα binding, and ERα ChIP would enrich 
ERα-mediated interactions for detection. Meanwhile, we were also concerned about the 
likelihood that ChIP enriched loci with more DNA fragments would result in proportionally 
higher chances of more inter-ligation PETs, leading to false positives between highly 
enriched sites. Hence, we conducted statistical analyses to calculate the probability for any 
overlapping clusters of inter-ligation PETs to occur if the ligations between DNA fragments 
occurred based on random chance. The assumption in this analysis is that in a ERα ChIP 
enriched DNA fragment population, if each of the DNA fragments has equal chance to 
interact with and be ligated to any other fragment randomly, the analysis would calculate the 
expected level of interaction frequency between two genomic loci and be able to estimate the 
p-value for the frequency of interactions observed by inter-ligation PETs. This statistical 
analysis would also neutralize the enrichment effect by ChIP that could potentially result in 
higher chances of finding overlapping inter-ligations among highly enriched ChIP DNA 
fragments (Materials and Methods, Chapter 6). In performing this analysis, we first identified 
205 overlapping inter-ligation PET clusters (a cluster consists of 2 or more inter-ligation 
PETs) from one library and 228 clusters from another, suggesting putative chromatin 
interactions mediated by ERα. Approximately two thirds (64% in library 1 and 66% in library 
2) of the putative interactions have ERα binding sites on both sides of the suggested 
interactions, more than 90% have at least one binding site, and less than 10% have no binding 
site at all (Appendix). Next, we applied the statistical analysis, and calculated confidence p-
values for each putative interaction. We applied Bonferroni correction and used Bonferroni-
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corrected p-values < 0.05 as the cutoff to determine high confidence interactions. After 
performing manual curation to remove some obvious false interactions due to chromosomal 
aberrations in MCF-7 cells, we identified 29 high confidence interactions from one replicate 
and 34 from another (Appendix). In total, we identified 56 high-confidence interactions from 
these two libraries. All of them have at least 3 overlapping inter-ligation PETs. Some of them 
have more than 10 overlapping PETs. For example, the interaction sites with the highest 
numbers of overlapping inter-ligation PET clusters at the GREB1 and P2RY2 loci have14 
and 13 overlapping inter-ligation PETs in both libraries, respectively. We also observed that 
most of these high confidence interactions have ChIP enrichments in both of the interacting 
regions, suggesting genuine interactions mediated by ERα binding (Appendix). Previously 
characterized chromatin interactions including GREB1 and TFF1 (4 inter-ligation PETs and a 
Bonferroni-corrected p-value of 4.1E-03 in library 1; 8 inter-ligation PETs and a Bonferroni-
corrected p-value of 2.33E-16 in library 2) (Figures 12 and 13) are included in this class. In 
addition, the category of high confidence interactions includes many new chromatin 
interactions identified by this study that are at the loci of genes that were previously described 
as ERα-responsive genes (Figures 11 and 14, Table 5, and Appendix). Interestingly, all high 
confidence interactions are between sites within an individual chromosome, suggesting that 
most strong interactions mediated by ERα binding are intrachromosomal. The detection of 
interchromosomal interactions by ERα, if any, would require much deeper PET sequencing. 
The high confidence interactions identified in the two ChIA-PET libraries showed a high 
percentage of overlaps between the two libraries (>70% of library 1 and >80% of library, 
Figure 15D and Table 6), suggesting that the detection of chromatin interactions by the ChIA-
PET method is qualitatively reproducible. With the understanding that the sequencing 
coverages of these two libraries are still very modest (Figure 17), we believe that further 




Table 5. Genes associated with ERα binding and interactions identified in 
previous studies and in this chapter. 
Gene Identified previously (Carroll et al. 
2005; Deschenes et al. 2007; Lin et 
al. 2007; Pan et al. 2008) 
Identified in this study 
ERαBS ERα-mediated 
Interaction 






TFF1 Yes Yes^ Yes Yes 6.26082E-26 Yes 
GREB1 Yes Yes# Yes Yes 4.14542E-26 Yes 
NAV2 Yes No No Yes 1.67931E-18 No 
SIAH2 Yes No Yes Yes 2.82192E-16 No 
P2RY2 Yes No No Yes 1.87406E-24 Yes 
TMPRSS3 Yes No Yes Yes 6.26082E-26 No 
SLC9A3R1 Yes No Yes Yes 3.79477E-14 Yes 
CXXC5 Yes No Yes Yes 4.37714E-18 Yes 
CDH26 Yes No Yes Yes 8.07967E-14 No 
ZMYND11 Yes No Yes Yes 4.20366E-13 No 
Notes: EXP= Expression of the gene is regulated by estrogen induction as 
detected by microarray experiments; A: Hypergeometric p-value of ERα 
mediated chromatin interactions detected in either or both ERα ChIA-PET library 





Figure 17. Library sequencing saturation analyses.  
We carried out a saturation analysis on each library to assess the sequencing 
depth reached and to estimate the upper bound unique sequencing attainable. The 
saturation is modeled using the Hill Function. Based on the redundancy of the 
sequenced PETs, we found that the ChIA-PET library 1 and 2 were about 16.2% 










Table 6. Statistics of overlaps between ChIA-PET library 1 and 2 interactions. 
















5 24 49 
Library 1  
inter-ligation 
singleton PETs 
12 43 1,913 
 
Of the remaining putative interactions with less significance (“medium confidence”), 
the average number of inter-ligation PETs is 2.1 in one library and 2.2 in another library. As 
expected, the number of medium confidence interactions that involve ERα binding sites is 
high: 84 of 169 (49.7%) and 78 of 190 (41.1%) interactions from each library have good 
binding sites on both sides of the interaction. Again, the vast majority of medium confidence 
interactions are intrachromosomal: 154 of 169 (91.1%) interactions from one library and 170 
of 190 (89.5%) interactions from another are intrachromosomal.  
By contrast, in the control ChIP-PET libraries (libraries not subjected to proximity 
ligation, but submitted to ERα ChIP enrichment), we did not observe any high confidence 
overlapping clusters of inter-ligation PETs. Only abundant self-ligation PETs, singleton inter-
ligation PETs scattered along the genome, and a few extremely long intrachromosomal or 
interchromosomal PET clusters were found in both of the ERα ChIP-PET control libraries 
(Table 7), indicating significant ERα ChIP enrichment but no detected interactions. The 
singleton inter-ligation PETs most likely reflect a level of possible technical noise due to 
artifactual chimeric ligation and mapping errors. Of the few inter-ligation PET clusters 
detected, most do not have ERα direct binding support (Table 7), suggesting that they were 
derived from either non-ERα mediated interactions (such as through other protein factors) or 
non-specific noise. Also as expected, the control IgG ChIA-PET library data had no 
significantly enriched sites and had no significant inter-ligation PET clusters. Together, the 
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low numbers of inter-ligation PET clusters in control libraries suggest that even medium 
confidence intrachromosomal interactions found through ChIA-PET approach in this dataset 
are likely to be specific, and not due to library construction errors, mapping errors or 
chromosomal aberrations in the MCF-7 genome. The presence of a few interchromosomal 
PET clusters in the control libraries suggests that the “medium confidence” interchromosomal 
PET clusters found in ChIA-PET are most likely non-specific random noise, further 
indicating that the vast majority of real interactions mediated by ERα binding are 
intrachromosomal.    
Table 7. Statistics of inter-ligation PET clusters in all libraries 










198 183 (115) 15# (2^) 
ChIA-PET 
Library 2 
224 203 (133) 20# (0) 
Chimeras 
 
3 2* (1) 1 (0) 
ChIP-PET 
Library 1 










0 0 (0) 0 (0) 
Note: Except for the number of all inter-ligation PET clusters, all other numbers 
for other categories in ChIA-PET replicate 1 and 2 numbers include the manual 
curation of the high confidence interactions. The intrachromosomal numbers and 
interchromosomal numbers in bracket indicate those that have ERαBS. § This is 
the previous library (Lin et al. 2007) which was reprocessed to hg18. There were 
635K raw sequences, of which 361K unique PET sequences were derived. 312K 
(87%) mapped to the genome. 501 ERαBS and 6 intrachromosomal inter-ligation 
PET clusters were found. * 1 interaction can be found in an amplicon region. The 
other interaction looks normal, but as it just occurred once, it could be a random 
noise. ** All these interactions were over 10 Mb. Based on what random 
mapping of tags would generate, this finding suggests that the interactions found 
were random. In ChIA-PET libraries 1 and 2, only 2 interactions were over 10 
Mb. 
^ 
These appear to be due to genomic structural variations. # These 
interchromosomals were subjected to manual curation as well. We found that 14 
interchromosomal interactions had significant structural variations overlapping 




We conducted 3C and ChIP-3C analyses to validate selected high confidence and 
medium confidence interactions detected by ChIA-PET sequencing data (Figures 18 and 19). 
We found that the intrachromosomal interactions detected by ChIA-PET at the GREB1 and 
P2RY2 sites are bona fide and are ligand dependent by ER binding. To further validate if 
the interacting ERα binding sites detected by ChIA-PET data specifically interact with each 
other, and not non-specifically with other ERα binding sites, we conducted ChIP-3C analysis 
between two strong ERα binding sites, one located at the GREB1 locus and the other one at 
the P2RY2 locus (Figure 18). The ChIP-3C result proved that there were no interactions 
between these two sites although they were both highly enriched by ERα ChIP, suggesting 
that the ChIA-PET detected interactions are locus-specific, and not solely dependent on high 
levels of enrichment of the ChIP fragments at the GREB1 and P2RY2 sites, or any enriched 
ERα binding sites. Moreover, we conducted 3C analysis with multiple points between the 
interacting fragments, and showed that the interactions found are not solely due to random 
flexing of the DNA polymer (Figure 19). In addition, we conducted 3C analyses in estrogen-
treated and untreated conditions, and found that interaction levels were higher in the 




Figure 18. Validation of ChIA-PET interaction data by ChIP-3C analysis. 
A.  ERα ChIA-PET mapping on chromosome 2. ERα binding sites are shown as 
blue vertical bar and ERα-mediated interactions are shown as purple rings. The 
zoomed-in view on the GREB1 locus is shown in an 80Kb window. Six ERα 
binding sites were identified in this region. The binding sites #1, #5 and #6 were 
selected to represent long (40Kb) and short (8Kb) genomic distances of 
interactions for ChIP-3C validation tests (purple arrowed lines). In addition, 
internal non-interacting sites were chosen to be negative controls of ChIP-3C 
experiments (grey dotted arrowed lines). B.  ERα ChIA-PET mapping on 
chromosome 11 and the zoomed-in view on the P2RY2 locus. Two ERα binding 
sites were identified in this region. The binding sites #1 and #2 were tested by 
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ChIP-3C experiments (purple arrowed line). Internal non-interacting sites were 
included in the ChIP-3C experiments as negative controls (grey dotted arrowed 
lines). C. Result of ChIP-3C analysis between the GREB1 binding sites #1 and 
#6 with negative controls and positive controls. D. Result of ChIP-3C between 
the GREB1 binding sites #5 and #6 with controls. E. Result of ChIP-3C between 
the P2RY2 binding sites #1 and #2 with controls. F. Result of ChIP-3C between 
the GREB1 and the P2RY2 loci. Positive controls of 3C PCR reactions using 
various primers were tested using digested, mixed and ligated BAC clones from 
the GREB1 and P2RY2 regions. (Note: ChIP-3C was performed by the lab of 





Figure 19. 3C and ChIP-3C validation of a novel chromatin interaction at 
P2RY2.  
A. Genome browser views are provided of the P2RY2 locus, which has a novel 
interaction identified by ChIA-PET. B. A 3C validation experiment shows that 
the interaction is bona fide, but would not specify if the interaction is ERα 
dependent. C. A further ERα ChIP-3C validation experiment further shows that 
the interaction is bona fide, and also that it is bound by ERα. (Note: 3C was 




Further detailed analysis focusing on high confidence interactions revealed that many 
of the ERα mediated interactions have at least one interacting locus in close proximity to the 
promoters of putative target genes (Figure 20 and Table 5). RNAPII ChIP-PCR and ChIP-
Sequencing data derived from the estrogen-induced MCF-7 cells indicate that these 
promoters and genes are transcriptionally active (Figure 21). We performed ChIP-3C analysis 
at these sites to validate the interactions, and conducted RT-qPCR analysis to show that the 
transcriptional levels of these genes are modulated over the time course of estrogen treatment. 
These results showing that many transcriptionally active genes are in close proximity to 
interacting loci suggest that the interaction structures identified by ChIA-PET analysis are 




Figure 20. Chromatin interactions and target gene expression. 
Examples of 6 loci mapped with inter-ligation PET sequences of the ChIA-PET 
experiments showing chromatin interactions. Each interaction locus tested in a 
ChIP-3C experiment is indicated by a number. ERα ChIP-3C experiments were 
performed with estrogen-treated and untreated MCF-7 cells, and the interactions 
were validated. The interacting loci are indicated by the numbers in pink. RT-
qPCR experiments suggest that the target genes are modulated during estrogen 
induction. (Note: ChIP-3C and RT-qPCR experiments were performed by the lab 






Figure 21. Transcriptional activity at the GREB1 chromatin interaction 
locus.  
We performed ChIP-qPCR and ChIP-Seq analyses to investigate transcriptional 
activity mediated by the ChIA-PET interaction. The ChIA-PET interaction near 
GREB1 could recruit RNAPII, which then transcribes the GREB1 mRNA. (Note: 
ChIP-qPCR and upstream ChIP-Seq analyses were performed by Pan You Fu, 
and downstream ChIP-Seq analyses were performed by Liu Jun). 
 
Discussion 
In this study, we demonstrated that the ChIA-PET strategy combined with ultra high 
throughput sequencing is an unbiased, whole genome approach for de novo analysis of 
chromatin interactions, which represents a significant advance in our ability to study higher-
order organization of chromosomal structures and functions. Because a single ChIA-PET 
experiment is capable of providing two global datasets: the protein factor binding sites and 
the interactions among the binding sites, this method is conceptually superior to all currently 
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available methodologies including the recently reported ChIP-Seq (Johnson et al. 2007) that 
provides only protein/DNA binding information for chromatin interactome analysis.  
The most distinctive technical component that sets the ChIA-PET method apart from 
the 3C and its variants is the introduction of a linker sequence to the junction of two DNA 
ends in proximity ligation. With this common biotinylated oligonucleotide sequence ligated 
to all proximity ligation products, we can easily manipulate the proximity ligation products 
for efficient PET extraction and ultra high throughput sequencing analysis. In addition, the 
oligonucleotide linker can be used for barcoding purposes. In this way, similar technical 
conditions can be used to compare two ChIA-PET profiles of two different biological 
replicates, or even two different samples. This PET strategy is particularly suitable for 
sequencing analyses using massively parallel tag-based sequencing platforms (Fullwood et al. 
2009b). Although in this study we used the Roche 454 sequencing technology, the ChIA-PET 
method is flexible and can be coupled with any of the tag-based next-generation sequencing 
systems such as Illumina/Solexa (Barski et al. 2007; Johnson et al. 2007) and SOLiD 
(Shendure et al. 2005).  
 The incorporation of ChIP into the ChIA-PET method is also critical. First, ChIP 
helps to reduce the complexity of proximity ligation products for sequencing analysis. The 
use of ERα ChIP allowed us to enrich ERα-mediated interactions for sequencing-based 
detection within the current sequencing capacity. Second, the use of ChIP also elucidates 
whether a particular protein factor is bound to the interactions, which is information that 3C 
cannot provide. The detection scope of a ChIA-PET analysis can be well defined by the 
choice of the protein factor for ChIP. The use of transcription factors such as ERα for ChIA-
PET analysis will identify all ERα-mediated interactions. If the target is a general factor for 
transcription such as RNAPII or TAF, the ChIA-PET analysis would identify all 
transcription-related interactions. Similarly, if chromatin structure proteins are applied to 
ChIA-PET, then chromatin structure-related interactions will be revealed. Therefore, there 
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will be a balance between the specificity and the scope of interactions. Collectively, all 
specific interactions mediated by protein factors can be identified by the ChIA-PET approach.  
 The complexity of a ChIA-PET library is very high. In this ERα ChIA-PET 
experiment, although we generated close to one million PETs for each of the two libraries, 
they are still far from saturation (Figure 17). With the depth of sequencing analysis presented 
in this study, we probably only detected highly frequent interactions. Thorough analysis by 
much deeper sequencing of ChIA-PET libraries will provide comprehensive whole genome 




Chapter Four: The Estrogen Receptor α-mediated Human Chromatin Interactome 
 
Introduction 
Encouraged by findings in Chapter Three indicating that ChIA-PET can find bona fide de 
novo chromatin interactions, we went on to comprehensively characterize ERα-mediated 
chromatin interactions in estrogen-treated human breast adenocarcinoma cells (MCF-7). 
Thus, we generated the first human chromatin interactome map. Using this map, we explored 
chromatin interactome biology. We asked whether most high quality ERα binding sites 
(ERαBS) are involved in chromatin interactions. Furthermore, using active promoter and 
transcriptional marks such as H3K4me3 and RNAPII from ChIP-sequencing as well as gene 
expression microarray data, we asked whether ERα-mediated chromatin interactions are 
functionally involved in regulating specific genes.  
Results 
ERα-mediated chromatin interactome map 
Using the ChIA-PET method to examine ERα binding and chromatin interactions in estrogen-
treated MCF-7 cells, we generated 5.9 million non-redundant ChIA-PET sequences using 
next-generation sequencing. 3.6 million (61%) PET sequences were mapped to the human 
reference genome (hg18), and 1.7 million uniquely aligned PET sequences were processed 
for further analysis (Table 8). Of the uniquely aligned PET sequences (1.7 million), 0.46 
million (25.7%) were considered “self-ligation PETs” as the two tags of each PET mapped 
within 3 kb of each other (Lin et al. 2007; Wei et al. 2006). 32.1% self-ligation PETs formed 
overlapping PET groups, representing 9,015 putative ERαBS (False Discovery Rate, FDR< 
0.01) (Appendix). Besides self-ligation, the tethered DNA fragments in individual chromatin 
complexes could also ligate with each other. We found 0.11 million (6.2% of uniquely 
aligned PETs) intrachromosomal inter-ligation PETs (both tags of each PET are from the 
same chromosome) and 1.2 million (68%) interchromosomal inter-ligation PETs (the tags are 
from different chromosomes) (Table 8). 
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Total PET sequences 
5,924,521 
(100.0) 
    
  Unmapped PETs 
2,339,986 
(39.5) 
    
  Mapped PETs 
3,584,535 
(60.5) 








    







































Notes: 1. The uniquely mapped PETs were further collapsed if different PET 
sequences with their two tags were aligned in same genomic location with a 
difference of only two base pairs. 2. If the alignment locations of the two tagged 
DNA fragments of a PET overlapped with the two tagged DNA fragment 
locations of another PET, these two PETs were considered to be “Overlap PETs”. 
3. The clusters of overlapping self-ligation PETs are based on FDR<0.01. 4. The 






 After filtering out inter-ligation PETs that mapped as singletons (non-overlapping 
PET sequences) in the reference genome, which is presumed experimental background noise, 
we identified a set of 2,496 intrachromosomal and 303 interchromosomal overlapping 
clusters of inter-ligation PETs, representing paired inter-ligating ChIP fragments which 
indicate potential distant chromatin interactions bound by ERα (Appendix) (Figure 22).  
 
Figure 22. A whole genome view of the human chromatin interactome map 
mediated by ERα binding. 
This map consists of ERαBS (blue vertical bars; the arrow heads indicate peak 
intensities above the display cutoff limit) and chromatin interactions with 3 or 
more inter-ligation PETs (purple circles with color gradient corresponding to 
PET count in each interaction) in the MCF-7 genome. Inset: The length 
distribution of the chromatin interactions. (Note: Binding sites and interactions 
were found by Han Xu and Vinsensius Vega. The Whole Genome Interaction 
View was developed by Hong-Sain Ooi, Pramila Ariyaratne, and Yusoff Bin 
Mohamed). 
 
Each interaction detected by an inter-ligation PET cluster consists of two anchor 
regions (the two interacting loci) and a loop (the intermediate genomic region between the 
two anchors), and is therefore called a duplex interaction (Figure 23). While some of the 
interaction anchors showed weak ERα binding that did not reach an arbitrary cut-off to be 
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called a binding site, most of the anchors (4,378/5,598=78%) were identified as ERαBS 
(FDR< 0.01). 
 
Figure 23. Illustration of structural components of ERα-mediated 
interactions. 
Structures of tags, PETs, duplex interactions, complex interactions, anchors, 
loops, and genes associated with interactions. 
 
Manual evaluation of the inter-ligation PET clusters revealed that most 
interchromosomal inter-ligation PET clusters (Appendix) derived from either highly 
repetitive or highly amplified genomic regions, representing mostly tag mapping artifacts. 
PET clusters located in these regions were filtered out. To reduce mapping noise, we used 
more stringent parameters by requiring 3 or more inter-ligation PETs to be present in an inter-
ligation PET cluster (as depicted in Figure 22). This left 21 interactions, of which 3 had 
ERαBS on both sides. The 3 interchromosomal interactions are: chr1:121185663-121186957 
to chr19:32423623-32426631 (4 inter-ligation PETs), chr8:126146208-126153795 to 

























chr10:43408532-43416137 (3 inter-ligation PETs). We consider these 3 interchromosomal 
inter-ligation PET clusters to be of the highest confidence within the interchromosomal class, 
pending further validation studies. Nevertheless, all inter-ligation PET clusters were found to 
only have 2-4 inter-ligation PETs, and to date, have not yielded positive results in FISH 
validation tests. In contrast, most (2,287, 92%) of the 2,496 intrachromosomal inter-ligation 
PET clusters did not show such characteristics, and were taken to involve genuine 
interactions. Several intrachromosomal interactions could also be validated. Hence, ERα 
appears to primarily mediate intrachromosomal interactions. Our remaining analyses, 
therefore, focused on intrachromosomal interactions.  
In all, we validated a number of selected putative intrachromosomal interactions (16 
duplex interactions in 9 different interaction regions) by 3C, ChIP-3C, 4C, and FISH 
experiments (Chapter 3 shows some validations; others are shown in Figure 24). In each case, 
the intrachromosomal interactions could be repeatedly confirmed by alternative validation 
technologies. The 3 interchromosomal interactions were tested by FISH, but to date, have not 
given positive FISH results, suggesting the interactions are either too weak to be detected by 




Figure 24. ChIA-PET interaction validations.  
A. An example of ChIA-PET data as shown in a genome browser at the GREB1 
locus. The data tracks below the gene model are: 1. Peak density of H3K4me3 
ChIP-Seq data (green); 2. Peak density of RNAPII ChIP-Seq data (blue); 3. 
ChIP-chip data of ERα binding (red for high and orange for low confidence) and 
FoxA1 binding (green for high and light green for low confidence) (Lupien et al. 
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2008); 4. Density peaks of ERα ChIA-PET self-ligation PETs (brick red); 5. 
Intrachromosomal inter-ligation PETs (purple), in which tag alignments are 
shown as vertical bars with extended solid lines to represent DNA fragments and 
dotted lines for connecting the paired tags; 6. Compact density view of 
interchromosomal inter-ligation PETs (light blue). Inset: 3C using quantitative 
(qPCR) validation of chromatin interactions between ERαBS 1, 2, and 6 of the 
GREB1 interaction complex. B. ERα-mediated chromatin interaction complex at 
the keratin gene cluster and validation data by 4C. The vertical bar shows the 
“bait” anchoring detection site, and the horizontal bars show interacting 
fragments as determined by 4C sequencing. C. ERα-mediated chromatin 
interaction complex near NR2F2 and FISH validation. P1 represents a control 
BAC probe. P2 and P3 are test BAC probes near the two anchors of the 
interaction complex covering >1 Mb. The FISH experiments using the combined 
probes of P1/P2 and P2/P3 were done in ET (ethanol control) treated and E2 
(estrogen) treated MCF-7 cells. The FISH images of the probe pairs show red and 
green spots when the probes are separated (ET-P1/P2 and E2-P1/P2), and yellow 
sections between red and green spots when the probes overlap (ET-P2/P3 and 
E2-P2/P3). The probe overlap rate in E2-P2/P3 (73.9%) is significantly higher 
than the overlap rate in control experiments of E2-P1/P2 (20.7%) and ET-P2/P3 
(60.3%) by Fisher’s Exact Test (Fisher’s Exact Test 2-tailed p-value is 3.3e-59 
and 9.8e
-12
 respectively). (Note: 3C was performed by Mei-Hui Liu, 4C was 
performed together with Phillips Huang, and FISH was performed together with 
Valere Cacheux-Rataboul). 
 
Interestingly, manual evaluation revealed that many duplex interactions are 
connected to other duplex interactions, linking three or more anchors into “daisy-chain” 
aggregated complex interactions, each involving 2 or more duplex interactions (Figures 25-
26). While 663 interactions were stand-alone duplex interactions (Figure 25), based on such 
connectivity, 1,684 of the 2,287 duplex interactions were further assembled into 406 complex 
interactions (Figure 26). Collectively, we identified 1,009 ERα-mediated interaction regions 




Figure 25. Example of a stand-alone duplex interaction structure. 
The data tracks below the UCSC Known Gene isoforms are: 1. Peak density of 
H3K4me3 ChIP-Seq data (green); 2. Peak density of RNAPII ChIP-Seq data 
(blue); 3. ChIP-chip data of ERα binding (red for high and orange for low 
confidence) (Lupien et al. 2008); 4. Density peaks of ERα ChIA-PET self-
ligation PETs (brick red); 5. Intrachromosomal inter-ligation PETs (purple), in 
which tag alignments are shown as vertical bars with extended solid lines to 
represent DNA fragments and dotted lines for connecting the paired tags; and 
clusters of overlapping inter-ligation PETs are shown as anchor (thick purple 
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Figure 26. Example of a complex interaction structure.  
(Note: Clustering of interactions was performed by Han Xu). 
 
Often, the strongest ERαBS in a complex interaction is either far upstream of the TSS 
(Figures 27-28), or downstream of the polyadenylation signal sequence (PAS) or within 
introns (Figures 29-30), with each ERαBS linked through interactions with the promoter; and 
anchors adjacent to gene promoters may lack significant ERαBS but still have weak ERα 
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binding (Figures 31). These observations suggest that direct ERα binding might be initiated at 
multiple distal sites, and then recruit other binding sites as anchors to form an interaction 





Figure 27. Example on chr 5 (STC2) showing stronger binding sites at distal 
regions than promoters. 
chr5:172650000..172970000
Supplementary Figure 3B. Example of gene and interaction with stronger anchors 




Figure 28. Example on chr 8 (KLF10) showing stronger binding sites at 
distal regions than promoters. 
 
Chr8:103670000..103745000 
Supplementary Figure 3C. Example of gene and interaction with stronger anchors 




Figure 29. Example on chr11 (DHCR7, NADSYN1) showing stronger 
binding sites at distal regions than promoters. 
 
Chr11:70820000..70903582 
Supplementary Figure 3D. Example of gene and interaction with stronger anchors 




Figure 30. Example on chr20 (TFAP2C) showing stronger binding sites at 
distal regions than promoters. 
chr20:54613236-55081395
Supplementary Figure 3G. Example of genes and interactions with weak anchor 




Figure 31. Example on chr17 (TOB1) showing stronger binding sites at 
distal regions than promoters. 
Chr17:46275000..46390000 
Supplementary Figure 3E. Example of genes and interactions with weak anchor 
and no significant ERαBS at promoter.
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 Taken together, the ERαBS and chromatin interactions identified by ChIA-PET data 
constitute a whole genome chromatin interaction map mediated by ERα binding (Figure 22). 
The genomic span of most interactions (~80%) is less than 100 Kb, about 20% are in the 
range of 100-1000 Kb, and very few are over 1 Mb. Complex interactions extend genomic 
span by connecting multiple duplex interactions. Hence, most complex interactions (~60%) 
have genomic spans in the range of 100-1000 Kb, with a few that are over 1 Mb (Figure 22; 
Appendix). 
ERαBS association with interactions and other DNA elements 
 In this interactome map, we asked how many ERαBS are involved in chromatin interactions. 
We classified the involvement of ERαBS with chromatin interactions into 4 levels: binding 
sites involved in complex interactions (strong-interactions) (Figures 25, 31 and 32A); in 
stand-alone duplex interactions (intermediate-interactions) (Figures 24 and 32B); with 
singleton inter-ligation PETs, which are regarded as “weak-interactions” (Figure 32C) and 
may require even deeper sequencing to distinguish whether they are signal or noise; and 




                                                          
1
 Here we used 2 or more inter-ligation PETs to define a cluster as opposed to 3 or more inter-
ligation PETs previously. The reason is that otherwise, we would have to create a further 
category, interactions with only 2 inter-ligation PETs, which would complicate results. This 




Figure 24. Different classes of involvements of ERαBS with chromatin 
interactions. 
 
Of the 9,015 putative ERαBS (FDR < 0.01, PET count per ERαBS ≥5), 20% were 
involved in strong-interactions, 11% in intermediate-interactions, 65% in weak-interactions, 
and only 3% did not associate with any interactions at all (no-interaction) (Figure 33). 
ERαBS with low-enrichment (5-19 PET counts per site) are less involved in strong- and 
intermediate-interactions (16%), and less associated with ERα ChIP-chip data (Carroll et al. 
2006; Lupien et al. 2008), while ERαBS with high-enrichment (≥20 PET counts per site) are 
more frequently involved in interactions (56%) and more associated with ERα ChIP-chip data 
(Figure 34).  
 
Figure 25. Numbers of ERαBS in different classes of interaction association.  
These charts show the number of ERαBS in different classes of interaction 
association: ERαBS with strong-interactions (complex interactions) are shown in 
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dark purple; ERαBS with intermediate-interactions (stand-alone duplex 
interactions) are shown in light purple; ERαBS with weak-interactions are shown 
in yellow; and ERαBS with no-interactions are shown in white. ERαBS were also 
classified according to ChIP enrichment levels: all 9,015 ERαBS (left, FDR< 
0.001, PET count per ERαBS ≥5); ERαBS with low-enrichment (middle, 5-19 
PET counts per site); and ERαBS with high-enrichment (right, ≥20 PET counts 
per site). 
 
Figure 26. Association of binding sites with interactions and genomic 
elements. 
Association of  A. all ERαBS (≥5 PET counts per binding site), B. ERαBS with 
low ChIP enrichment (5-19 PET counts per binding site) and C. ERαBS with 
high ChIP enrichment (≥20 PET counts per binding site) involved in strong-
interactions (dark purple), intermediate-interactions (purple), weak-interactions 
(yellow), no-interactions (light blue) and background controls (grey) with ERα 
and FoxA1 binding sites identified by ChIP-chip (Lupien et al. 2008), 
Transcription Start Sites (TSS) of known genes (UCSC known genes (Hsu et al. 
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Supplementary Figure 4. ERαBS association with interactions and other DNA elements
97 
 
used were singleton ChIA-PETs, and these were also associated with different 
genomic elements. As the singletons are random in the genome, they show the 
expected level of association by random chance. The ratios of the number of 
ERαBS in strong-interactions vs. weak-interactions were calculated for each 
genomic element. (Note: H3K4me3 ChIP-Seq was performed by Roy Joseph). 
 
Furthermore, FoxA1 (a known “pioneer factor” to ERα-chromatin binding (Carroll et 
al. 2006; Lupien et al. 2008)) binding sites are significantly enriched in association with 
ERαBS involved in strong- and intermediate-interactions as compared to ERαBS involved in 
weak-interactions or no-interactions (Fisher’s Exact Test 2-tailed p-value = 5.4e-15, Materials 
and Methods in Chapter 6, Figure 34). These results suggest that ERαBS with high PET 
counts are more reliable, and most bona fide ERαBS are engaged in chromatin interactions.  
Besides FoxA1, we were interested in finding potential co-factors of ER from our 
data and assessing whether they were significantly involved in the chromatin interaction 
detected using the ChIA-PET assay. We used the presence of binding motif (as defined using 
TRANSFAC weight matrices and criteria) as a proxy to the transcription factor binding. First, 
we looked for motifs that were enriched in the datasets of binding sites. This analysis was 
performed in a similar manner as previously described (Lin et al. 2007), except hg18 was 
used instead of hg17. In addition to finding the ERα motif, we also found many motifs that 
had previously been found to be associated with ERα binding, such as FoxA1 (Lin et al. 
2007). Next, we looked for motifs that were enriched in ERαBS with high- and intermediate- 
interactions as compared to ERαBS with weak-interactions. To do this, we began with motifs 
that were enriched in binding sites within interaction regions, and filtered out non-vertebrate 
motifs, motifs without FDR< 0.05, and motifs with fewer than 50 sequences with at least 1 
hit (called "hits"). On the remaining motifs, we employed Fisher’s Exact Test to determine 
which motifs were significantly enriched in the dataset of binding sites with interactions as 
opposed to those that do not. We also performed Bonferroni correction for multiple 
hypothesis testing. Vitamin D Receptor (VDR; V$VDR_Q3, Bonferroni-corrected 1-tailed p-
value = 0.00095614) was significantly enriched within the pool of binding sites with 
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interactions. Vitamin D receptor has been shown to be involved with estrogen receptor 
functioning (Lee et al. 2007).  While the FoxA1 motif was found to be enriched in binding 
sites, it was not found to be significantly enriched between binding sites with and without 
interactions (Bonferroni-corrected 1-tailed p-value = 1). A possible explanation for the 
disparity between the experimental findings and the findings from motif predictions with 
respect to FoxA1 is that not all motifs are occupied by FoxA1 proteins, such that even though 
the number of motifs might be similar between the two datasets, the levels of occupation by 
FoxA1 protein are higher in the binding sites with interactions category. In addition, while 
the ERE motif was found to be enriched in binding sites, it was not found to be significantly 
enriched between binding sites with and without interactions (ER; V$ER_Q6, Bonferroni-
corrected 1-tailed p-value =1). This finding suggests that the significant enrichment of VDR 
within the pool of binding sites with interactions is not due to similarities between it and the 
ERE motif. TRANSFAC analyses are given in the Appendix.  
Next, we analyzed the relationship between ERαBS and gene promoters, and found 
that ERαBS are rarely at the transcription start sites (TSS) of known genes (UCSC known 
genes (Hsu et al. 2006)) (Figure 34), which is consistent with early experimental data 
showing that most ERαBS are distal to gene promoters (Carroll et al. 2005; Carroll et al. 
2006; Lin et al. 2007).  
To further investigate the involvement of ERαBS in transcription activation, we 
generated genome-wide histone H3 lysine 4 trimethylation (H3K4me3) and RNA Polymerase 
II (RNAPII) ChIP-Seq data from MCF-7 cells under estrogen induction (Materials and 
Methods, Chapter 6). H3K4me3 is a histone modification mark specific to active promoters 
(Barski et al. 2007), and the presence of RNAPII is strong evidence for genes that are actively 
transcribed (Phatnani et al. 2006). H3K4me3 and RNAPII marks are significantly enriched in 
ERαBS with strong- and intermediate-interactions as opposed to ERαBS with weak-
interactions (Fisher’s Exact Test 2-tailed p-value = 0.00034827 and 2.5e-17 respectively) 
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(Figure 34), suggesting that ERα-mediated interactions are associated with transcriptional 
activation, by potentially employing long-distance looping to bring remote ERαBS close to 
gene promoters. Thus, this explains why H3K4me3 and RNAPII marks can be found even at 
distal ERαBS (Figure 31A, B).  
To further understand transcriptional activation with respect to ERαBS with and 
without interactions, we examined the percentages of upregulated and downregulated genes. 
As previously described, genes in proximity to transcription factor binding sites such as ERα 
and p53 appear to be more likely to be upregulated than downregulated (Lin et al. 2007; Wei 
et al. 2006). Considering all 9,015 binding sites, more binding sites are associated with 
downregulated genes (418) than those associated with upregulated genes (378); however, 
such binding sites tend to be low-enrichment ERαBS. This association is not significant 
(Fisher’s Exact Test 2-tailed p-value = 0.157) When high-enrichment ERαBS (≥20 PET 
counts per site; 3454 binding sites) are considered, more binding sites are associated with 
upregulated genes (176) than those associated with downregulated genes (128). This 
association is significant (Fisher’s Exact Test 2-tailed p-value = 0.00575). Partitioning all 
binding sites, we found that ERαBS with strong- and intermediate- interactions tend to have 
significantly better association with upregulated genes than binding sites with weak- or no- 
interactions (Fisher’s Exact Test 2-tailed p-value = 0.000809). This trend continues into the 
high-enrichment ERαBS, although significance testing failed to show significance (Fisher’s 
Exact Test 2-tailed p-value = 0.640). By contrast, we found that ERαBS with strong- and 
intermediate interactions are significantly under enriched in downregulated genes compared 
with binding sites with weak- or no-interactions (Fisher’s Exact Test 2-tailed p-value = 
0.0000187). This trend continues into the high-enrichment ERαBS, and is significant 





Table 9. Upregulated and downregulated genes near ERαBS. 
 Strong Intermediate Weak No Background 
ERαBS (≥20 PET counts per site) 
UCSC known genes 
transcription units 
33.8% 36.0% 37.7% N.A. 25.8% 
Downregulated gene 
transcription units 
2.5% 3.0% 5.1% N.A. 2.2% 
Upregulated gene 
transcription units 
6.0% 3.8% 4.9% N.A. 1.7% 
ERαBS (5-19 PET counts per site) 
UCSC known gene 
transcription units 
34.0% 37.0% 37.7% 39.7% 25.8% 
Downregulated gene 
transcription units 
4.0% 5.4% 5.2% 7.2% 2.2% 
Upregulated gene 
transcription units 
6.1% 4.3% 3.4% 2.4% 1.7% 
ERαBS (≥5 PET counts per site) 
UCSC known gene 
transcription units 
33.9% 36.4% 37.7% 39.7% 25.8% 
Downregulated gene 
transcription units 
2.9% 3.9% 5.2% 7.2% 2.2% 
Upregulated gene 
transcription units 
6.0% 4.0% 3.8% 2.4% 1.7% 
Note: ERαBS were partitioned into different categories and associated with UCSC 
Known gene transcription units, as well as up or downregulation information. 
 
Chromatin interaction and transcription regulation 
Subsequently, we examined the ERα-mediated chromatin interaction regions with respect to 
gene transcription. For added stringency, we focused on the 406 complex interactions and the 
181 stand-alone duplex chromatin interactions that consist of 3 or more inter-ligation PETs 
(587 interaction regions). We envisage that multiple ERαBS may function as “anchor” 
regions generating looping structures in 3-dimensional space (Figures 24, 25 and 35A). We 
annotated the 587 interaction regions in relation to UCSC known gene database entries (Hsu 
et al. 2006). A gene was considered associated with a chromatin interaction region if a 
transcriptional unit has a TSS in or within 20 kb of the interaction boundaries. Most 
interaction regions (400/587=68%) were associated with genes (altogether, 3,957 UCSC 
known gene entries; Appendix). Many interaction regions include multiple genes, such as the 
keratin gene cluster (Figure 31B) and NR2F2 locus (Figure 31C). 1,490 entries (38% of 3,957 
interaction-associated genes) have their TSS proximal (within 20 kb) to at least one anchor in 
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an interaction region. Genes with such transcriptional units are called “anchor genes”. The 
remaining 2,467 transcriptional units are far away from interaction anchors and reside in 
loops of the interactions; genes with such transcriptional units are therefore denoted “loop 
genes” (Fig. 35A).  
We found that most interaction-associated genes have active promoter status 
(associated with H3K4me3 peaks) and are actively transcribing (associated RNAPII peaks) 
while non-associated genes are significantly less associated (Fisher’s Exact Test 2-tailed p-
value = 0.0507 and 7.18e
-18
; Table 10). Moreover, in the interaction-associated genes, 
significantly higher percentage of anchor genes are actively transcribing (RNAPII marks) 
than the loop genes (Fisher’s Exact Test 2-tailed p-value = 0.00384 and 0.00001653 
respectively; Table 10). We further analyzed the expression profiles of genes involved in 
chromatin interactions using microarray gene expression data over a time course of estrogen 
induction (Materials and Methods, Chapter 6), and validated selected examples using RT-












Table 10. Association of ERα-mediated chromatin interactions with genes. 



























































































Notes: ^All numbers are given in terof gene transcription units. “Transcription 
unit” is abbreviated as “TU”. *This number only shows the transcription units 
present on chromosomes 1-22 and chromosome X, and minus the genes involved 
in interactions. ¶ The percentages of genes with H3K4me3 and RNAPII marks 
are based on the number of TU in each category. § The percentages of genes 
differentially expressed are based on the number of TU in each category. # The 
percentages of up or down regulated genes are based on the number of 





Figure 27. ERα-mediated chromatin interaction regions are associated with 
gene upregulation 
A. Proposed model of multi-looping structure of chromatin interactions with 
multiple anchors by ERα binding. Anchor genes (green for top strand and blue 
for bottom strand) have promoters in close proximity to interaction anchoring 
center, where the transcription machinery are assumed in high concentration, and 
hence are active. Loop genes (gray) tucked inside the loop structure far away 
from the interaction anchoring center are less active. Similarly, genes outside the 
interaction structures (gray) may not be regulated through ERα binding. B. Gene 
expression microarray results over an estrogen induction time course (0, 3, 6, 9, 
12, 24, 48h) of differentially expressed genes involved in chromatin interactions. 
Enclosed anchor genes, anchor genes and loop genes are presented. The UCSC 
Known Genes (Hsu et al. 2006) less the interaction-associated genes, “Known 
genes”, were used as a general background control set for comparison. Red 
denotes estrogen-mediated activation and green denotes estrogen-mediated 
repression. C. and D. Examples of complex interactions involving multiple genes 
that are differentially transcribed as shown by H3K4me3 and RNAPII marks as 
well as RT-qPCR analysis. (Note: Microarray data was prepared and analyzed 





We found that interaction-associated genes are preferentially upregulated compared 
to non-associated genes (Fisher’s Exact Test 2-tailed p-value = 2.73e-25; Table 10). 
Interaction-associated genes are weakly preferentially associated with downregulated genes 
compared to non-associated genes (Fisher’s Exact Test 2-tailed p-value = 0.0701; Table 10). 
Moreover, anchor genes are preferentially upregulated compared to loop genes (Fisher’s 
Exact Test 2-tailed p-value = 3.013e
-17
; Figure 35B, Table 10). By contrast, anchor genes are 
not significantly downregulated compared to loop genes (Fisher’s Exact Test 2-tailed p-value 
= 0.349; Table 10). 
Intriguingly, within the anchor gene category, we found that the majority (1,096 out 
of 1,490, 74%) of gene entries have 5’ and 3’ ends within the interaction boundaries. Such 
entries, called “enclosed anchor genes”, frequently occupy the entirety of short interaction 
loops and are often found to engage multiple anchor sites within the gene structure as well. 
We observed that the “enclosed anchor genes” tend to have intense RNAPII marks covering 
the entire gene (examples in Figures 32A, B and 36-37), and are preferentially associated 
with RNAPII marks compared to non-enclosed anchor genes (Fisher’s Exact Test 2-tailed p-




Figure 28. Example of an enclosed anchor gene on chr 5 (CXXC5). 
 
 
Supplementary Figure 5B. An example of genes tightly enclosed by a number of 





Figure 29. Example of an enclosed anchor gene on chr 2 (MLPH).  
 
Moreover, enclosed anchor genes are preferentially upregulated compared to non-
enclosed anchor genes (Figure 35B, Fisher’s Exact Test 2-tailed p-value = 0.017; Table 10). 
Taken together, our data shows a gradient of functional association with ERα binding 
involved chromatin interactions and gene transcriptional activation: the enclosed anchor 
genes are closely correlated with upregulation as measured by gene expression microarray 
data and the RNAPII ChIP-Seq peaks, followed by non-enclosed anchor genes, loop genes, 
Chr2:238040000..238145000 
Supplementary Figure 5C. An example of genes tightly enclosed by a number of 
chromatin interaction loops in a complex interaction.    
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and then genes not associated with interactions. Collectively, these results suggest that gene-
centric interaction structures may provide an enclosed compartment for achieving higher 
local concentrations of ERα, transcription co-factors, and general transcriptional components 
at the target genes. We further speculate that transcriptional machinery could recirculate and 
cycle between transcription starting and ending sites of “enclosed anchor genes” tethered by 
ERα binding. This would represent a parsimonious strategy for transcriptional enhancement.  
 We also found evidence that ERα-mediated interactions may coordinate transcription 
regulation for genes involved in same functional pathways. One example is the complex 
interaction that encompasses 3 genes, FOS, JDP2, and BATF (Figure 35D) which encode the 
dimerization partners of JUN to form the AP-1 transcription factors. AP-1 is important in 
estrogen-mediated transcription, functioning either as a DNA tethering partner or as an ERα 
co-factor (Kushner et al. 2000). In this complex interaction, FOS and BATF are enclosed 
anchor genes, and are upregulated as shown by RNAPII marks and RT-qPCR; whereas JDP2 
is a loop gene and is downregulated as shown by RT-qPCR and the lack of an RNAPII mark. 
We also noted that JDP2 has H3K4me3 marks, and that many loop genes are only marked by 
H3K4me3 (Table 10). It is conceivable that JDP2 and other loop genes could be “poised” and 
ready to be activated if it escapes from the interaction loop (Figure 35D).  
 Another very interesting example is the interaction region at the keratin gene cluster 
(Fig. 31B). Keratins play major structural roles in cells (Fuchs et al. 1994; Rogers et al. 2005; 
Steinert et al. 1988), and mutations give rise to various human hereditary keratin diseases, 
such as epidermolysis bullosa simplex (Moll et al. 2008). Keratins are also known to be 
involved in signaling and regulatory pathways (Moll et al. 2008). Keratins have very distinct 
expression patterns, and epithelial tumors frequently have the same patterns as the originating 
cells. This finding has led some genes, including KRT8, KRT18, and KRT7, to be used in 
immunohistochemistry analyses of cancers to identify tumor origins (Moll et al. 2008). 
Keratins are present in the human genome as two families: type I genes on chr17, and type II 
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genes on chr12 (Rogers et al. 2005). Keratins are unique in that type I genes and type II genes 
pair up by the formation of a heterodimer between one type I and one type II. Any keratin 
proteins that deviate from this rule are rapidly degraded (Lu et al. 1990). Therefore, gene 
expression in the keratin gene cluster has to be highly regulated in order to maintain distinct 
coexpression patterns. We hypothesize that chromatin interactions help in coordinating gene 
regulation and in maintaining coexpression patterns. We examined MCF-7 human breast 
adenocarcinoma cells, which are derived from ductal epithelial cells. Of the keratins used in 
immunohistochemistry diagnosis, breast adenocarcinomas typically express KRT8, KRT18, 
KRT19, KRT7, and occasionally KRT5, but not KRT20. Analysis of chromatin interactions 
in the keratin region suggests that chromatin interactions are correlated with gene expression 
coordination. Both ChIA-PET and 4C data shows that KRT7, KRT8, and KRT18 are all 
pulled into the “hub” of the same interaction complex. KRT7, 8, and 18 are known to be 
expressed in breast carcinomas. In particular, KRT8 and KRT18 are tightly coexpressed 
genes, and the gene products bind tightly to each other. These two genes are connected by 
many inter-ligations. By contrast, KRT5, 6, 1, 2, and the hair keratins are not expressed, and 
they are present in the “loop” of the interaction complex. Hence, chromatin interactions in the 
keratin region may bring together relevant genes into transcriptional foci, and loop out 
irrelevant genes, in order to achieve tightly coordinated gene expression regulation.  
Taken together, our results suggest that long-range transcriptional regulation by ERα 
may be a fine-tuning mechanism that evolved to differentially regulate specific sets of related 
genes. To functionally determine whether such ERα-associated interaction regions are 
dependent on ERα, we used siRNA to knock down the level of ERα protein in MCF-7 cells 
(Materials and Methods, Chapter 6) and then measured if the interactions are disrupted and if 
gene transcription is affected. As shown in Figure 38, siRNA against ERα (siERα) efficiently 
reduced the amount of ERα protein compared to control siRNA, and effectively abolished the 
long-range chromatin interactions as demonstrated by a set of 3C assays at the GREB1 locus. 
Furthermore, siERα blocked GREB1 transcription as determined by measuring the mRNA 
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using RT-qPCR. This experiment was also previously conducted at the TFF1 site – resulting 
in a total of two sites examined in this manner, and similar results were obtained at the TFF1 
site (Pan et al. 2008). In both cases, the chromatin loop and gene expression levels were 
greatly reduced, to close to zero. These data indicate that long-range chromatin interactions 
identified by ERα ChIA-PET data are dependent on ERα, and are required for the 
transcription regulation of estrogen target genes. Further work examining more sites would be 
desirable, and would help to substantiate the notion that ERα mediates chromatin interactions 
at most sites, as opposed to being a passive binder of chromatin interactions. 
 
Figure 30. ERα-mediated chromatin interactions are required for 
transcription of estrogen-regulated genes. 
MCF-7 cells were transfected with either control (siControl) or siRNA against 
ERα (siER), respectively, and then analyzed by (A) western blot with 
antibodies directed against ERα and calnexin as a control, (B) 3C assays at the 
GREB1 locus, and (C) RT-qPCR to assess the mRNA levels of GREB1. (Note: 
siRNA knockdown analysis was performed by the lab of Edwin Cheung). 
 
Discussion 
 Early genome-wide ChIP studies have found many more TFBSs than regulated genes and 
raised  questions such as, why there are so many binding sites distal to gene promoters, are 
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these distal TFBSs functional, and if these TFBSs function at such distances, then which 
genes are regulated by these binding sites? Our results provided plausible answers to these 
questions. From this comprehensive map of a human chromatin interactome, we postulate a 
primary mechanism for ERα function in transcription regulation: ERα protein dimers are 
recruited to multiple ERαBS which may interact with one another to form looping structures 
around target genes; such topological architectures may partition individual genes in sub-
compartments of nuclear space for differential transcriptional activation or repression.  
 
Figure 31. A model for ERα function via chromatin interactions. 
In particular, anchor genes and enclosed anchor genes which are near the 
anchoring center especially in interactions with small loops, are packaged into a 
tight sub-compartment of chromatin looping structures, which could increase the 
local concentration of ERα, and transcriptional cofactors. Interactions may 
coordinate the regulation of different genes involved. Loop genes, especially 
those in large loops, may be separated from the transcriptional hub and thus be 
silenced. 
 
An intriguing question is why a transcription factor such as ERα evolved to use such 
an extensive and intensive chromatin interaction mechanism for transcription regulation. 
When viewed in total, our data suggest that these chromatin interactions represent the most 
parsimonious use of binding sites constrained by an imposed linear distribution (order) in 
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several levels. First, the obvious redundancy in ERα binding and interactions is thought to 
enhance the robustness of ERα transcriptional control such that mutations at any one 
interaction site would not entirely eliminate regulatory control. Second, as a matter of 
topology, looping and anchor clustering provides greater degrees of advance for direct 
regulation of the transcriptional machinery than the proximity constraints of linear DNA. We 
further speculate that chromatin interaction centers involve many strands of chromatin 
coming together that could help achieve and maintain high local concentrations of 
transcriptional components. Loops that connect gene transcription start and end sites may 
allow for cycling of transcriptional machinery in a highly efficient manner. It is now known 
that ERα-DNA interactions at a defined ERαBS oscillate in an on-off state with periodicity, 
and oscillators use boundaries to change wave direction (Metivier et al. 2003). Given the 
extensive system of interaction complexes, ERα could oscillate between spatially proximate 
anchors of interaction regions, using the chromatin boundaries to provide oscillation 
dynamics to ERα behavior. Thus, the looping and anchor system we hypothesize represents a 
topological solution to a number of mechanistic observations of this transcription factor . 
Similar mechanisms may also be employed by other transcription factors in mammalian 
genomes.   
We anticipate that this first-ever global chromatin interactome map and the ChIA-
PET assay will constitute a valuable starting point for future studies into the 3-dimensional 




Chapter Five: Conclusions 
 
Summary 
In this thesis, I have demonstrated new methods for constructing PET libraries, and 
developed a new application of the PET method. This new application, Chromatin Interaction 
Analysis using Paired-End Tags (ChIA-PET), addresses a major issue in transcriptome 
biology:  Are distal binding sites found in many whole genome transcription factor binding 
site ChIP experiments functional in gene regulation? If so, what is the mechanism of remote 
transcriptional control?  Through the application of our tested and validated ChIA-PET to the 
system of ERα human breast cancer cells, we generated the first human chromatin 
interactome and showed that chromatin interactions are a primary mechanism by which ERα 
mediates transcriptional regulation. We proposed a new model for ERα functioning via 
chromatin interactions. In this model, we speculate that ERα protein dimers bind to distal 
regulatory elements and initiate long-range chromatin interactions involving promoter regions 
of target genes. These interactions form DNA loop structures with multiple ERα binding at 
the anchoring center. Multiple small and gene-centric loops could package genes near the 
anchoring center in a tight sub-compartment of chromatin looping structures, which could 
increase the local concentration of ERα, and therefore, attract and retain more molecules of 
cofactors as well as transcriptional machinery for enhanced transcriptional activation. This 
topological structure could also provide transcription efficiency, allowing RNAPII to cycle 
the tight circular gene templates. The large interaction loops, however, are more likely to link 
together distant genes at either end of the loop residing near anchor sites for coordinated 
regulation, and separate the genes in long loops from the active ERα regulation. This model 
may be used by other transcription factors in other systems.   
   
The future of chromatin interactome biology 
While we have developed the first global, high-throughput, de novo assay for chromatin 
interactions, and performing the ChIA-PET method is relatively straightforward, performing 
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multiple validations using FISH and 3C is laborious as site-specific BACs or PCR primers 
have to be chosen. Ideally, an alternative whole-genome chromatin interaction assay should 
be developed, such that both ChIA-PET and an alternative assay would complement each 
other to allow for validation of chromatin interactions found by each other. If the resolution 
of microscopy techniques could be refined while retaining the structure of chromatin 
interactions, microscopy would provide an ideal parallel approach. Atomic Force Microscopy 
and Electron Microscopy could be future candidates, given such further improvements.   
While our findings have explained many questions in transcriptome genome biology, our new 
model of chromatin interactomes also raises many new questions. What factors are required 
for chromatin interaction formation and maintenance? Are there certain features of DNA that 
predict whether interactions will occur (Meaburn et al. 2007a)? Do other transcription factors 
employ similar mechanisms to regulate genes? Are transcription factor mediated chromatin 
interactions mainly intrachromosomal like ERα? How do chromatin structural proteins, such 
as histones, CTCF, and cohesin, contribute to the 3-dimensional structures of chromosomes? 
Do interaction locations tend to show translocations, as different DNA elements are brought 
together in close proximity (Meaburn et al. 2007a; Meaburn et al. 2007b)? Do chromatin 
interactions indeed coordinately regulate genes? In this regard, further work seeking evidence 
for cross-species conservation in the linear organization of the genes, particularly the 
coordinately-regulated genes, could help to support a conserved biological role. Going further 
into the question of conservation, are chromatin interactions at conserved genes themselves 
conserved in other organisms? How did chromatin interactions evolve? One possibility is that 
“junk DNA” could have separated out genes and enhancers. Chromatin interactions could 
then bridge the gap between these enhancers and their target genes. Furthermore, it would be 
interesting to explore the dynamics of chromatin interactions such as in response to cell cycle 




This first-ever global chromatin interactome map and the ChIA-PET assay constitute 
a valuable starting point for future studies into the unknown 3-dimensional space of the 
nucleus, investigating these questions. ChIA-PET can be readily applied to transcriptional 
cofactors such as RNA Polymerase II and p53, as well as chromosomal structural proteins 
such as cohesion. Together, these global chromatin interactome maps may be mined for 
deeper insights into chromatin interactome biology. Certain protein motifs may be found to 
be associated with “interaction status” of the binding site, allowing one to predict whether the 
binding site is likely to show interactions or not. These proteins may then be analyzed 
through knockdown studies to see whether knockdown abolishes interactions. Comparison of 
profiles of different factors can help to answer whether different factors show different 
patterns – for example, while ERα mainly employs local, intrachromosomal chromatin 
interactions, other factors could predominantly employ interchromosomal chromatin 
interactions. Certain proteins with chromosome structural roles might be expected to employ 
different mechanisms from ERα. It would also be interesting to see whether chromatin 
interactions could also “daisy-chain” towards gene promoters and then repress them, rather 
than activate them as was the case with ERα. ChIA-PET using the same factor in multiple 
different cell-lines can also help to identify whether chromatin interactome networks remain 
the same or different. Cell-specific chromatin interactions may be one method by which 
genomes are regulated to give rise to cell-specific changes. Moreover, ChIA-PET using 
different environmental conditions, such as using estrogen-treated and estrogen-untreated 
MCF-7 cells, might answer questions as to how environmental conditions are translated into 
genomic changes in cells (Meaburn et al. 2007a).  
Chromatin interactome networks could possibly have important clinical implications. 
Studying drug-treated as opposed to drug-untreated cells, or virus-challenged and 
unchallenged cells, using ChIA-PET, may also reveal how such challenges affect the 
chromatin interactome network in cells, and demonstrate the mechanisms by which these 
exert their changes on the cells. Chromatin interactome changes could be important early 
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signals of cellular transformation, particularly as they might be involved in cancer-causing 
translocations (Meaburn et al. 2007b). FISH probes, or other markers, that reveal such 
changes could be used as early diagnostic markers (Meaburn et al. 2007a).  Moreover, drugs 
which directly affect chromatin interactomes may even have clinical utility, as aberrant 
chromatin interactome networks may play critical roles in global dysregulation of genes.  
Taken together, ChIA-PET, as the first method that can uncover chromatin 
interactions in a de novo, whole-genome manner, has helped to start a new field of chromatin 
interactome genomics, for understanding chromatin interactome networks. This new field 
could potentially prove to be important in the clinic.   
 
The future of the PET technology 
The unique feature of building connectivity between two points of DNA from linear and non-
linear structures in PET analysis has tremendous value in many aspects of genomic analysis 
that cannot be simply and easily replaced by just improving sequencing capacity in near 
future. The PET concept is versatile allowing for ready adaptation to new sequencing 
technologies. In the future, PET technology will grow by incorporating new sequencing 
technologies, overcoming existing limitations, and finding new applications for answering 
biological questions. 
One limitation arises from sequencing: while sequencing costs have dropped 
dramatically in recent years, it is still very high, and current next-generation sequencing 
methods have biases, and inaccuracies (Holt et al. 2008). Additional advancements in current 
and future next-generation sequencing machines promise to bring forth further improvements 
in costs, read lengths, through-puts, run times, preparation times, and accuracies (Metzker 
2005). One example is Helicos sequencing, a very new sequencing technology for single 
molecule sequencing, which has the advantages of not requiring an additional clonal 
amplification step as well as allowing sequencing to operate in an asynchronous manner 
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which reduces the number of misincorporations (Harris et al. 2008); such a method is 
expected to result in lower costs and required sample amounts for sequencing. Once this 
platform becomes available for large scale data production, one such machine run would 
generate billions of PET sequences that could be enough paired sequences for de novo 
assembly of a complete individual human genome. Hence, with rapid development of next-
generation sequencing machines, the PET techniques will also need to develop rapidly for 
easy, cost-effective and timely integration with the particular format that the sequencing 
machines use. As sequencing read lengths become longer, concatemers and length-controlled 
ligation methods such as the diPET method (Ng et al. 2006a) would become increasingly 
useful for making full use of the maximum read lengths of the machines.  
Another limitation of the current PET technology is the library construction. The 
current protocols for making PET constructs using both cloning-based and cloning-free 
methods are still tedious, require large numbers of cells to start the experiment, and involve 
relatively short tags. Although optimizations of each step involved in PET construction could 
make incremental improvements, eventually, the PET method would have to be performed by 
robotic or miniaturized lab-on-a-chip systems in order to match the speed and efficiency of 
DNA sequencing machines. An important benefit of making PET constructs in a nanometer 
scale system is that this might allow PET analysis for smaller numbers of cells. Only with this 
nano-scale capability can PET analysis be applied to clinical samples that usually are not 
present in such large amounts. The use of microfluidics technologies to manipulate tiny 
amounts of fluids using tiny channels (Whitesides 2006) would be necessary for the 
development of such miniaturized assays. Emulsion technologies can also be used to create 
“microreactors” for partitioning reactions, by using water droplets dispersed in oil (Griffiths 
et al. 2006). 454 pyrosequencing relies on emulsions to separate amplicons when amplifying 
templates for sequencing (Margulies et al. 2005). Further developments promise to make 
contributions to library construction methods. Longer tags are more desirable because they 
give rise to increased mapping specificity, particularly when dealing with repeat regions. 
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However, PET preparation methods that use tagging enzymes are constrained by the 
restriction enzymes available. The current maximum tag length is 27 bp, from EcoP15I. 
Ideally, in the future, restriction enzymes that can cut longer tags would be found, and 
sequencing technologies would be able to accept longer templates.  
Paired-End Tag sequencing is a fundamental concept, and can be implemented to any 
application that generates DNA fragments for analysis; for example, DNAse I hypersensitive 
sites could be mapped using PET technologies. Functional elements and transcription factor 
binding sites in the genome have been associated with open chromatin regions which can be 
easily digested with DNAse I, most likely due to nucleosome displacement during cell 
processes such as transcription activation. This feature has been used to obtain DNAseI-
digested DNA, which is then sequenced in a high-throughput manner to identify these genetic 
elements (Sabo et al. 2004a; Sabo et al. 2004b). As an alternative, PETs could be obtained for 
identification of these genetic elements – the DNA could be sequenced in a bidirectional 
manner. Alternatively, FAIRE (Giresi et al. 2007) could be used to prepare DNA, which 
could then be processed by the PET method and sequenced. In other applications to look at 
nucleosome positioning, micrococcal nuclease (Schones et al. 2008) could be used. 
Micrococcal nuclease makes double-stranded cleavages between nucleosomes. The benefits 
of using PETs to analyze these genetic elements are that the exact 5’ and 3’ boundaries can be 
read out, to give precise positioning information. In addition, genetic elements that are 
associated with repeats may be more easily identified, because the additional information 
content in PETs leads to higher specificity, as well as the ability of PETs to cross over the 
boundaries of repeats.    
With the capability to perform fast, cheap, and robust PET analyses on a wide variety 
of applications, we expect that PET-based methods will become the method of choice for 
many sequencing projects. Particularly, PET technologies have great potential to make big 
contributions to the field of personal genomics. In the near future, DNA-PET could be 
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combined with ultra-high-throughput sequencing technologies to give rise to a robust, cost-
effective platform for individual personal human genome sequencing. In addition, the wide 
variety of PET applications for genome structure, transcriptome, and interactome 
characterizations will be useful in annotating the human genomes in great detail for 
functional and clinical implementations. With these new capacities, personal genome 
sequences combined with patient-specific transcriptomes and interactomes could become a 
practical reality, and greatly benefit human healthcare and society.  
In conclusion, the PET technology is a versatile method which can couple methods 
for asking biological questions with next-generation sequencing. With sequencing improving 
rapidly and increasing demands for sequencing to interrogate biological and clinical 




Chapter Six: Materials and Methods 
Note: Except for a test run performed by Illumina, USA, all sequencing described here was 
performed by the Sequencing Team of Genome Technology and Biology led by Wei Chia-
Lin, Genome Institute of Singapore, Singapore. The members of the Sequencing team are: 
Herve Thoreau (lab manager), Melvyn Tan, Yow Jit Sin, Dawn Choi, Low Hwee Meng, 
Eleanor Wong (now in the Research Team), Ong Chin Thing (Jo), Neo Say Chuan, Yap 
Zhei Hwee, Poh Tong Shing, Leong See Ting, Adeline Chew, Jeremiah Decosta (now in 
the Research Team), Alexis Khng Jiaying, and Lim Kian Chew.  
Materials and Methods used in Chapter 2 
Cell culture 
HES3 Human Embryonic Stem (ES) Cells were grown and prepared as described (Zhao et al. 
2007). Note: Cells were obtained from ES Cell International, Singapore, and grown and 
prepared by Andrew Choo from the lab of Steve Ho, Bioprocessing Technology Institute, 
Singapore. 
Full length cDNA library construction 
A full length cDNA library was constructed from the human embryonic stem cells and PETs 
were prepared for sequencing as described  in the classic bacterial propagation protocol (Ng 
et al. 2006b). Briefly, RNA was isolated from HES3 cells, and poly A+ RNA was isolated 
from RNA using the μMACS mRNA isolation kit. The poly A+ RNA was converted into 
cDNA by oligo-dT-primed reverse transcription. RNA ends were biotinylated. Cap-trapper 
selection was performed to select full-length first strand cDNA. 5’ adapters were added to 
prime for second strand cDNA synthesis, and the material was then digested to give rise to 
sticky ends for cloning. The flcDNA was then ligated with pGIS4b vector cut with NotI 
(NEB) and GsuI (Fermentas). The flcDNA library was amplified by bacterial amplification at 
37°C on solid surface agar Q-trays followed by scraping and plasmid extraction by Maxiprep 
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(Qiagen). Note: FlcDNA library construction was performed by Yao Fei, Genome Institute 
of Singapore, Singapore. 
GIS-PET library construction 
An aliquot of the Maxiprep was used to prepare a GIS-PET library by the classic bacterial 
propagation GIS-PET protocol (Ng et al. 2006b). Briefly, MmeI digestion was performed, 
and the single-PET plasmids were end-polished with T4 polymerase (Promega). The single-
PET plasmids were then self-ligated and amplified by bacterial amplification at 37°C on solid 
surface agar Q-trays followed by scrapping and plasmid extraction by Maxiprep (Qiagen). 
Single PETs were released with BseRI, purified, and concatenated. The concatemers were 
then blunted by T4 DNA polymerase (Promega), cloned into EcoRV-cut pZErO-1 vectors 
(Invitrogen), and 300 384-well plates were sequenced with Sanger capillary sequencing. This 
library was called SHE001. The library was analyzed, and the results were reported 
separately (Zhao et al. 2007). Note: This library was created by Liu Jun, Genome Institute 
of Singapore. 
Selection-MDA GIS-PET library construction 
To construct the MDA-amplified library using the new Selection-MDA protocol, we took an 
aliquot of 8 ng of maxiprep from the GIS-PET full-length cDNA library and added it to 50 µl 
of Templiphi 500 sample buffer (GE Healthcare). The sample was denatured at 95°C for 3 
min, and then cooled to 4°C. 2 µl of Templiphi 500 enzyme mix (GE Healthcare) was added 
to 50 µl Templiphi sample buffer on ice, and the mixture was then added to the 50 µl sample 
buffer with denatured template. The reaction was incubated at 30°C for 18h, and then heat 
inactivated at 65°C for 10 minutes. The material was quantitated with Picogreen Fluorimetry 
(Invitrogen), and an MmeI (New England Biolabs) digestion was performed following the 
Single PET construction method as described (Ng et al. 2006b). 800 ng of self-ligation 
reaction was purified to remove salts before electroporation by phenol/chloroform 
isopropanol precipitation as described (Ng et al. 2006b). The pellet was resuspended in 5 µl 
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of Elution Buffer (Qiagen). The entire ligation mix was transformed into 50 µl of Top10 E. 
coli electrocompetent cells (Invitrogen) and recovered in 1 ml of Lucigen Recovery Medium 
(Lucigen) with shaking at 37°C for 4 hours. Because recovery was for only 4 hours, the 
bacteria would not have multiplied sufficiently so as to compete with each other; hence the 
library should contain no size bias. To monitor bacterial growth, the optical density at 600 nm 
(OD600) of aliquots were taken at various time points by Nanodrop. Cells were spun down at 
10,000 g for 5 min and washed twice with 750 µl of Lucigen Recovery Medium to remove 
free floating DNA that was not introduced into the cells. Next, plasmids were extracted by 
performing Miniprep (Qiagen). 40 µl of Elution Buffer was used for the elution, and the 
DNA was quantitated with Picogreen fluorimetry. 1 µl was run on a PAGE gel to check that 
plasmids were prepared correctly. Plasmid-Safe DNAse (Epicenter) treatment was then 
performed to remove any linear species, such as bacterial genomic DNA, that might be 
present. Phenol/chloroform ethanol precipitation was then performed and pellets were 
resuspended in 20 µl of Elution Buffer (Qiagen). MDA was performed on aliquots of 8 ng of 
material as described above. The material was quantitated with Picogreen Fluorimetry, and 
digested with BamHI (New England Biolabs) according to the manufacturer’s protocols. The 
PETs were PAGE gel purified, then cloned, concatenated, partially digested with BamHI, 
cloned into BamHI-cut pZErO-1 vectors (Invitrogen), and prepared for sequencing as 
described (Ng et al. 2006b). 10 plates of 384 colonies consisting of concatenated PETs were 
sequenced as a GIS-PET library, SHE002. A more detailed protocol is in the Appendix. Note: 
Jack Tan, Genome Institute of Singapore, Singapore conceived of and performed the 
experiments on Selection-MDA. 
Data analysis 
Data analysis was performed using PET-Tool for PET extraction and genome mapping (Chiu 
et al. 2006), followed by visualization in the T2G browser, a specially designed visualization 
system for Paired-End Tags mapped to genome assemblies (Ng et al. 2005). Calculations 
were performed with Microsoft Excel. Categories of the genes were identified using RefSeq 
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(Pruitt et al. 2007), UCSC Known Genes (Hsu et al. 2006), Genbank mRNA 
(http://www.ncbi.nlm.nih.gov/sites/entrez?db=Nucleotide), MGC (Gerhard et al. 2004), 
Ensembl (Hubbard et al. 2007), ESTs (Boguski et al. 1993), Twinscan (Korf et al. 2001), 
SGPGene (Guigo et al. 2003; Parra et al. 2003), and Genescan (Burge et al. 1997) databases.    
 
Materials and Methods for Chapter 3 
Note: The Materials and Methods for Chapter 3 and 4 have a number of overlaps; where this 
occurs, Chapter 4 refers to Chapter 3, and the description in Chapter 3 includes slight 
modifications used in Chapter 4.  
Cell culture and estrogen treatment 
MCF-7 cells were grown to at least 80% confluence in DMEM/F12 (Invitrogen/Gibco) 
supplemented with 5% FBS (Invitrogen/Gibco), penicillin (Invitrogen), streptomycin 
(Invitrogen), and gentamycin (Invitrogen). In preparation for the 17 beta-estradiol 
(“estrogen”; Sigma) treatment, cells were grown in hormone-free media: they were washed 
with PBS and incubated in phenol red-free medium (Invitrogen/Gibco) supplemented with 
5% charcoal-dextran stripped FBS (Hyclone), penicillin, streptomycin, gentamycin, and L-
glutamine (Invitrogen) for a minimum of 72 hours. Hormone-depleted cells were treated with 
estrogen (17 beta-estradiol, E2, (Sigma) to a final concentration of 100 nM for 45 min before 
the ChIP procedure. The control cells were treated with an equal volume and concentration of 
vehicle, ethanol (Merck), for 45 min. For a ChIA-PET experiment, we routinely use 
approximately 1 x 10
8
 cells from 6 150-mm diameter cell culture plates. Note: Starter 
cultures and some batches of MCF-7 cells kindly provided by the lab of Edwin Cheung, 




Chromatin immunoprecipitation (ChIP) 
ChIP protocol was performed as described previously (Lin et al. 2007). Briefly, we used 1% 
formaldehyde to crosslink the cells, and sonication to break the chromatin fibers. ERα 
specific antibody (HC-20, Santa Cruz) was used to enrich ERα bound chromatin fragments. 
IgG specific antibody (sc-2027, Santa Cruz) were also used for ChIP analyses. ChIP material 
bound on the antibody beads was subjected to ChIA-PET library construction. Note: Some 
ERα and IgG ChIP preparations were performed by the lab of Edwin Cheung, in 
particular Pan You Fu, Genome Institute of Singapore, Singapore. 
ChIA-PET library construction and sequencing 
The DNA fragments tethered in chromatin fragments were end-repaired using T4 DNA 
polymerase (NEB), followed by overnight ligation of biotinylated half-linkers that contain a 
flanking MmeI site (IDT), using T4 DNA ligase (Fermentas) at 16ºC, with mixing. The linker 
added DNA fragments were then phosphorylated with T4 polynucleotide kinase (NEB), and 
followed by a second ligation reaction overnight at 22ºC under dilute conditions. The 
conditions for ligation were based on previous PET protocols for self-circularization of 
plasmids in a complex library (Ng et al., 2005; Wei et al., 2006). The cross-links in the 
DNA/protein complexes were then reversed by incubation at 65ºC overnight with 0.2% SDS 
(Ambion) and proteinase K (Ambion), and the DNA fragments were purified by 
phenol/chloroform isopropanol precipitation. Any nicks present were subsequently repaired 
by incubation with E. coli DNA ligase (NEB) and E. coli DNA polymerase I (NEB) at 16ºC 
overnight.  The purified DNA was then digested by MmeI (NEB) for at least 2h at 37ºC to 
release the tag-linker-tag structure (Paired-End Tag, PET). The biotinylated PETs were then 
immobilized on streptavidin-conjugated magnetic Dynabeads (Invitrogen) and the ends of 
each PET structure were then ligated to an adapter by T4 DNA ligase (Fermentas) at 22ºC 
overnight with mixing followed by 20 cycles of PCR reaction to amplify the PETs.  This PCR 
product was the template for sequencing analysis using Roche 454 pyrosequencer (GS20) 
following the manufacturer’s protocol. For two ERα ChIA-PET libraries, we conducted 5 
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GS20 runs and generated a total of 1.8 million raw PET sequences for further analysis. More 
details are available in the Appendix. In addition, as a genome-wide control, we prepared an 
IgG ChIA-PET library, conducted 1 GS20 run, and generated a total of 0.52 million raw PET 
sequences. Note: ERα ChIA-PET construction was performed together with Liu Jun, 
Genome Institute of Singapore, Singapore. The IgG ChIA-PET library was prepared by 
Andrea Ho and Ruan Xiaoan, Genome Institute of Singapore, Singapore.  
ChIA-PET barcoding 
We constructed the two ERα ChIA-PET libraries with two biological replicates of MCF-7 
cell cultures treated with estradiol (E2) using two linker sequences with different nucleotide 
barcodes. As a linker sequence can include unique nucleotide barcode, multiple linkers with 
distinctive barcode sequences can be used to specify different experiments or replicates. 
Advantages of PET barcoding are that different biological samples or replicates may be 
analyzed within the same experiment, leading to time and cost savings, as well as reductions 
in technical variations of measurement. The barcoding was performed as follows: The two 
biological replicates were kept separate throughout the ChIP procedure and the first ligation. 
In the first ligation, half-linker 1 was introduced to replicate 1 in a microfuge tube, and half-
linker 2 was introduced to replicate 2 in a separate microfuge tube. After the first ligation, the 
samples were washed well to remove any unligated half-linkers, and combined. The second 
ligation was then performed. More details are available in the Appendix. Another benefit of 
barcoding in this manner was that the number of chimeric ligations in the second ligation 
could be estimated. Any PETs with combinations of half-linker 1 and half-linker 2 into full 
linker sequences would have to result from chimeric, random ligations. The two different 
half-linker sequences are reported in the Appendix. We generated 941,151 and 867,751 
unique PET sequences from the two libraries. We found very few chimeras, only 40,165 




Illumina single-read sequencing was used to analyze serine-5 phosphorylated RNAPII 
(ab5131, Abcam) ChIP material. Examples of this data are shown in the GREB1 locus  as 
well as in Table 2. RNAPII ChIP-Seq library construction was performed by Pan You Fu 
and Liu Jun, Genome Institute of Singapore, Singapore. 
Cloning-free ChIP-PET library construction and sequencing 
As a genome-wide control, we compared the ERα ChIA-PET data with the ERα ChIP-PET 
data generated by a cloning-free method similar to the ChIA-PET method. As the ChIP-PET 
library did not use proximity ligation to capture the relationship of DNA fragments tethered 
by chromatin complex, we do not expect to see many inter-ligation PETs. If we see any, these 
inter-ligation PETs should be from non-specific ligations. A key difference between the 
methods involved the second ligation. In detail, in the ChIP-PET procedure, after the first 
ligation (ligation of the half-linkers) and the chromatin phosphorylation with T4 
polynucleotide kinase, cross-links were reversed by incubation at 65ºC overnight with 0.2% 
SDS (Ambion) and proteinase K (Ambion). DNA was purified by phenol/chloroform 
isopropanol precipitation. Subsequently, overnight dilute ligation was performed on the ChIP 
DNA with T4 DNA ligase (Fermentas) at 22ºC without agitation. Nick repair was then 
performed by incubation with E. coli DNA ligase (NEB) and E. coli DNA polymerase I 
(NEB) at 16ºC overnight, followed by DNA purification which included a Plasmid-Safe 
Enzyme (Epicenter) step for removing uncircularized products. MmeI digestion and 
subsequent steps were performed as per the ChIA-PET protocol. For the ER ChIP-PET 
library, we conducted 4 GSFLX runs and generated a total of 2.82 million raw sequences for 
further analysis. In addition, we reprocessed SHC007, the ERα ChIP-PET library described 
previously (Lin et al. 2007), in order to convert it from hg17 to hg18 genomic assembly. 
635K raw sequences were generated. Note: The ERα control ChIP-PET library was 
prepared by Ruan Xiaoan’s team, from the Genome Institute of Singapore, Singapore.  A 
full list of people involved in the preparation and analysis of SHC007 can be found in the 
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journal reference. Reprocessing was performed by Han Xu, Genome Institute of 
Singapore, Singapore.  
Library saturation analysis 
We carried out a saturation analysis on each library to assess the sequencing depth reached 
and to estimate the upper bound unique sequencing attainable. The saturation is modeled 








with x as the number of PETs sequenced and f(x) as the number of distinct PET sequences 
obtained. Using the Marquardt-Levenberg nonlinear least-square fitting algorithm, we fitted 
the Hill Function to each library, with the order of sequencing randomly permuted. Based on 
the redundancy of the sequenced PETs, we found that the ChIA-PET library 1 and 2 were 
about 16.2% and 17.4% saturated. The combination of these two libraries was about 16.7% 
saturated. Note: Library saturation analyses were performed by Vinsensius Vega, Genome 
Institute of Singapore, Singapore. 
DNA-PET 10 Kb insert data 
It is known that the MCF-7 genome involves lots of rearrangements (Volik et al. 2006). 
Therefore, ChIA-PET data generated from this genome for detecting long-range interactions 
could be complicated by genome structural differences between this and the reference 
genome (hg18). To avoid such complications, we constructed DNA-PET libraries with insert 
sizes around 10 Kb in span. We generated 35 million DNA-PET sequences, which is a 100-
fold physical coverage of the MCF-7 genome. This dataset provides comprehensive 
karyotyping information regarding deletions, inversions, translocations, and insertions in the 
MCF-7 genome, and identifies rearranged genomic regions. We used this information to filter 
out inter-ligation PET clusters located in these genome aberration regions, and therefore 
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reduce false positive calls. MCF-7 DNA-PET libraries were prepared by Yao Fei. Data 
analysis was performed by Wing-Kin Ken Sung’s lab.  
PET extraction and mapping    
The raw sequence reads generated by the Roche 454 pyrosequencer were processed through 
the 'PET-Tool' program (Chiu et al. 2006) for extraction of PET sequences and mapping of 
the PETs using compressed suffix arrays (Hon et al. 2007) to the reference human genome 
sequence (hg18). The PET sequence was extracted based on the basic unit of tag/linker/tag 
with defined parameters such as the linker sequence and the tag length. As PET barcoding 
was used in the ChIA-PET procedure, we identified PETs belonging to either replicate 1, 2 or 
“chimeras” by examining the linker sequences in each PET, and assigning each PET 
containing a particular linker to that particular category. Up to 1 mismatch was allowed in the 
linker sequences of the PETs. The mismatch could be an insertion, deletion or substitution. 
The average length of the tag is 20bp with +/- one nucleotide variation due to a known 
characteristic of plasticity by MmeI enzyme (Dunn et al. 2002). The tag sequences were then 
aligned to the human reference genome sequence (hg18), and the two tags of the same PET 
were paired for their mapping coordinates. Each tag had a tag length, n. For every tag, first 
we attempted to map all n bases of the tag. If the mapping found a hit or several hits, mapping 
stopped on the particular tag. If not, then we tried n-1, n-2, and so on until n = 18. If this 
failed, the tag was transferred to the “unmapped” category. This set of PETs represented the 
“uniquely mapped PETs”. The “uniquely mapped PETs” were further merged if any PETs 
shared the same mapping locations (as up to 1 mismatch was tolerated, any two PETs might 
be unique before mapping, but after mapping they might be found to match the exact same 
locations).  This set of merged data was called “uniquely mapped and merged PETs”. Note: 
PET mapping was performed by Pramila Ariyaratne, Hong-Sain Ooi, Yusoff bin 
Mohamed, and Chiu Kuo Ping, Genome Institute of Singapore, Singapore. 
PET classification    
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Based on mapping characteristics, each PET sequence can be classified by whether it was 
derived from one DNA fragment or two DNA fragments. If the two tags of a PET were 
mapped on the same chromosome with the genomic span in the range of ChIP DNA 
fragments (less than 3 kb), with expected self-ligation orientation and on the same strand, we 
considered that this PET was most likely derived from a self-ligation of a single ChIP DNA 
fragment (Lin et al. 2007), and therefore called the PET a “self-ligation PET”. We chose to 
use 3 kb as the cutoff for “self-ligation PETs” because it is the upper range of ChIP DNA 
fragments in this experiment. If a PET did not fit into these criteria, we considered that the 
PET most likely resulted from a ligation product between two DNA fragments, therefore we 
called the PETs “inter-ligation PETs”. The two tags of the “inter-ligation PETs” do not have 
fixed tag orientations, might not be found on the same strands, might have any genomic span, 
and might not map to the same chromosome. In addition, specifically for the “inter-ligation 
PETs”, if the two tags of a PET mapped in same chromosome but with a span > 3 kb in any 
orientation or if the two tags mapped with spans of less than 3 kb but not with expected 
orientation or to the same strands, these PETs were called “intrachromosomal inter-ligation 
PETs”. PETs which mapped to different chromosomes were called “interchromosomal inter-
ligation PETs”. Further analysis was performed on these PETs to determine whether they 
were the result of specific ChIP, ligation and mapping, or the result of non-specific processes. 
Note: PET classification was performed by Hong-Sain Ooi, Han Xu, and Yusoff bin 
Mohamed, Genome Insitute of Singapore, Singapore. 
Identification of ERα binding sites    
Binding site peaks were found based on self-ligation PETs (Lin et al. 2007). Self-ligation 
PETs were converted into a density histogram representing enrichment density, and local 
maxima represent peaks that indicate ChIP enriched binding sites. Binding sites were found 
using a threshold of FDR < 0.01. We identified whether peaks correspond to any satellites 
using the “RepeatMasker” (Smit et al. 1996-2004) track in the UCSC Genome Browser 
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(Karolchik et al. 2003). We removed binding sites found in satellite regions, as manual 
curation showed these to be the result of nonspecific ChIP pulldown. Accuracy of the 
automatic analyses was also double-checked using manual curation. From 1 replicate of the 
ChIA-PET experiment, we found 2,179 binding sites; from another, we found 2,720. From 
the ChIP-PET experiment, we found 1,211. As expected, from the IgG control ChIA-PET 
experiment, 0 binding sites could be found. All binding sites are listed in the Appendix. Note: 
Identification of binding sites was performed together with Han Xu, Genome Institute of 
Singapore, Singapore. 
Identification of ChIP enrichment levels    
As ChIP enrichment of a given DNA-binding protein target can be reflected by overlapping 
virtual ChIP DNA fragments represented by ChIP-PETs (Lin et al. 2007), or ChIP-Seq 
(Johnson et al. 2007) fragments, and regions with higher numbers of ChIP-PETs are more 
likely to be true binding sites (Lin et al. 2007), similarly, multiple virtual ChIP DNA 
fragments represented by “self-ligation PETs” and “inter-ligation PETs” derived from a 
particular region will indicate the ChIP enrichment of that region. Note: ChIP enrichment 
level identification was conceived of by Ruan Yijun, Genome Institute of Singapore, 
Singapore. 
ERE motif analysis of ERα binding sites     
We analyzed the presence of the Estrogen Response Element (ERE) motif in the ERα binding 
sites identified in this study, according to the method in our previous publication (Lin et al. 
2007). Briefly, we looked for the presence of the full consensus ERE motif (GGTCA-nnn-
TGACC), allowing for a maximum of 2 mismatches (Lin et al. 2007). The distribution of 
ERE motifs relative to the binding sites was plotted in Figure 15C. ERE motifs are enriched 
at the center of the ChIA-PET identified ERα binding sites. We also investigated the 
distribution of ERE motifs in other datasets, and found them to be similar. Note: ERE 
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analysis was performed by Han Xu and Vinsensius Vega, Genome Institute of Singapore, 
Singapore. 
Comparative analysis of ERα binding sites     
To understand whether the binding sites identified by ChIA-PET were valid, first we 
compared the two library replicates with each other. We extended ± 200 bp from the mid-
point of each binding site to do the comparison. 1459 binding sites overlapped between the 
two ChIA-PET replicates, out of 2,720 (54%) and 2,179 (67%) binding sites found in each 
replicate. While the overlap is good, a reason why the overlap is not even higher could be that 
the libraries are not yet saturated. For the binding sites that did overlap, the correlation of 
intensity was very high, with a Pearson correlation of 0.90, indicating strong correlation 
(Figure 2A). Next, we compared the two ChIP-PET experiments, one of which was 
previously published (Lin et al. 2007) and cloning-based (called SHC007, “old”), and one of 
which was based on a cloning-free procedure very similar to the ChIA-PET method (“new”). 
For consistency, we re-mapped the previous cloning-based ChIP-PET to hg18 and processed 
the library with the same pipeline to identify high confidence (FDR < 0.01) binding sites. 
Because the FDR was more stringent than previously used, therefore fewer binding sites were 
found: 501 as compared with the previous 1,234. We extended ± 200 bp from the mid-point 
of each binding site of the two datasets for the comparison. 231 binding sites were found to 
overlap, out of 501 (46%) in the old dataset and 1,211 (19%) in the new dataset. Again, a 
reason why the overlap is not higher could be that the libraries are not yet saturated. Next, we 
compared the combined ChIA-PET datasets with the combined ChIP-PET datasets and the 
3,665 binding sites (p-value < E-05) found by ChIP-chip experiment (Carroll et al. 2006; 
Lupien et al. 2008). We extended ± 200 bp from the mid-point of each binding site of the 
ChIA-PET and ChIP-PET datasets, and used the entire binding site region reported in the 
ChIP-chip region, to look for overlaps. Accuracy of the automatic analyses was double-
checked using manual curation. Multiple numbers are given in the overlaps, as sometimes, 2 
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or more peaks in one dataset might overlap to a single peak in a different dataset. We 
observed that most of the ChIP-PET binding sites that did not overlap had low peak values. 
Using independent ChIP-qPCR, we experimentally validated a subset of 9 highest ChIA-PET 
sites that did not have any overlaps with ChIP-chip and cloning-based ChIP-PET datasets. 3 
of the 9 sites overlapped with the cloning-free ChIP-PET dataset, and many were in repeat 
regions, supporting the idea that sites that did not overlap could be sites difficult to identify 
with ChIP-chip due to repeats, or were unclonable such that the cloning-based ChIP-PET 
would not have been able to pick them up. Note: Library comparison was performed 
together with Han Xu, Genome Institute of Singapore, Singapore. 
ChIA-PET data visualization     
We adopted the “Generic genome browser” system (Stein et al. 2002) and developed the 
“ChIA-PET Genome Browser” to organize and visualize the ChIA-PET data. The “self-
ligation PETs” and the “inter-ligation PETs” are displayed in separate tracks to show 
transcription factor binding sites and interactions, respectively. This browser also includes a 
custom 'Whole Genome Interaction Viewer' which provides a macroscopic picture of binding 
sites and interactions along with a whole genome landscape (http://cms1.gis.a-star.edu.sg). 
The username is “guest” and the password is “gisimsgtb”. A manual is provided in the 
Appendix. Note: ChIA-PET visualization was performed by Hong-Sain Ooi, Pramila 
Ariyaratne, and Yusoff bin Mohamed, Genome Institute of Singapore, Singapore. 
Using inter-ligation PETs to identify ER-mediated interactions     
As each inter-ligation PET was derived from two ChIP DNA fragments, the majority of 
which were less than 1,500 bp in size, we extended the mapped 20 bp tags to 1,500 bp along 
the reference genome to represent the virtual DNA. Multiple overlapping virtual DNAs are 
merged into DNA regions. To determine the DNA regions that were bound together in close 
spatial proximity by an ER-mediated protein complex, we made the following assumptions. 
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First, if an interaction between two DNA regions is specific, it would be enriched by the ChIP 
procedure, and hence the inter-ligation PETs that “link” these regions would be over-
represented in the ChIA-PET data; while if it is non-specific and occurs randomly, it would 
be sampled much less frequently than real interactions and at the level expected by chance. 
We modeled the non-specific interactions such that each DNA fragment has an equal chance 
to interact with and be ligated to any other fragments.  
Consider a library with N inter-ligation PETs, the total number of sampled DNA fragments is 
N2 . We denote AR and BR as representing two DNA regions with Ac and Bc virtual DNAs, 
where Ncc BA , .  Under the random model, the number of inter-ligation PETs that link 
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By this, we are able to compute a p-value to test if BAI , is over-represented. Note that the p-
values were Bonferroni-corrected for multiple hypothesis test. We found 228 and 205 
interactions with multiple inter-ligation PETs from each replicate of the ChIA-PET libraries. 
Interactions with satellite repeats were filtered out, as these tend to be non-specifically 
enriched by ChIP. In addition, interactions with genomic distances of < 5 kb were filtered out 
automatically (chapter 3) or subjected to manual curation (in chapter 4), because we reasoned 
that these interactions could result from multiple unusually long ChIP-PET fragments. As this 
filtering is based on the genomic span, it is not expected to carry any bias leading to 
interactions close to gene promoters being dropped at a greater frequency than interactions 
that are far from gene promoters. Using the Bonferroni correction, we looked for high 
confidence interactions with Bonferroni-corrected p-value < 0.05. However, because analyses 
of the medium confidence interactions suggested that they could also contain many bona fide 
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interactions, in Chapter 4, we used both high and medium confidence interactions. All 
interactions are in the Appendix. Note: Interactions were identified by Han Xu and 
Vinsensius Vega (chapter 4), Genome Institute of Singapore, Singapore. 
Manual curation  
To understand the characteristics of interactions, subsets of interactions were manually 
curated by visualizing them on the ChIA-PET browser (described in a separate section) in 
order to (1) examine the binding sites to see whether they were present and if they formed 
well-shaped peaks, (2) check if the interactions found by automatic methods indeed had inter-
ligation PETs between them, and (3) check whether the interactions could be found in both 
libraries, and (4) check whether the interactions involved amplicon regions and 
rearrangements. Note: Manual curation was performed together with Phillips Huang and 
Brenda Yuyuan Han, Genome Institute of Singapore, Singapore. 
Assignment of genes to high confidence interactions     
We assigned UCSC Known Gene transcription units (Hsu et al. 2006) to high confidence 
interactions. Although the UCSC Known Gene browser has some “redundancies” in the sense 
that the same gene has multiple different transcription units, we used the database on an “as-
is” basis because different transcription units might have different characteristics (some might 
have RNAPII marks but not others, and some might be within the interactions but not others), 
so we wanted to capture all these features in an unbiased manner. We assigned genes if they 
were present within the genomic span of the interactions or if they were within 20 kb of the 
loci of the interactions. In addition, RNAPII ChIP-sequencing data from estrogen-treated 
MCF-7 cells was used provide information regarding transcription status for genes involved 
in interactions. A transcript was said to be marked by RNAPII if the promoter (a region of + 




Chromosome Conformation Capture (3C)     
3C was performed as described previously (Hagege et al. 2007) with modifications. Briefly, 
MCF-7 cells were treated as mentioned in the ChIP protocol up to the crosslinking step with 
1% formaldehyde. Nuclei were resuspended in 500 l of 1.2 x restriction enzyme buffer at 
37C for 1 hr, 7.5 l 20% SDS for 1 hr, followed by 50 l 20% Triton X-100 for additional 1 
hr. Samples were then incubated with 400 units of selected restriction enzyme at 37C 
overnight. After digestion, 40 l 20% SDS was added to the digested nuclei and incubated at 
65C for 10 min. 6.125 ml of 1.15x ligation buffer and 375 l 20% Triton X-100 was added 
and incubated at 37C for 1 hr prior to the addition of 2000 units of T4 DNA ligase (NEB) at 
16C for 4 hr. Samples were then de-crosslinked at 65C overnight followed by phenol-
chloroform extraction and ethanol precipitation. Primers and restriction enzymes for the 3C 
procedure were chosen based on the ChIA-PET interactions. All primers had to be within a 
region of ±150 bp from the restriction enzyme digestion site. Primers (1stBase) were 
designed using Primer3 software available from: http://frodo.wi.mit.edu/cgi-
bin/primer3/primer3_www.cgi (Rozen et al. 2000). PCR products were amplified with 
AccuPrime Taq High Fidelity DNA Polymerase (Invitrogen) for 40 cycles. PCR products 
were run on a 2% agarose gel. Each validation experiment was repeated at least twice. Note: 
3C was performed by Mei Hui Liu, Genome Institute of Singapore, Singapore. 
Chromatin Immunoprecipitation Chromosome Conformation Capture (ChIP-3C)    
ChIP-3C was performed as described previously (Hagege et al. 2007) with modifications. 
Briefly, chromatin immunoprecipitation was performed overnight as described in the ChIP 
protocol. Beads were then washed twice with PBS, and restriction enzyme digestion was 
performed overnight in 100 l of 1x buffer at 37ºC with nutation (all from NEB). The beads 
were then spun down, and the buffer removed. A further restriction digest was performed 
with fresh buffer and enzyme at 37ºC for half a day. The beads were then spun down, and the 
buffer removed. The beads were then washed 3x with PBS, and ligation was performed using 
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1x ligation buffer and T4 DNA ligase (NEB) in 100 l at 16ºC. A further ligation was 
performed by adding 100 l of fresh buffer and enzyme to the mixture and incubating at 16ºC 
for half a day. 100 l of Elution Buffer containing 1% SDS was then added to the beads, and 
the beads were incubated at 65ºC for at least 6 hours. The supernatant was purified with a 
PCR purification kit (Qiagen). Primers and restriction enzymes for the ChIP-3C procedure 
were chosen based on the ChIA-PET sequences. All primers and restriction enzymes had to 
be within a region of ±100-500 bp from the targeted ERα binding site peak. Primers (1stBase) 
were designed using Primer3 software available from: http://frodo.wi.mit.edu/cgi-
bin/primer3/primer3_www.cgi (Rozen et al. 2000). PCR products were amplified with 
AccuPrime Taq High Fidelity DNA Polymerase (Invitrogen) using an MJ thermocycler 
(GMI). The PCR program used was (1) 94°C for 2 min, (2) 94°C for 30s, (3) 56-60°C for 
40s, (4) 68°C for 40s (5) 68°C 5 min, (6) 4°C forever. Steps (2) to (4) were run for 35-47 
cycles. PCR products were run on a 1% agarose gel with ethidium bromide. PCR products 
were sequenced to verify the long-range ligation product.  Each validation experiment was 
repeated at least twice for confirmation. Note: ChIP-3C was performed by the lab of Edwin 
Cheung, in particular by Pan You-Fu, Genome Institute of Singapore, Singapore. 
RT-qPCR     
Total RNA was prepared from MCF-7 cells induced with estrogen for 0, 3, 6, 12 and 24 
hours using an RNA purification kit (Qiagen), following the manufacturer’s protocols. 1 g 
of total RNA was incubated with 50 ng of random primer (Roche) at 70ºC for 10 min and 
then cooled on ice for 1 min. To the mixture, first strand buffer (Clontech) was added to a 
final concentration of 1x, DTT (Clontech) was added to 0.01 M, dNTP mix (Invitrogen) was 
added to 1 mM, and 1 l of Powerscript RT enzyme (Clontech) was added. The mixture was 
heated to 42ºC for 90 min, and heat inactivated at 70ºC for 15 min. Real-time quantitative 
PCR was performed using an ABI Real-time PCR 7500 system. PCR was performed with a 
10 l reaction volume consisting of substrate, 0.5 M of primer pairs (1stBase) and 1x SYBR 
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Green PCR Master Mix (ABI). Reactions were incubated at 95ºC for 10 min, and then 40 
cycles (95ºC for 15s, 60ºC for 1 min) were carried out. Fluorescence was acquired at the end 
of each cycle at 60°C during the amplification step. The control pair of primers used was that 
of 36B4 (ribosomal protein mRNA). All experiments were repeated at least twice. Note: RT-
qPCR was performed by the lab of Edwin Cheung, Genome Institute of Singapore, 
Singapore. 
ChIP-qPCR 
ChIP-qPCR experiments were performed against ERα, unphosphorylated RNAPII (8WG16, 
Covance), and serine-5 phosphorylated RNAPII (ab5131, Abcam). ChIP material was 
prepared from MCF-7 cells induced with estrogen for 45 min (“estrogen-treated”), as well as 
negative control MCF-7 cells induced with an equal volume of ethanol for 45 min (“ethanol-
treated”), as described earlier. ChIP material was reverse cross-linked under conditions of 1% 
SDS and 65°C, and purified using a PCR purification kit (Qiagen). Real-time PCR 
quantification was performed as described earlier. The control primer used was from Zhao et 
al., 2007 (Zhao et al. 2007). All experiments were repeated at least twice. Note: ChIP-PCR 
was performed by Pan You Fu and Shi-Chi Leow, Genome Institute of Singapore, 
Singapore. 
 
Materials and Methods for Chapter 4 
Note: There is some overlap between the Materials and Methods for Chapter 3 and 4. Where 
they are the same, reference is made to Chapter 3. The descriptions in Chapter 3 include 
slight modifications used for Chapter 4.  
ChIA-PET library construction and sequencing 
As described in “Materials and Methods for Chapter 3”. 454 pyrosequencing and Illumina 
paired end sequencing analysis was performed. In total we generated 7.4 million raw PET 
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sequences that passed Illumina’s filtering for quality base calling. We also generated 1.8 
million raw PET sequences from 454 pyrosequencing analysis. We combined these two 
libraries and removed redundant PETs, which resulted in 5.9 million total PET sequences for 
further analysis. 
H3K4me3 ChIP-Seq data 
H3K4me3 antibody (ab8580, Abcam) was used to generate ChIP-enriched DNA fragments 
for Illumina single read sequencing analysis. The H3K4me3 ChIP-Seq data was mapped to 
hg18 genome, and enrichment peaks for H3K4me3 binding were identified using ChIP-Seq 
peak calling algorithm as previously described (Chen et al. 2008b). 37,542 H3K4me3 binding 
sites were identified in the MCF-7 genome from this dataset. This dataset characterize the 
promoter status of genes in MCF-7 cells during estrogen induction, which were used to 
annotate the genes involved in ERα-mediated chromatin interactions. Note: H3K4me3 ChIP-
Seq was prepared by Roy Joseph, Genome Institute of Singapore, Singapore. 
RNAPII ChIP-Seq data 
As described in “Materials and Methods for Chapter 3”.   
DNA-PET 10 Kb insert data 
As described in “Materials and Methods for Chapter 3”.   
Microarray gene expression data to identify estrogen-regulated genes     
A comprehensive dataset of time-course microarray experiments was performed to 
investigate the effects of estrogen treatment on gene expression profiles and identify estrogen 
responsive genes. Estrogen treated (10 nM) and DMSO-mock MCF-7 cells (negative control) 
for 0, 3, 6, 9, 12, 24, and 48 hours were collected for RNA extraction and the labeled probes 
were hybridized to microarrays (HG-U133 Plus). 3 replicates were performed for each time 
point. The data was analyzed using two different time-course differential expression analysis 
methods: Pooled Variance Meta Analysis (2) and LIMMA (3) and ranked by their scores. The 
138 
 
top 5,000 probes or ~10% of all probes were obtained from each ranking and combined 
resulting in ~7,500 probes. The set was further filtered using mean inclusive Data-driven 
Smoothness Enhanced Variance Ratio Test (dSEVRAT) with dSEVRAT score > 200 
resulting in ~3700 probes. Up and down regulation for each gene was decided based on their 
trend using hierarchical clustering carried out using Eisen software(Eisen et al. 1998) 
(http://rana.lbl.gov/EisenSoftware.htm). Note: Microarray data was prepared and analyzed 
by Kartiki Desai, Jane Thomsen, Yew Kok Lee, Haixia Li, and R. Krishna Murthy 
Karuturi, Genome Institute of Singapore, Singapore.  
PET sequence analysis 
The pipeline for processing PET sequences (PET extraction and mapping) is described in 
Chiu et al., 2006 (Chiu et al. 2006). PET classification was performed as described in 
“Materials and Methods for Chapter 3”. Identification of binding sites was performed as 
described in “Materials and Methods for Chapter 3”.  We have 9,015 binding sites with a 
false discovery rate (FDR) < 0.01. Identification of ERα-mediated chromatin interactions 
using inter-ligation PETs was also performed in a similar manner as described in “Materials 
and Methods for Chapter 3”. 
Interaction complexes 
Many of the putative chromatin interactions (duplex interactions involving two anchors) 
connect to each other by overlapping anchors (anchors can be thought of the base of the 
loop). Based on such connectivity, multiple individual interactions were collapsed together 
into interaction regions. We evaluated each genomic locus using manual curation to double-
check the automatic procedure, and also determine if that particular region has structural 
rearrangements, based on the DNA-PET library data that characterized the genomic 
aberrations in MCF-7 cells. We also identified the inter-ligation PET clusters located in 
amplicon regions where complicated rearrangements often happen, and filtered them out. We 
then required that the resulting interaction regions must have 3 or more inter-ligation PETs, 
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for further specificity. The resulting 406 complex interactions and 181 duplex interactions are 
listed in the Appendix. Note: Interaction complex analysis was performed together with 
Han Xu. Manual curation was performed together with  the labs of Ruan Yijun, Wei 
Chialin, and Ruan Xiaoan.  
ERαBS association with relevant genomic features 
First, ERα binding sites were grouped into categories based on their involvement with 
interaction characteristics. A. binding sites involved in complex interactions (“strong-
interactions”), B. in single interactions (“intermediate-interactions”), C. with singleton inter-
ligation PETs that may likely represent weak interactions or random background noise 
(“weak-interactions”), and D. with no inter-ligation PETs (“no-interactions”). These data are 
listed in the Appendix. 
Next, we performed association of ERαBS with ChIP-chip data of ERα binding. We 
associated ERαBS involved in the 4 categories with the 12,193 ChIP-chip defined ER 
binding sites (Lupien et al. 2008). For analyses of the 9,015 ERαBS identified by ChIA-PET, 
a region of +100bp from the middle of the ChIA-PET-identified binding sites was used, and 
overlapped with a region of + 100 bp from the middle of the ChIP-chip-identified binding 
sites. For a random noise reference, we used regions of + 100bp from the middle of a random 
sampling of 9,015 ChIA-PET singleton mapped loci. 0.87% of the PET singletons overlapped 
with the ER ChIP-chip defined loci. We used the Fisher’s exact test to see if there is 
significant enrichment in the association levels with ERα ChIP-chip data between high-
enrichment ERαBS (≥20 PET counts per site) with high- and intermediate- interactions as 
compared with high-enrichment ERαBS (≥20 PET counts per site) with weak-interactions. 
The 2-tailed p-value is 0.08487, which is weakly significant.  
In association of ERαBS with ChIP-chip data of FoxA1 binding, we associated 
binding sites and interaction loci with FoxA1 binding sites generated using ChIP-chip 
(Lupien et al. 2008). There are 23,745 FoxA1 binding sites in the human genome. For 
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analyses of the 9,015 binding sites found by ChIA-PET, a region of + 250bp from the middle 
of the ChIA-PET-identified binding sites was used, and overlapped with a region of + 250 bp 
from the FoxA1 binding sites (FoxA1 binding sites are reported as 1 bp in size). We chose + 
250bp from the middle because FoxA1 is a different protein that might bind to ERα directly, 
or other proteins that bind to ERα in a complex; hence the FoxA1 peak might be fairly far 
away from the ERα peak. For a random noise reference, we used regions of + 250bp from the 
middle of a random sampling of 9,015 ChIA-PET singleton loci. We used the Fisher’s exact 
test to see if there is significant enrichment in the FoxA1 content between high-enrichment 
ERαBS (≥20 PET counts per site) with high- and intermediate- interactions as compared with 
high-enrichment ERαBS (≥20 PET counts per site) with weak-interactions. The 2-tailed p-
value is 5.4e
-15
, which is very significant.  
In association of ERαBS with H3K4me3 ChIP-Seq mapping sites, we associated 
binding sites and interaction loci with H3K4me3 binding sites generated using Illumina 
sequencing. There are 37,542 H3K4me3 binding sites in the human genome. For analyses of 
the 9,015 binding sites found by ChIA-PET, a region of + 250bp from the middle of the 
ChIA-PET-identified binding sites was used, and overlapped with a region of + 250 bp from 
the H3K4me3 binding site peaks (H3K4me3 peaks are 1 bp in size). We chose + 250bp from 
the middle because H3K4me3 is a histone mark that might be fairly far away from the ERα 
protein binding site peak. For a random noise reference, we used regions of + 250bp from the 
middle of a random sampling of 9,015 ChIA-PET singleton loci. We used the Fisher’s exact 
test to see if there is significant enrichment in the H3K4me3 content between high-
enrichment ERαBS (≥20 PET counts per site) with high- and intermediate- interactions as 
compared with high-enrichment ERαBS (≥20 PET counts per site) with weak-interactions. 
The 2-tailed p-value is 0.021032, which is significant.  
In association of ERαBS with RNAPII ChIP-Seq mapping sites, we associated ERα-
mediated interaction loci with RNAPII binding sites generated using Illumina sequencing. 
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We generated 13,132 RNAPII peaks in the human genome. For analyses of the 9,015 binding 
sites found by ChIA-PET, a region of + 250bp from the middle of the ChIA-PET-identified 
binding sites was used, and overlapped with a region of + 250 bp from the RNAPII binding 
site peaks (RNAPII peaks are 1 bp in size). We chose + 250bp from the middle because 
RNAPII is a different protein that might bind to ERα directly, or other proteins that bind to 
ERα in a complex; hence the RNAPII peak might be fairly far away from the ERα peak. For a 
random noise reference, we used regions of + 250bp from the middle of a random sampling 
of 9,015 ChIA-PET singleton loci. We used the Fisher’s exact test to see if there is significant 
enrichment in the RNAPII content between high-enrichment ERαBS (≥20 PET counts per 
site) with high- and intermediate- interactions as compared with high-enrichment ERαBS 
(≥20 PET counts per site) with weak-interactions. The 2-tailed p-value is 2.5e-17, which is 
significant.  
In association of ERαBS with TSS of known genes   UCSC Known Genes(Hsu et al. 
2006) (hg18) were annotated to binding sites and interaction loci if the 5’ transcription start 
sites (TSS) was located within + 20 kb from the binding site. For a random noise reference, 
we also annotated TSS located within + 20 kb from the middle of a random sampling of 9015 
ChIA-PET singleton loci. We used the Fisher’s exact test to see if there is significant 
enrichment in the RNAPII content between high-enrichment ERαBS (≥20 PET counts per 
site) with high- and intermediate- interactions as compared with high-enrichment ERαBS 
(≥20 PET counts per site) with weak-interactions. The 2-tailed p-value is 0.17652, which is 
not significant. 
 
TRANSFAC analysis  
We were interested in finding potential co-factors of ER from our data and assessing 
whether they were significantly involved in the chromatin interaction detected using the 
ChIA-PET assay. We used the presence of binding motif (as defined using TRANSFAC 
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weight matrices and criteria) as a proxy to the transcription factor binding. First, we looked 
for motifs that were enriched in the datasets of binding sites. This analysis was performed in a 
similar manner as previously described (Lin et al. 2007), except hg18 was used instead of 
hg17. In addition to finding the ERα motif, we also found many motifs that had previously 
been found to be associated with ERα binding, such as FoxA1 (Lin et al. 2007). Next, we 
looked for motifs that were enriched in ERαBS with high- and intermediate- interactions as 
compared to ERαBS with weak-interactions. To do this, we began with motifs that were 
enriched in binding sites within interaction regions, and filtered out non-vertebrate motifs, 
motifs without FDR < 0.05, and motifs with fewer than 50 sequences with at least 1 hit 
(called "hits"). On the remaining motifs, we employed Fisher’s Exact Test to determine 
which motifs were significantly enriched in the dataset of binding sites with interactions as 
opposed to those that do not. We also performed Bonferroni correction for multiple 
hypothesis testing. The TRANSFAC analysis data is in the Appendix. Note: TRANSFAC 
analysis was performed together with Vinsensius Vega, Genome Institute of Singapore, 
Singapore. 
Association of ERα-mediated chromatin interactions with genes 
Genes (UCSC Known Genes, hg18) (Hsu et al. 2006) were assigned to complex and 
standalone duplex interactions (collectively called “interaction regions”). Some genes have 
multiple alternative transcripts and thus are reflected in the genome as different gene models 
(transcription units), which are each given a different unique gene ID. These different 
transcription units may share the same gene name, but can have different features, for 
example, some transcripts might have RNAPII marks but not others. An example of such a 
gene with different gene models is GREB1. In addition, some transcription start sites from a 
particular gene might be near the interactions but not other transcription start sites belonging 
to the same gene. In order to fully capture all features of all transcript units, and obtain the 
most accurate mapping of interactions to genes, we used all gene IDs as given in the UCSC 
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Known Genes database. In the text, these different gene models which each have unique gene 
IDs as given by the UCSC Known Gene database, are called “transcription units”. 
If the 5’ transcription start site of a transcription unit falls anywhere within the interaction 
boundaries of the interaction complex plus 20 kb (20 kb upstream of the middle of the 5’-
most anchor to 20kb downstream of the middle of the 3’-most interaction anchor), then we 
assigned the associated gene as an “interaction-associated gene”. If the TSS of a 
transcription unit was within + 20 kb of the middle of any anchor in an interaction unit, the 
associated gene was assigned as an “anchor gene” otherwise it was assigned as a “loop 
gene”. If the transcription unit was not just within + 20 kb of the middle of any anchor in an 
interaction unit but also had the entire transcription unit (5’ transcription start site to 3’ 
transcription end site for that particular transcription unit) entirely wrapped up within 
interaction boundaries of the interaction unit, then the associated gene was further called an 
“enclosed anchor gene”. Otherwise, if the gene was an anchor gene but not classified as an 
“enclosed anchor gene” because none of the associated transcription units were entirely 
wrapped up within the interaction boundaries of the interaction unit, it was called a “non-
enclosed anchor gene”. The gene was marked as upregulated or downregulated based on 
whether it showed such microarray expression probes. The gene was marked as H3K4me3 
associated if the promoter (1 kb upstream and downstream of the gene transcription start site) 
had such a peak. Similarly, it was marked as RNAPII associated if the promoter (1 kb 
upstream and downstream of the gene transcription start site) had such a peak. 27 genes have 
multiple transcription units wherein one transcription unit is defined as “anchor” and one 
transcription unit is defined as “loop”. This means that one transcription unit for one gene had 
a TSS within 20 kb of an anchor, whereas another transcription unit for the same gene had a 
TSS that was not within 20 kb of an anchor. All genes are listed in the Appendix.  
Gene expression visualization and analysis     
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Gene transcription units in different categories  were clustered using Cluster version 2.11 
(http://rana.lbl.gov/eisen/?page_id=42) and visualized using TreeView version 1.60 
(November 2002) (http://rana.lbl.gov/eisen/?page_id=42) (Eisen et al. 1998). If two or more 
probes could be assigned to the same transcription unit, one probe was chosen randomly.  
Circular Chromosome Conformation Capture (4C)     
We developed a new sonication-based method for performing Circular Chromosome 
Conformation Capture (4C) (Zhao et al. 2006). Briefly, MCF-7 cells were treated as 
mentioned in the ChIP protocol up to the crosslinking step with 1% formaldehyde. An 
additional centrifugation step was performed to further clarify the supernatant by removing 
cellular debris. Aliquots were removed and diluted 10 times with Tris-HCl buffer (Qiagen, 
Buffer EB) containing 1x Protease Inhibitor Cocktail (Roche). The chromatin was incubated 
for 1h at 37°C. 1 % (final concentration) Triton X-100 was added and the chromatin material 
was allowed to stand for a further hour at 37 °C. End-blunting was performed at room 
temperature for 45 min, using the End-It DNA End-Repair Kit (Epicentre). The chromatin 
samples were diluted to 10 ml with sterile water containing 1 x Complete Protease Inhibitor 
Cocktail, and we performed ligation by adding 1000 units of T4 DNA ligase (Fermentas) and 
letting the reaction stand at 16°C overnight. 0.15 µg/µl (final concentration) of Proteinase K 
(Invitrogen) was added, and the chromatin material was reverse cross-linked at 65 °C 
overnight. The DNA was purified by phenol extraction and isopropanol precipitation, and 
treated with RNase A (Qiagen) at 37°C for 30 min. Non-circularized DNA was digested 
away by incubation with Plasmid-safe DNase (Epicentre) at 37°C overnight, and the DNA 
was re-purified by phenol extraction and isopropanol precipitation. The DNA samples were 
amplified using nested inverse PCR. Primers (1
st
 Base) had to be within 100 bp of the 
targeted ERα binding site peak and were designed using Primer3 software available from: 
http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi(Rozen et al. 2000). The 
RepeatMasker track (Smit et al. 1996-2004) in the UCSC Genome Browser 
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(http://genome.ucsc.edu/) (Karolchik et al. 2003) was used to ensure that the primers did not 
lie in repeat regions. An MJ thermocyler (GMI) and the high-fidelity DNA polymerase 
Phusion (Finnzymes) were used for the PCR reactions. The PCR program used for first-round 
amplification was: (1) 98°C for 30 s; (2) 25 cycles of 98°C for 10 s, 70°C for 30 s and 72°C 
for 30 s; (3) 72°C for 10 min; and (4) 4 °C forever. The PCR program used for second-round 
amplification was: (1) 98 °C for 30 s; (2) 25 cycles of 98 °C for 10 s and 72 °C for 1 min; (3) 
72 °C for 10 min; and (4) 4 °C forever. The resulting amplification product was run in a 6 % 
PAGE gel, and the fraction of the smear band above about 500 bp in size was excised. The 
DNA samples were sequenced using a 454 GSFLX long reads kit. Note: 4C analysis was 
performed together with Phillips Huang, Brenda Han and Charlie Lee, Genome Institute 
of Singapore. 
Fluorescence in-situ hybridization (FISH)   
For FISH studies, we chose one of the longest intrachromosomal interaction complexes, 
chr15:93128663-94685818, which is about 1.5 Mb in genomic span. This interaction involves 
many genes, including NR2F2, AK000872, AK307134, AK057337, and BC040875. For 
convenience, we refer to this interaction as the “NR2F2 interaction”. BAC probes P1, P2, and 
P3 were chosen from the list of available BACs 
(http://www.ncbi.nlm.nih.gov/projects/mapview/). P1 and P2 span a region of about 756K, 
and do not involve interactions. This is the “negative control” region. P2 and P3 span a region 
of about 966K, and involve interactions. This is the “experimental” region. MCF-7 nuclei 
were harvested by treating cells with 0.75 M KCl for 20 min at 37°C. The cells were fixed in 
Methanol/Acetic acid (3/1), and nuclei were dropped on slides for FISH. Following overnight 
culture in LB media, DNA’s BAC were extracted with Nucleobond PC500 (Macherey-
Nagel), and then labeled by nick translation in the presence of biotin-16-dUTP or 
digoxigenin-11-dUTP using Nick translation system (Invitrogen). In presence of 1µg/µl of 
Cot1DNA (Invitrogen), DNAs BAC clones were resuspended at a concentration of 5ng/µl in 
146 
 
hybridization buffer (2SSC, 10% dextran sulfate, 1X PBS, 50% formamide). Prior to 
hybridization, MCF-7 nuclei slides were treated with proteinase K (Sigma) at 37°C for 2 min 
followed by 2 1X PBS rinses (5 min at room temperature) and dehydratation through ethanol 
series (70%, 80% and 100%). Denaturated probes were applied to these pretreated slides and 
codenaturated at 75°C for 5min and hybridized at 37°C overnight. Two posthybridization 
washes were performed at 45°C in 2SSC/50% formamide for 7 min each followed by 2 
washes in 2SSC at 45°C for 7 min each. After blocking, the slides were revealed with avidin-
conjugated fluorescein isothiocyanate (FITC) (Vector Laboratories, CA) for biotinylated 
probes and anti-digoxigenin- Rhodamine for digoxigenin-labeled probes (Roche). After 
washing, slides were mounted with vectashield (Vector Laboratories, CA) and observed 
under an epifluorescence microscope (Nikon). Between 100-200 interphase nuclei were 
analyzed for each mix of probes. Fusion and colocalization spots were counted in each nuclei. 
Fisher’s Exact Test was used to evaluate whether the number of fusions were significantly 
higher when comparing the various types of cells. Comparing control probes (P1/P2) with 
experimental probes (P2/P3) in ethanol-treated (ET) cells, there is a very significant (Fisher’s 
Exact Test 2-tailed p-value = 2.39277e
-14
) enrichment in the number of fusions when 
experimental probes are used, indicating the interaction is present in ethanol-treated cells. 
Comparing control probes (P1/P2) with experimental probes (P2/P3) in estrogen-treated (E2) 
cells, there is an extremely significant (Fisher’s Exact Test 2-tailed p-value = 3.33981e-59) 
enrichment in the number of fusions when experimental probes are used, indicating the 
interaction is present in estrogen-treated cells. Comparing control probes (P1/P2) in ethanol-
treated (ET) cells with control probes (P1/P2) in estrogen-treated (E2) cells, there is a very 
weakly significant difference between the two datasets (Fisher’s Exact Test 2-tailed p-value = 
0.044127). The control site is therefore weakly estrogen-dependent. By contrast, comparing 
experimental probes (P2/P3) in ethanol-treated (ET) cells with control probes (P2/P3) in 
estrogen-treated (E2) cells, there is a significant difference between the two datasets (Fisher’s 
Exact Test 2-tailed p-value = 9.7873e
-12
). The experimental site is therefore strongly 
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estrogen-dependent – that is, the interaction is present in more of the estrogen-treated cells 
than the ethanol-treated cells. Note: FISH analysis was performed together with Valere 
Cacheux-Rataboul, Genome Institute of Singapore, Singapore. 
siRNA knockdown     
MCF-7 cells were seeded in hormone depleted medium for 1 day prior to transfection. 100 
nM siGENOME Non-Targeting siRNA Pool #1 or ER ON-TARGETplus SMARTpool 
siRNA (Dharmacon) was then transfected into MCF-7 cells using Lipofectamine 2000 
(Invitrogen) according to manufacturer’s protocol. 48 hrs following transfection, the cells 
were treated with either E2 or ethanol for 45 min (for western blot analysis, 3C and ChIP 
assays) or 8 hrs (for mRNA analysis). Total RNA was isolated with TRI® Reagent (Sigma) 
and purified using QIAGEN RNeasy. The RNA was reverse transcribed with oligo (dT)15 
primer (Promega), dNTP Mix, and M-MLV RT (Promega). Real-time PCR quantification 
was performed as described earlier. All experiments were repeated at least twice. Note: 
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